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SUMMARY
Evidence suggests that diets high in fat and calories (HFD) can induce detrimental hippocampal-
specific behavioural effects starting after as little as 24 hours on the diet. Such a rapid and region-
specific cognitive impact is unexpected given the brain is largely insulated from rapid peripheral
changes by the blood-brain barrier (BBB). Understanding why this occurs will not only add valu-
able insight into how influential diets are on our brains, but could also help explain why the hip-
pocampus appears to be one of the regions most sensitive to damage in a myriad of disease states,
most prominently in Alzheimer’s Disease.
To investigate this I compared mice fed a HFD to those fed a control diet at numerous timepoints,
and looked for changes in animal behaviour, microglial and immune responses in the brain, and
changes in the brain’s blood supply. The techniques used to do this included behavioural tests, tis-
sue immunostaining, antibody arrays, cranial window implantations, and confocal and two photon
microscopy. I compared the measures between timepoints, diets, and brain regions - the hippo-
campus, cortex, and hypothalamus - to identify which of these measures appeared to change in a
hippocampal-specific manner.
Results showed that HFD feeding disrupts the relationship between increased neural efficiency
and cognitive performance in the hippocampus, with this perhaps driving early hippocampus-
specific impairment. This disruption may be related to changes occurring in the vasculature,
where HFD-induced capillary bed structural changes increase the resistance to blood flow. Short-
term HFD feeding also led to an increased density of microglial cells. This, and the capillary
bed changes, were not region-specific, and my results suggest that these were likely translated
to hippocampus-specific cognitive deficits due to the impoverished relationship between vascular
support and neuronal metabolism in the hippocampus.
iv
Acknowledgements
First and foremost my thanks go to Catherine, my supervisor, for all the support, kind words,
and inspiration you have provided over what have been some of the most challenging years of my
life. At the start of this journey I didn’t fully appreciate just how important having a supervisor
who is not only a mentor and a leader, but also a friend (and fellow karaoke lover), would be. I
couldn’t have asked for a better guide.
I also feel privileged to have been part of the fantastic group of scientists that Catherine has
assembled. It’s special to find friends that are so supportive and inspirational, but also so much
fun. I wouldn’t trade my time in this lab for anything, and I know I am lucky to have had such
great people around me. Katie, you never failed to make me laugh and are always willing to share
interesting facts. Having your support an arm’s length away in these final months have made them
far easier to get through, and given me moments of laughter that I desperately needed. Orla, I
will always cherish your enthusiasm, kindness, laughter, and our mutual love of a milky coffee.
Though it was exhausting, lab-parenting project students with you is one of my favourite PhD
memories. Kira, I’m so grateful to have had your guidance, whether that be for programming
advice or what to make for dinner. I’ve thoroughly enjoyed having you by my side, chatting about
football, grabbing treats from the co-op, or stealing a bowl from your assortment of crockery.
Laura, since you joined the lab I’ve wondered how we ever managed without you. A significant
part of this thesis wouldn’t have been possible without the work you do, and Monday mornings are
always brighter after hearing about your adorable feline companions. Finally, Dori, your arrival in
the lab broadened our horizons and I’m so fortunate to know someone who I am always learning
from, in more ways than one. Without you we wouldn’t have the Sinterklaas tradition, or the
fantastic poems to go with it. I’m proud to have been on the same programme as you. To all of
you, thank you for making my time in the lab such a joy, and for joining the Hall lab in the first
place, otherwise I would never have had the privilege of knowing you.
To those at Sussex Neuroscience, particularly those who founded and run the PhD programme
without which I would not have these years to cherish, thank you. Not only for funding my
vresearch, or giving me the chance to take part in international conferences and training opportun-
ities, but also for allowing me to be part of such a great community. I still remember my interview
fondly, and was so impressed by the people I met that day, an impression that has only grown
over time. I would also like to thank the Ancillary Unit staff, without your support none of my
project would have been possible. To Roger, formerly of the Centre for Advanced Microscopy,
your guidance started me down this long, fluorescently-illuminated road, for which I am grateful.
To Ruth, you have been a fantastic help throughout my time at Sussex, from helping me settle
in to looking after me once I did. For doing it all with such kindness, thank you. To Hans, my
second supervisor, joint meetings with you and Catherine were always stimulating, and usually
entertaining. Without you I wouldn’t have had the basis for such a fascinating project to pursue.
To Sarah, my assessor, I always enjoyed our annual review meetings, and the enthusiasm you had
for my research and my future helped to revive me when I needed it.
To my rotation project supervisors, Jenny and Keith. Thank you for letting me work with
you. Without the experience I had in both your labs, and the people I met, my PhD journey
would never have been so enjoyable, or satisfying. I have taken my first steps in the world of
scientific publishing thanks to you, Jenny, and Keith, without your help I wouldn’t have earned the
scholarship that allowed me to chance to do so. Thank you both.
I must also thank the first friends I ever made in Brighton. Rich, Sofia, Leonie, and Ana. When
I consider how lucky I have been to have had such a fantastic supervisor, lab, and university to
work in, it seems almost excessive that my programme contemporaries are so wonderful as well. I
have such fond memories of our first year lunches together, adventures on weekend (and weekday)
evenings, and trips to Amsterdam and Lisbon. You made starting a new life in a new place much
more enjoyable than I dared hope. Rich, my fellow flapjack enthusiast, our chats on the bridge, in
the sunshine, were highlights of this last year. Ana, you have been not only a great flatmate, but
a fantastic friend. I’m very lucky to have met someone that I could share all the highs and lows
of the last four years with, and I don’t know how I would have managed without you in this final
year especially. Thank you for reigniting my passion for Harry Potter, something I never would
have guessed would be a part of the thesis writing experience.
Lastly, I have to thank my incredible parents, Graham and Gaelene. Thank you for all the
opportunities you have given me through hard work and sacrifice. I would never have been able to
complete this PhD without your unending love and support, and though I know I can never repay
you, I can make the most of what you have given me. This achievement is as much mine as it is
yours.
vi
Contents
List of Tables xii
List of Figures xiv
List of Abbreviations xvii
1 Introduction 1
1.1 Inflammation-Related Mechanisms of HFD-Induced Cognitive Deficits . . . . . 5
1.1.1 Leptin and Insulin Resistance . . . . . . . . . . . . . . . . . . . . . . . 8
1.1.2 Oxidative Stress . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
1.1.3 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
1.2 Vascular Mechanisms of HFD-Induced Cognitive Deficits . . . . . . . . . . . . . 13
1.2.1 Blood-Brain Barrier Disruption . . . . . . . . . . . . . . . . . . . . . . 14
1.2.2 Pericyte Dysfunction . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
1.2.3 Basal Hippocampal Susceptibility . . . . . . . . . . . . . . . . . . . . . 19
1.2.4 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
1.3 Aims and Hypotheses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
2 Methods 22
2.1 Animals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
2.2 Dietary Manipulations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
2.3 Novel Object-Context Recognition Task . . . . . . . . . . . . . . . . . . . . . . 23
2.4 Surgical Window Implantation Procedure . . . . . . . . . . . . . . . . . . . . . 26
2.5 In Vivo Experimental Set-up . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
2.6 Lipopolysaccharide-Induced Microglial Activation . . . . . . . . . . . . . . . . 29
2.7 Statistical Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
3 Short-Term HFD-Induced Changes in Microglial and Vascular Function 31
3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
3.1.1 Hippocampus-Specific Novel Object-Context Recognition . . . . . . . . 32
3.1.2 Microglia and Inflammation . . . . . . . . . . . . . . . . . . . . . . . . 32
vii
3.1.3 The Blood-Brain Barrier . . . . . . . . . . . . . . . . . . . . . . . . . . 33
3.1.4 Blood Supply and the Cerebrovasculature . . . . . . . . . . . . . . . . . 34
3.1.5 Aims, Hypotheses, and Experimental Approach . . . . . . . . . . . . . . 34
3.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
3.2.1 Animals, Dietary Manipulation, and Experimental Approach . . . . . . . 36
3.2.2 Immunofluorescence Protocol . . . . . . . . . . . . . . . . . . . . . . . 37
3.2.3 Antibodies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
3.2.4 Immunofluorescence Image Capture . . . . . . . . . . . . . . . . . . . . 39
3.2.5 Immunofluorescence Image Quantification . . . . . . . . . . . . . . . . 39
3.2.6 Protein Profiler Array . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
3.2.7 Statistical Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
3.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
3.3.1 Two Weeks of HFD Increases Weight Gain and the Rate of Weight Gain . 43
3.3.2 HFD Mice Trended Towards Impaired Hippocampal Cognition . . . . . . 45
3.3.3 Short-Term HFD Does Not Alter Hippocampal Protein Expression . . . . 45
3.3.4 Microglial Cell Density was Increased by HFD . . . . . . . . . . . . . . 45
3.3.5 Using Dimensionality Reduction to Create a Compound Morphology Score 48
3.3.6 Short-Term HFD Does Not Alter Microglial Morphology . . . . . . . . . 48
3.3.7 HFD Did Not Effect BBB Integrity and GLUT1 Expression . . . . . . . 48
3.3.8 Pericyte Coverage is Smallest in the Hippocampus and Resistant to Short-
Term HFD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
3.3.9 Capillary Perfusion Showed a Trend Level Reduction by HFD . . . . . . 54
3.3.10 The Hippocampus had the Smallest Capillary Radii, and Lowest Radius
Variance and Capillary Density, with Radius and Radius Variance De-
creased by Short-Term HFD . . . . . . . . . . . . . . . . . . . . . . . . 55
3.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
3.4.1 HFD Increased the Rate of Weight Gain, with Differences in Weight Emer-
ging Shortly After Beginning HFD Feeding . . . . . . . . . . . . . . . . 57
3.4.2 HFD Treatment Impairs Hippocampal Cognition . . . . . . . . . . . . . 62
3.4.3 Hippocampal Protein Levels were Unaffected by HFD and Did Not Cor-
relate with Behavioural Performance . . . . . . . . . . . . . . . . . . . . 65
3.4.4 Microglial Cell Density was Increased by HFD, Though Morphology was
Unchanged . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
3.4.5 Short-Term HFD Did Not Affect BBB Integrity . . . . . . . . . . . . . . 69
3.4.6 The Distance Between Capillary Pericytes is Greatest in the Hippocampus
and Unaffected By HFD . . . . . . . . . . . . . . . . . . . . . . . . . . 71
3.4.7 GLUT1 Levels are Unaffected by Two Weeks of HFD . . . . . . . . . . 73
3.4.8 HFD Increases Capillary Bed Resistance . . . . . . . . . . . . . . . . . 75
3.4.9 Short-Term HFD Does Not Affect Capillary Density . . . . . . . . . . . 76
viii
3.4.10 HFD Decreases Capillary Luminal Radii . . . . . . . . . . . . . . . . . 76
3.4.11 Capillary Radius Variation is Reduced by HFD . . . . . . . . . . . . . . 77
3.4.12 Two Weeks of HFD Decreases Capillary Perfusion . . . . . . . . . . . . 77
3.4.13 The Hippocampus has a Poorer Ratio of Vascular Supply to Metabolic
Demand than the Cortex . . . . . . . . . . . . . . . . . . . . . . . . . . 78
3.5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
4 In Vivo Microglial Changes 81
4.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81
4.1.1 Microglial Priming . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82
4.1.2 Phasic Inflammatory Changes . . . . . . . . . . . . . . . . . . . . . . . 82
4.1.3 Aims, Hypotheses, and Experimental Approach . . . . . . . . . . . . . . 83
4.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
4.2.1 Animals, Dietary Manipulation, and Experimental Approach . . . . . . . 85
4.2.2 Two-Photon Microscopy . . . . . . . . . . . . . . . . . . . . . . . . . . 86
4.2.3 Image Processing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87
4.2.4 Image Quantification . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87
4.2.5 Statistical Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
4.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95
4.3.1 HFD Did Not Significantly Affect Weight Gain of In Vivo Mice . . . . . 95
4.3.2 NOCR Performance was Unaffected by Diet or Surgery . . . . . . . . . 96
4.3.3 Semi-Automated Quantification of Activation-Induced Microglial Mor-
phological Changes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97
4.3.4 Inflammation Index, Diet, Region, and LPS . . . . . . . . . . . . . . . . 102
4.3.5 Microglial Process Motility . . . . . . . . . . . . . . . . . . . . . . . . 104
4.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
4.4.1 Semi-Automated Quantification of Morphological Changes . . . . . . . 111
4.4.2 LPS Induced Microglial Activation is Consistent Across Diet Groups and
Brain Regions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111
4.4.3 Microglial Activation is Resistant to 8 Weeks of HFD Feeding . . . . . . 114
4.4.4 Hippocampal Cognitive Deficits Were Not Detected Following Two Weeks
of HFD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
4.5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 120
5 In Vivo Neurovascular and Blood Supply Changes 121
5.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121
5.1.1 Aims, Hypotheses, and Experimental Approach . . . . . . . . . . . . . . 122
5.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 124
5.2.1 Animals, Dietary Manipulation, and Experimental Approach . . . . . . . 124
ix
5.2.2 Combined Laser Doppler Flowmetry/Haemoglobin Spectroscopy . . . . 125
5.2.3 Stimulation of Visual Cortex Neuronal Activity . . . . . . . . . . . . . . 125
5.2.4 Resting Data Detection . . . . . . . . . . . . . . . . . . . . . . . . . . . 126
5.2.5 CMRO2 Peak Aligned Data Extraction . . . . . . . . . . . . . . . . . . 126
5.2.6 Statistical Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 127
5.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131
5.3.1 HFD Did Not Significantly Affect In Vivo Weight Gain or NOCR Per-
formance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131
5.3.2 Neurovascular Coupling in Visual Cortex . . . . . . . . . . . . . . . . . 131
5.3.3 Resting Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136
5.3.4 Data Aligned to Peaks of Oxygen Metabolism . . . . . . . . . . . . . . . 142
5.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 147
5.4.1 Locomotion During Visual Stimulation Accelerated the Vascular Response
and Increased Blood Volume . . . . . . . . . . . . . . . . . . . . . . . . 148
5.4.2 HFD Feeding May Induce Transient, Astrocyte-Mediated, Deficits in Cor-
tical Neurovascular Coupling . . . . . . . . . . . . . . . . . . . . . . . . 149
5.4.3 The Mechanisms Driving Hippocampus-Specific Trends Over Time in
Haemodynamic Measures Are Unclear . . . . . . . . . . . . . . . . . . 150
5.4.4 Uncoupling of Oxygen Availability and Neuronal Metabolism in the Hip-
pocampus at Rest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 151
5.4.5 Neurovascular Coupling is Consistent Between Brain Regions, but Mech-
anisms Differ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 152
5.4.6 HFD Affects Cortical Neuronal Activity and Haemodynamic Regulation
at Rest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 153
5.4.7 Hippocampus-Specific HFD-Induced Vascular Dysfunction during Neur-
ovascular Coupling . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 155
5.4.8 Hippocampal Vascular Responses Correlate with NOCR Behavioural Per-
formance but not Following HFD Feeding . . . . . . . . . . . . . . . . . 157
5.5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 158
6 General Discussion 160
6.1 Main Findings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 160
6.2 Diet-Induced Weight Gain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 162
6.3 Hippocampus-Specific Cognitive Deficits . . . . . . . . . . . . . . . . . . . . . 163
6.4 Phasic Microglial Activation and Microglial Priming . . . . . . . . . . . . . . . 164
6.5 Dietary Vascular Changes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 166
6.6 Hippocampal Susceptibility . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 168
6.7 Limitations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 168
6.8 Future Directions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 170
6.9 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 171
x7 References 172
A Appendix 206
A.1 In Vivo Microglial Changes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 206
A.1.1 Components of the Inflammation Index . . . . . . . . . . . . . . . . . . 206
A.1.2 Motility Indices . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 218
A.2 In Vivo Neurovascular and Blood Supply Changes . . . . . . . . . . . . . . . . . 222
A.2.1 V1 Neurovascular Coupling . . . . . . . . . . . . . . . . . . . . . . . . 222
A.2.2 Resting Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 223
A.2.3 CMRO2 Peak Aligned Data . . . . . . . . . . . . . . . . . . . . . . . . 223
xi
List of Tables
2.1 Diet Calorie Percentages . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
2.2 Diet Ingredients . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
3.1 Summary Statistics of Mice Used in Chapter 3 . . . . . . . . . . . . . . . . . . . 37
3.2 Hippocampal Protein Levels are Unaffected by HFD . . . . . . . . . . . . . . . 46
3.3 Short-Term HFD Microglial Density Statistics . . . . . . . . . . . . . . . . . . . 47
3.4 Short-Term HFD GLUT1 Intensity Statistics . . . . . . . . . . . . . . . . . . . . 50
3.5 Short-Term HFD IgG Intensity Statistics . . . . . . . . . . . . . . . . . . . . . . 51
3.6 Short-Term HFD ISD Statistics . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
3.7 Short-Term HFD Perfusion Statistics . . . . . . . . . . . . . . . . . . . . . . . . 55
3.8 Short-Term HFD Vessel Statistics . . . . . . . . . . . . . . . . . . . . . . . . . 59
4.1 Summary Statistics of Mice Used in Chapters 4 and 5 . . . . . . . . . . . . . . . 86
4.2 Automatically Generated Microglia Morphology Measures . . . . . . . . . . . . 91
4.3 Record of Missing In Vivo Weights . . . . . . . . . . . . . . . . . . . . . . . . . 93
4.4 Morphological Measures Included in Finalised Inflammation Index . . . . . . . . 102
4.5 Inflammation Index Analysis Statistics . . . . . . . . . . . . . . . . . . . . . . . 104
4.6 Compound Motility Score Analysis Statistics . . . . . . . . . . . . . . . . . . . 108
5.1 Statistics for the Effect of Locomotion on Visually Stimulated Neurovascular Coup-
ling . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 134
5.2 Statistics for the Effect of Diet on Visually Stimulated Neurovascular Coupling . 137
5.3 Statistics for the Differences between Regions in Resting Haemodynamic Values 138
5.4 Statistics for the Effect of Diet on Resting Haemodynamic Values . . . . . . . . 141
5.5 Statistics for the Differences between Regions in Neurovascular Coupling . . . . 144
5.6 Statistics for the Effects of Diet on Neurovascular Coupling . . . . . . . . . . . . 146
A.1 Soma Area Analysis Statistics . . . . . . . . . . . . . . . . . . . . . . . . . . . 208
A.2 Maximum Branch Length Analysis Statistics . . . . . . . . . . . . . . . . . . . 208
A.3 Log-log Regression Coefficient Analysis Statistics . . . . . . . . . . . . . . . . . 211
A.4 Log-log Regression Intercept Analysis Statistics . . . . . . . . . . . . . . . . . . 211
xii
A.5 Coefficient of Variation for All Radii Analysis Statistics . . . . . . . . . . . . . . 214
A.6 Mean Radius from Circle’s Centre Analysis Statistics . . . . . . . . . . . . . . . 214
A.7 Lacunarity Analysis Statistics . . . . . . . . . . . . . . . . . . . . . . . . . . . . 217
A.8 Statistics for the Effect of LPS on Motility Indices . . . . . . . . . . . . . . . . . 219
A.9 Statistics for the Effects of Dietary Timecourse Treatment on Motility Indices . . 220
A.10 Statistics for the Effect of Two Weeks of HFD on Motility Indices . . . . . . . . 221
xiii
List of Figures
1.1 Metabolic and Motivational Regulation of Food Intake . . . . . . . . . . . . . . 5
1.2 Hypothalamic and Hippocampal Regulation of Energy Homeostasis . . . . . . . 6
1.3 HFD-Induced Inflammation Promotes Oxidative Stress . . . . . . . . . . . . . . 10
1.4 The Blood-Brain Barrier . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
2.1 Experimental Setup Schematic . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
3.1 Two Weeks of HFD Increases Weight . . . . . . . . . . . . . . . . . . . . . . . 43
3.2 HFD Impairs NOCR Performance . . . . . . . . . . . . . . . . . . . . . . . . . 44
3.3 Short-Term HFD Increases Microglial Density . . . . . . . . . . . . . . . . . . . 47
3.4 Microglial Morphology is Resistant to Short-Term Dietary Effects . . . . . . . . 50
3.5 GLUT1 Expression is Unaffected Following Two Weeks of HFD . . . . . . . . . 51
3.6 HFD Did Not Affect BBB Integrity . . . . . . . . . . . . . . . . . . . . . . . . 52
3.7 Pericyte Spacing is Greatest in the Hippocampus . . . . . . . . . . . . . . . . . 53
3.8 Short-Term HFD Reduces Capillary Perfusion . . . . . . . . . . . . . . . . . . . 56
3.9 Capillary Density, Radius, and Radius Variance, are Lowest in the Hippocampus
and Radius and Radius Variance are Reduced by HFD . . . . . . . . . . . . . . . 59
4.1 Example of Automated Morphology Measure Generation . . . . . . . . . . . . . 90
4.2 Calculation of Indices of Process Motility . . . . . . . . . . . . . . . . . . . . . 92
4.3 HFD Did Not Affect In Vivo Weight Gain . . . . . . . . . . . . . . . . . . . . . 96
4.4 NOCR Performance was Resistant to the Effects of HFD and Hippocampal Win-
dow Surgery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97
4.5 LPS Discrimination by Morphological Measures per TCA Value Trialled . . . . . 100
4.6 Inflammation Index Sensitivity by TCA Value . . . . . . . . . . . . . . . . . . . 101
4.7 Inflammation Index Sensitivity by Number of Measures Included . . . . . . . . . 101
4.8 Inflammation Index Example Cells . . . . . . . . . . . . . . . . . . . . . . . . . 103
4.9 LPS Increased the Inflammation Index, which was Resistant to Dietary Effects at
all Timepoints . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
4.10 LPS Decreases Process Motility . . . . . . . . . . . . . . . . . . . . . . . . . . 106
4.11 Trend Level Region-Specific Dietary Effects on Process Motility . . . . . . . . . 107
xiv
4.12 Process Motility is Unaffected by Diet and Lower in the Hippocampus . . . . . . 110
5.1 Experimental Setup and Example Data . . . . . . . . . . . . . . . . . . . . . . . 127
5.2 CMRO2 Peak Aligned Data Extraction . . . . . . . . . . . . . . . . . . . . . . . 128
5.3 Visual Stimulus Composite Measure PC1 Loadings by Time . . . . . . . . . . . 130
5.4 Locomotion Increases Blood Volume, Decreases Oxygen Availability, and Accel-
erates Haemodynamic Responses . . . . . . . . . . . . . . . . . . . . . . . . . . 133
5.5 HFD Feeding Induces Early Dysfunction in V1 Neurovascular Coupling During
Locomotion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 135
5.6 Three Days of HFD Prolongs Visually Stimulated Haemodynamic Responses in V1 136
5.7 Changes in V1 Neurovascular Coupling Did Not Coincide with Hippocampus-
Specific Behavioural Deficits . . . . . . . . . . . . . . . . . . . . . . . . . . . . 138
5.8 Neuronal Metabolism is Uncoupled from Oxygen Supply in the Hippocampus . . 139
5.9 Early HFD Induced Dysfunction in Resting Cortical Haemodynamic Regulation . 140
5.10 Cortical Neurovascular Coupling, Relative to the Hippocampus, Relies to a Greater
Extent on Blood Volume Regulation . . . . . . . . . . . . . . . . . . . . . . . . 143
5.11 HFD Induces Dysfunctional Haemodynamic Regulation during Hippocampal Neur-
ovascular Coupling . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 145
5.12 The Magnitude of Neuronal Activity During Peak Events Correlates Negatively
with Hippocampal Performance only in Control Animals . . . . . . . . . . . . . 147
A.1 Analysis of LPS and Dietary Effects on Soma Area. . . . . . . . . . . . . . . . . 207
A.2 Analysis of LPS and Dietary Effects on Maximum Branch Length. . . . . . . . . 209
A.3 Analysis of LPS and Dietary Effects on the Log-log Regression Coefficient. . . . 210
A.4 Analysis of LPS and Dietary Effects on the Log-log Regression Intercept. . . . . 212
A.5 Analysis of LPS and Dietary Effects on the Coefficient of Variation for All Radii. 213
A.6 Analysis of LPS and Dietary Effects on the Mean Radius from Circle’s Centre. . 215
A.7 Analysis of LPS and Dietary Effects on Lacunarity. . . . . . . . . . . . . . . . . 216
A.8 The Effect of Locomotion on V1 Neurovascular Coupling . . . . . . . . . . . . . 226
A.9 V1 Visual Stimulus Peak Values . . . . . . . . . . . . . . . . . . . . . . . . . . 227
A.10 V1 Visual Stimulus AUC Values . . . . . . . . . . . . . . . . . . . . . . . . . . 228
A.11 Regional Differences in Resting Values . . . . . . . . . . . . . . . . . . . . . . 229
A.12 Resting Values Over the Dietary Timecourse . . . . . . . . . . . . . . . . . . . . 230
A.13 Ratio of Resting Values to CMRO2 Over the Dietary Timecourse . . . . . . . . . 231
A.14 Regional Differences in CPA Data . . . . . . . . . . . . . . . . . . . . . . . . . 232
A.15 CPA Peak Values . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 233
A.16 CPA AUC Values . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 234
A.17 Peak Value Correlations with NOCR . . . . . . . . . . . . . . . . . . . . . . . . 235
A.18 AUC Value Correlations with NOCR . . . . . . . . . . . . . . . . . . . . . . . . 236
xv
List of Abbreviations
Adora2a Adenosine Receptor 2A
AgRP Agouti-Related Peptide
ARC Arcuate Nucleus
ATP Adenosine Triphosphate
AUC Area Under the Curve
BBB Blood-Brain Barrier
BCA Bicinchoninic Acid
BDNF Brain-Derived Neurotrohpic Factor
BrdU Bromodeoxyuridine
CA1 Hippocampal Cornu Ammonis 1
CBF Cerebral Blood Flow
CCR2 Chemokine Receptor Type 2
CMRO2 Cerebral Metabolic Rate of Oxygen Consumption
CMS Compound Motility Score
CNS Central Nervous System
COX-1 Cyclooxygenase 1
CPA CMRO2 Peak Aligned
CVO Circumventricular Organ
Cx3CR1 C-X3-C Motif Chemokine Receptor 1
EI Extension Index
FITC Fluorescein Isothiocyanate
GFP Green Fluorescent Protein
GLUT1 Glucose Transporter 1
HbO Oxygenated Haemoglobin
HbR Deoxygenated Haemoglobin
xvi
HbT Total Haemoglobin
HFD High Fat Diet
i.p. Intraperitoneal
IgG Immunoglobulin G
II Instability Index
IKBKB Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta
IKBKE Inhibitor of Nuclear Factor Kappa B Kinase Subunit Epsilon
IL-1 Interleukin 1
IL-1β Interleukin 1 Beta
IL-6 Interleukin 6
ISD Inter-Soma Distance
LMM Linear Mixed Model
LPS Lipopolysaccharide
LTP Long-Term Potentiation
m Minimum Value
MI Motility Index
NaF Sodium Fluorescein
NFκB Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells
NG2 Neuron-Glial Antigen 2
NI Novelty Index
NOCR Novel Object-Context Recognition
NPY Neuropeptide Y
NRF2 Nuclear Factor Erythroid 2-Related Factor 2
p Peak Value
PBS Phosphate Buffered Saline
PC1 First Principal Component
PCA Principle Component Analysis
PFA Paraformaldehyde
POMC Pro-Opiomelanocortin
PUFA Polyunsaturated Fatty Acid
RI Retraction Index
ROC Receiver Operating Characteristic
xvii
ROI Region of Interest
ROS Reactive Oxygen Species
SFA Saturated Fatty Acid
SI Stability Index
SO2 Oxygen Saturation
SOCS3 Suppressor of Cytokine Signalling 3
t2m Time to Minimum Value
t2o Time to Onset
t2p Time to Peak Value
t2r Time to Offset
TCA Target Cell Area
TLR4 Toll-like Recetor 4
TNF-α Tumour Necrosis Factor Alpha
TrkB Tropomyosin Receptor Kinase B
V1 Primary Visual Cortex
VEGF Vascular Endothelial Growth Factor
ZO-1 Zonula Occludens-1
1Chapter 1
Introduction
Modern life in many countries is linked to low levels of physical activity, and when coupled with
the easy availability of energy dense, cheap, palatable foods, can lead to an energy imbalance.
This isn’t exclusively down to poor dietary choices, as these foods can alter the brain in ways that
affect not only decision making processes but also energy homeostasis mechanisms, promoting
the further intake of calories in a positive feedback cycle. Such a relationship can promote the de-
velopment of obesity, which is a major risk factor for a host of diseases (type 2 diabetes, coronary
heart disease, depression, dementia, cancer, and all causes of death; Pi-Sunyer et al. 1998; Bhas-
karan et al. 2014; Xu et al. 2011; Luppino et al. 2010) and is on the rise. In the United Kingdom,
over 50% of the population is projected to be obese by 2050 (compared to 23% in 2004) with the
cost to the National Health Service of treating obesity and its consequences in the same year pre-
dicted to rise to £6.5 billion from £1 billion in 2007. Over the same period the wider cost to society
is expected to grow from £15.8 billion to £49.9 billion (Butland et al., 2007). Obesity is also linked
to cognitive impairment that long precedes dementia onset. Higher body mass index values are
associated with deficits in memory and executive functioning in otherwise healthy young adults,
and being obese at any two of early adulthood, early midlife, and late midlife stages, is associated
with impaired memory and executive function after adjusting for age and education (obesity and
cognitive impairment reviewed in Miller and Spencer 2014). These deficits could be linked to
obesity associated changes in the brain’s vasculature or the promotion of neuroinflammation.
Obesity is a risk factor for cardiovascular and microvascular disease and is linked to en-
dothelial dysfunction and the development of atherosclerosis. The microcirculation is critical
in nutrient exchange and oxygen supply, and obesity-associated microvascular dysfunction likely
contributes to the development of microvascular dementia. In the brain, changes in the microvas-
culature could impair neurovascular coupling - the link between neuronal activity and blood supply
2- and thus lead to vascular cognitive impairment. Given that in the brain there is no perivascular
adipose tissue, obesity induced vascular changes are likely to result from changes in neuronal/glial
metabolic activity, haemodynamic changes, or from the influence of circulating factors (obesity
and the microcirculation reviewed in Sorop et al. 2017). With regards to inflammation, this has
been described as ’metainflammation’ in obesity owing to its tonic, low-grade, multi-organ nature.
Inflammation occurs in the pancreatic islets, adipose tissue, liver, skeletal muscle, and the brain,
in the obese state (Lumeng and Saltiel, 2011). Neuroinflammation has been linked to the devel-
opment of obesity following a switch to a diet high in saturated fat and calories (HFD) in rodents
(Valdearcos et al., 2017) and has been implicated in obesity and HFD-associated cognitive impair-
ment (Miller and Spencer, 2014)
Animal models of diet-induced obesity are typically associated with HFD feeding, where
switching rodents to diets where either 45% or 60% of the total calories are derived from fat
promotes the development of obesity, which typically occurs faster on 60% diets. This is in com-
parison to normal rodent diets that are roughly 10% fat. The composition of the diets used in HFD
studies sometimes varies quite significantly, with sucrose content and the profile of fatty acids
differing (the use of HFDs in the study of obesity discussed in Speakman 2019). Generally how-
ever rodent HFDs are enriched in saturated fatty acids (SFAs) and these diets show surprisingly
rapid effects on the brain, with cognitive impairment appearing after only 24 hours (McLean et al.,
2018) and hypothalamic inflammation being detected at the same timepoint (Thaler et al., 2012).
The fact that these changes occur so rapidly in spite of the fact that the brain is largely protected
from changes in the periphery and circulation by the blood-brain barrier (BBB) is particularly
interesting. It is important to note that a typical obesogenic diet in humans consists not only of
high levels of dietary fat, but also refined carbohydrates and sugars. Though the use of a HFD,
rather than a high fat and sugar, or high sugar, diet, is more common in rodent research, evidence
suggests that all three are capable of inducing cognitive impairments (Abbott et al., 2019).
The rapid central effects of HFD feeding in rodents suggests that dietary components them-
selves may have direct effects on the brain. This certainly seems to be the case in the hypothal-
amus, a brain region with an integral role in energy homeostasis, where SFAs are shuttled after
consumption and drive microglial activation (Valdearcos et al., 2014). In doing so, SFA feed-
ing drives increased food intake in a microglia-mediated manner (Valdearcos et al., 2017). SFAs
likely enter the hypothalamus through the median eminence, a circumventricular organ (CVO)
that allows the sampling of blood content (Rodríguez et al., 2010). CVOs consist of fenestrated
capillaries that have fewer tight junctions between endothelial cells and are therefore more per-
meable (Bennett et al. 2009 in Haddad-Tóvolli et al. 2017). Here SFA activation of microglia is
3likely via toll-like receptor 4 signalling (TLR4; Milanski et al. 2009), and this promotes not only
inflammation but also microglia-dependent neuronal injury (Valdearcos et al., 2014). Short-term
HFD feeding is associated with a number of hypothalamic changes that tip the balance in favour
of energy intake, where 48-hours of HFD exposure increases the firing rate of hypothalamic orex-
igenic (appetite stimulating) agouti-related peptide / neuropeptide Y (AgRP/NPY) neurons (Wei
et al., 2015), and 24 hours of HFD leads to an increase in the mRNA levels of inflammatory mark-
ers such as the proinflammatory cytokines interleukin 6 (IL-6) and tumour necrosis factor alpha
(TNF-α). After 3 days there are increases in the mRNA levels of SOCS3 (suppressor of cytokine
signalling 3), which regulates cytokine signalling, and components of the NFκB (nuclear factor
kappa-light-chain-enhancer of activated B cells) pathway IKBKB and IKBKE (inhibitor of nuc-
lear factor kappa B kinase subunits beta and epsilon; Thaler et al. 2012). The upregulation of
SOCS3 and IKBKB/IKBKE promotes leptin and insulin signalling resistance, blunting the central
response to satiety signalling from the gut, a key component of diet induced obesity (reviewed in
Velloso and Schwartz 2011).
Dietary components likely also play a role in non-hypothalamic routes of obesogenesis. As
reviewed in Berthoud et al. (2011) obesity is associated with changes in both energy homeostasis
and reward functions (i.e. ’liking’ and ’wanting’). Whether addiction-like behaviour can be driven
by repeated exposure to palatable food is still under debate, but evidence for sucrose-associated
addiction-like behaviour exists. In rodent models, repeated access to sucrose leads to sucrose
bingeing, cross-sensitization to amphetamine-induced locomotor activity, withdrawal symptoms -
such as increased anxiety and depression (Avena et al., 2008) - and a reduced reinforcing efficacy
of normal foods (Cottone et al., 2008). These changes are associated with an upregulation of
dopamine release (Avena et al., 2008) and dopamine transporter expression (Bello et al., 2003),
as well as changes in the availability of dopamine receptors D1 and D2 in the nucleus accumbens
(Avena et al., 2008; Bello et al., 2002). Evidence for drug-addiction-like changes is weaker for
non-sweet palatable foods that are typically high in fat, but intermittent corn oil access in rats can
stimulate dopamine release in the nucleus accumbens (Liang et al., 2006).
Another brain region implicated in the development of obesity is the hippocampus. Much
like the HFD-induced positive-feedback cycle that links hypothalamic energy homeostasis to
food intake, evidence suggests that hippocampal deficits promote dysfunctional control of ap-
petite and eating behaviour. It is suggested that diets disrupts the role of the hippocampus in
determining when to start and end meals, promoting overeating, and furthering hippocampal
disruption in a vicious cycle (Hargrave et al. 2016 in Yeomans 2017). Indeed, communication
between the hippocampus and hypothalamus has been suggested to be important in the inhib-
4ition of food intake (Sweeney and Yang, 2015). In humans medial temporal lobe damage im-
pairs the use of interoceptive information regarding hunger and satiety, whilst in rats, temporary
hippocampal inactivation leads to increased food intake and weight gain (reviewed in Davidson
et al. 2019). Interestingly, HFD-induced cognitive deficits in rodents appear to be hippocampus-
specific, at least with short-term feeding. McLean et al. (2018) report deficits on tasks that
are hippocampus-specific over 2 weeks of dietary manipulation, whilst Kanoski and Davidson
(2010) demonstrated hippocampus-specific cognitive deficits following 72 hours of feeding in rats,
though cognitive impairment on hippocampus-independent tasks appeared after 30 days. In gen-
eral rodents tested on hippocampus-specific behavioural tests, such as object-place-context (Lang-
ston and Wood, 2010) and object-place recognition, show impairments following HFD treatment
(Valladolid-Acebes et al., 2013; Heyward et al., 2012), in contrast to other behavioural paradigms
that involve more distributed neural networks or non-hippocampal learning where the effects of
dietary treatment are far more inconsistent (reviewed in Cordner and Tamashiro 2015). In hu-
mans, though not looking at hippocampal-dependent memory, both five and seven days of a HFD
impaired cognitive function in healthy subjects, suggesting that rapid dietary effects on cognition
occur in humans as well. With regards to hippocampus-specific effects, subjects with a higher
dietary fat and sugar intake were suggested to be impaired on hippocampal-dependent, but not
frontal-dependent, cognitive tests. However to date it appears no studies exist in humans that have
used short-term HFD interventions to assess hippocampus-dependent cognitive changes (effect of
high fat and high sugar diets on cognition reviewed in Yeomans 2017).
The mechanisms driving early hippocampus-specific cognitive impairments resulting from a
HFD are still unclear. In contrast to the strong evidence that the rapid dietary effects seen in the
hypothalamus result from the postprandial influx of SFAs into the region (Valdearcos et al., 2014),
the hippocampus lacks a close association with any CVO and is therefore more protected from
changes in circulating factors (such as SFAs). Numerous alternative mechanisms have been pro-
posed to mediate the early hippocampus-specific effects of diet reported, and these can be broadly
categorised into vascular or inflammation related, where besides direct associations with HFD in-
duced cognitive deficits (vascular changes; Tucsek et al. 2014b, hippocampal inflammation; Liu
et al. 2014; Thirumangalakudi et al. 2008; Pistell et al. 2010), vascular and inflammatory changes
are capable of mediating the other proposed mechanisms such as leptin and insulin resistance
(McLean et al., 2018), oxidative stress, BBB impairment, changes in brain-derived neurotrophic
factor (BDNF) levels (Cordner and Tamashiro, 2015), deficits in neurovascular coupling (Sorop
et al., 2017), and pericyte dysfunction (Gomez-Smith et al., 2018). However, no studies have
looked at region-specific changes across multiple proposed mechanisms at timepoints relevant
5to the early hippocampal deficits, making it difficult to ascertain what exactly drives the rapid,
hippocampus-specific, cognitive deficits associated with HFD feeding. My PhD aimed to address
this by looking at changes in vascular and immune response in the brain following short-term HFD
feeding across the hippocampus, cortex, and hypothalamus. The goals of this were to further our
understanding of how HFDs drive obesity through their effects on the hippocampus, and to shed
light on why the hippocampus appears to be particularly susceptible to various pathologies.
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Figure 1.1: Metabolic and Motivational Regulation of Food Intake. The metabolic and motivational changes
induced by the intake of high calorie, highly palatable foods, are regulated by hypothalamic homeostatic functions
and dopaminergic neurotransmission respectively. 1. Palatable foods can stimulate reward functions, and in doing so,
promote excessive food intake. 2. Similarly, dietary components such as saturated fatty acids (SFAs) can promote
inflammation and leptin and insulin signalling resistance (Lep/Ins Res.), which along with oxidative stress (ROS; re-
active oxygen species), can alter the mechanisms responsible for energy homeostasis driving a positive feedback cycle
that promotes the development of obesity. The obese state also influences both metabolic and motivational processes.
Figure adapted from Berthoud et al. (2011).
1.1 Inflammation-Related Mechanisms of HFD-Induced Cognitive
Deficits
Obesity and HFD exposure are strongly associated with inflammatory responses. Inflammation is
typically a coordinated response to harmful stimuli that is intended to return the system to baseline
levels, and is part of the innate immune system. It is initiated by immune cells that are resident
in the damaged tissue and recognise damage signals that are either associated with pathogens or
injury to the host itself. In acute inflammatory responses the detection of these signals leads to
6Figure 1.2: Hypothalamic and Hippocampal Regulation of Energy Homeostasis. 1. The balance of activity
between AgRP/NPY and POMC neuronal populations in the hypothalamus contributes to the control of energy homeo-
stasis, where increased activity in the former generally promotes food intake, whilst in the latter this promotes en-
ergy expenditure. Leptin and insulin can cross the BBB into the hypothalamus, where leptin inhibits and promotes
AgRP/NPY and POMC activity respectively. HFD feeding promotes the entry of SFAs into the ARC, where they stim-
ulate microglial activation and inflammation that can impair neuronal leptin and insulin signalling, tipping the energy
homeostasis balance in favour of food intake. 2. The hippocampus plays a role in the regulation of appetite control and
the use of interoceptive satiety information. Here, leptin and insulin signalling modulate receptor trafficking and syn-
aptic plasticity via neuronal receptors. HFD induced inflammation leads to resistance to leptin and insulin signalling,
impairing these processes, and disrupts the physiological action of hippocampal IL-1, which under normal conditions
promotes synaptic plasticity. 3. Communication between the hippocampus and hypothalamus is important for the
appropriate inhibition of food intake. Figure created with BioRender.com.
the generation of signalling molecules, such as inflammatory cytokines, which promote increased
blood flow to the region and the infiltration of circulating leukocytes. This aids in removal of
the initial cause of the inflammation, the clearance of necrotic cells, and the promotion of tissue
repair. Inflammatory changes can however be damaging to the tissue itself, a particular problem in
conditions associated with chronic inflammation, such as obesity, where chronic, low-grade, wide-
spread, inflammation is reported. Obesity is associated with increases in the levels of circulating
cytokines and acute phase proteins, leukocyte recruitment to inflamed tissues, and the generation
7of reparative tissue responses (reviewed in Lumeng and Saltiel 2011). Obesity-associated inflam-
mation may well underlie the cognitive deficits reported, as inflammation has been proposed to
promote cognitive dysfunction and the development of dementias, with observational studies in
humans showing a consistent relationship between inflammatory markers and dementia or cog-
nitive impairment (Gorelick, 2010). Metabolic syndrome, which can be defined as a grouping of
disorders including abdominal obesity, hypertriglyceridaemia, low high-density lipoprotein levels,
hypertension, and hyperglycaemia (Yaffe et al., 2004), is associated with dementias and cognitive
impairment (Gorelick, 2010), with this primarily seen in those with high levels of inflammation
(Yaffe et al., 2004). Indeed, in HFD rodent models cognitive deficits have been linked to elevated
levels of inflammatory cytokines (Liu et al., 2014; Thirumangalakudi et al., 2008; Pistell et al.,
2010).
In order for inflammation to alter neuronal processes it has to have an impact on the brain.
Microglia are the brain’s resident immune cells, and they play important roles in brain develop-
ment, plasticity, and immune surveillance. In a physiological state they monitor synapses, remove
apoptotic debris, and play a role in synaptic pruning, using highly motile processes to survey
their local environment thereby permitting a rapid response to any changes (Norden and God-
bout, 2013). Upon inflammatory activation they become proliferative and multiply (Kettenmann
et al., 2011), as well as altering their morphology (typically from a ramified to an amoeboid shape
during strong inflammatory responses), and producing inflammatory cytokines (Hanisch and Kett-
enmann, 2007). Their activation though is not a binary process, with different stimuli eliciting
different microglial reactions. An example of this is microglial priming, where primed microglia
show signs of activation such as proliferation (priming reviewed in Li et al. 2018) though with less
distinct morphological changes (they remain highly ramified despite showing larger and less-round
somata than resting cells; Torres-Platas et al. 2014) and do not produce inflammatory cytokines
(Perry and Holmes 2014 cited by Hoogland et al. 2018). They also show an elevated degree of cy-
tokine production in response to a secondary inflammatory stimulus (microglial priming reviewed
in Perry and Holmes 2014), and microglial priming occurs both in ageing and neurodegenerative
diseases (reviewed in Tay et al. 2017; Norden and Godbout 2013; Perry and Holmes 2014).
The peripheral inflammation associated with obesity and HFD feeding could drive neuroin-
flammation through inflammation of primary afferent nerves in the periphery, the activation of
microglial cells situated at CVOs, the transport of peripheral cytokines by transporters situated
on the BBB, or the activation of interleukin 1 (IL-1) receptors on perivascular macrophages and
endothelial cells in brain venules (reviewed in Dantzer et al. 2008). Conversely, neuroinflamma-
tion can also be facilitated by the breakdown of the BBB leading to the entry of plasma-derived
8factors and toxins such as fibrinogen (Ryu and McLarnon, 2009) that can promote inflammation,
or through the direct action of dietary components such as SFAs (Valdearcos et al., 2014) on mi-
croglial signalling (Milanski et al., 2009). With regards to hippocampus-specific effects, HFD
induced cognitive deficits could be mediated in part through receptors for IL-1 that are enriched
in the hippocampus (reviewed in Parnet et al. 2002) and IL-1β , along with other proinflammatory
cytokines, has been shown to impair hippocampal-dependent learning and long-term potentiation
(LTP; Lynch 2015), and contextual (Barrientos et al., 2002) and spatial (Goshen et al., 2007)
memory. Though basal IL-1 levels are required for hippocampal-dependent memory, any devi-
ation from the physiological range has detrimental effects (Goshen et al., 2007).
Regarding the fact that HFD induced hippocampus-specific cognitive impairment occurs rap-
idly after switching diets, it is important to consider the timecourse of inflammatory changes.
Within the brain inflammation appears to occur earliest in the hypothalamus, where 24 and 72
hours of HFD feeding induced elevations in the mRNA of proinflammatory cytokines and the
density of microglia respectively (Thaler et al., 2012). Hypothalamic inflammation seems to be
followed by the hippocampus, where one week of HFD supplemented with fructose syrup led
to astrocytic activation along with evidence of microglial morphological changes (Calvo-Ochoa
et al., 2014). In the cortex no signs of inflammation, as assessed by changes in the levels of proin-
flammatory cytokine mRNA, were detected after a week of HFD (Guillemot-Legris et al., 2016),
though Denver et al. (2018) report an increased cortical microglial density after 18 days. Whilst
these results suggest that hippocampal inflammation doesn’t occur early enough to coincide with
rapid cognitive changes (that are reported after only 24 hours; McLean et al. 2018), no studies
have looked at hippocampal inflammatory changes prior to one week of HFD feeding so it still
remains a strong possibility.
1.1.1 Leptin and Insulin Resistance
Besides these proposed direct effects on hippocampal processing, inflammation may also impair
cognition by promoting resistance to both insulin and leptin signalling. Leptin and insulin re-
ceptors are highly expressed in the hippocampus, and evidence suggests that they play a role in
hippocampal-dependent learning and memory, perhaps by regulating synaptic plasticity and re-
ceptor trafficking (briefly reviewed in Cordner and Tamashiro 2015).
Leptin was initially identified as an important player in weight gain when Ingalls et al. (1950)
described a mutant mouse strain associated with severe obesity. This mutation was later found
to be associated with the leptin gene (ob; Zhang et al. 1994). Leptin is a hormone produced
9predominantly by adipose tissue and whose levels in the circulation reflects total adipose mass
(Weigle et al., 1997). Increases in leptin are associated with reductions in appetite and decreased
body weight (Morioka et al., 2016), and though it is too large to cross the BBB by diffusion,
it likely enters the brain via an adjustable, saturable transport system associated with transcellu-
lar receptors (Maness et al. 2000 cited in Gruzdeva et al. 2019). Once in the brain, leptin acts
on the hypothalamic arcuate nucleus (ARC), where both AgRP/NPY and pro-opiomelanocortin
(POMC) neurons express leptin receptors (Gautron and Elmquist, 2011). Here it promotes the pro-
duction of appetite suppressing neuropeptides and weight-reducing α-melanocytostimulating hor-
mone in POMC neurons, whilst in AgRP/NPY neurons, leptin inhibits the production of appetite-
stimulating AgRP and NPY (reviewed in Zhou and Rui 2013; Myers et al. 2008).
Insulin is secreted by pancreatic beta cells during periods of nutrient uptake and inhibits the
output of glucose by the liver whilst promoting its transport into skeletal muscle and adipose tissue.
It can cross the BBB and has receptors in the hypothalamus (Havrankova et al., 1978) where its
direct administration inhibits food intake (Hatfield et al., 1974). Deletion of the insulin receptor
in neurons increases body fat mass (Bruning et al., 2000), and resistance to the blood glucose
lowering effects of insulin (Reaven, 2005) is pervasive in obesity and precedes the development
of type 2 diabetes, which along with hyperinsulinaemia, is a risk factor for weight gain in children
and adolescents (Kolb et al., 2018). However, the anorexigenic (appetite suppressing) effects
of insulin are not always replicated (Jessen et al., 2010), and when administered peripherally
insulin increases food intake. The uncertainty regarding the role of insulin in appetite and weight
regulation suggests that it plays a minor role in comparison to leptin, though the two are likely
involved in neuronal cross-talk given that leptin signalling is enhanced if insulin is also present
(Carvalheira et al., 2001). However, there is evidence that the two act on distinct populations of
neurons with insulin hyperpolarising, and leptin depolarising, a subset of POMC cells (Williams
et al., 2010). These results highlight the fact that despite some potential mechanistic overlap
and similarity of function, leptin and insulin still appear capable of differential effects on energy
homeostasis.
Diet-induced obesity is associated with impaired responses to leptin throughout the brain
(Morabito et al., 2017) and three days of HFD in rats is sufficient to induce both central insulin
resistance, which is associated with greater caloric intake (Clegg et al., 2011), and an attenuation
of leptin-driven changes in feeding behaviour (Wang et al., 2001). This is likely the result of in-
flammation, given that the intracerebroventricular administration of a low dose of proinflammatory
tumour necrosis factor alpha (TNF-α) induces insulin and leptin resistance and shifts neurotrans-
mitter expression to an obesity-like pattern (Romanatto et al. 2007 cited in Velloso and Schwartz
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2011). Hypothalamic insulin resistance induced after only 72 hours of HFD feeding (Thaler et al.,
2012) is thought to be the result of the inflammation-driven upregulation of SOCS3 and the ser-
ine kinase IKK (Zhang et al., 2008). Inflammation-induced insulin and leptin resistance could be
mediated by signalling through TLR4 on microglia, whose activation by SFAs can result in leptin
resistance (Milanski et al., 2009). Similar HFD-induced changes in leptin signalling have been
reported in the hippocampus by Mainardi et al. (2017), and though they did not look into the pres-
ence of concurrent inflammation, work by Calvo-Ochoa et al. (2014) demonstrated the presence of
low levels of hippocampal inflammation and changes in hippocampal insulin signalling following
7 days of HFD feeding. Therefore, inflammation-induced leptin and insulin signalling resistance
in the hippocampus could play a role in the observed hippocampus-dependent cognitive deficits,
and may also promote dysfunctional regulation of eating behaviour that leads to weight gain.
Figure 1.3: HFD-Induced Inflammation Promotes Oxidative Stress. HFD feeding promotes the activation of
microglia, stimulating their proliferation and phenotypic shift from a ramified towards an amoeboid morphology. Ac-
tivated microglia act as sources of ROS, promoting oxidative stress. HFD-induced oxidative stress has been detected
in both the hippocampus and cortex, and is associated with an impairment in hippocampal neurogenesis, neuronal
plasticity, and a downregulation of BDNF expression. Figure created with BioRender.com.
1.1.2 Oxidative Stress
Oxidative stress is an imbalance in the production of reactive oxygen species (ROS) and antioxid-
ant defences. It can lead to lipid peroxidation and protein damage, where the former is associated
with changes in cell membrane fluidity, permeability, potential, and can ultimately lead to mem-
brane rupture, and the latter involves protein changes such as the addition of carbonyl groups,
or protein cross-linking or fragmentation (oxidative stress reviewed in Betteridge 2000). While
ROS generation can be driven by the oxidative metabolism of glucose (Du et al., 2000), activated
microglia can also act as sources of ROS (reviewed in Lull and Block 2010) and inflammation is
closely linked with oxidative stress (as reviewed in Mittal et al. 2014; Biswas 2016). Oxidative
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stress can impair hippocampal learning and memory, which is related to changes in neurogenesis
and spine density (Huang et al., 2015). The degree of neurogenesis in the dentate gyrus also seems
to correlate negatively with levels of IL-1β , IL-1, and TNF-α (Boehme et al. 2014 cited in Borsini
et al. 2015). HFD feeding increases the levels of oxidative stress in the hippocampus, which coin-
cides with deficits in spatial memory (Xia et al., 2015; Kishi et al., 2015; Liu et al., 2014; Molteni
et al., 2004; Cui et al., 2012) though this is not region specific given HFD-induced oxidative stress
has also been detected in the cortex (Liu et al., 2014). These cognitive effects are attenuated by
anti-oxidant treatment (Xia et al., 2015; Liu et al., 2014; Cui et al., 2012).
Besides ROS derived from activated microglia, Morrison et al. (2010) provide evidence that
HFD decreases the signalling of nuclear factor erythroid 2-related factor 2 (NRF2), a major regu-
lator of antioxidant responses, which suggests this is partly responsible for the observed oxidative
stress and cognitive impairment. It is also likely that elevated blood glucose levels associated
with HFD feeding, seen after only a week (Winzell and Ahren, 2004), accelerate glucose oxidat-
ive metabolism and in doing so elevate the production of ROS (Du et al. 2000; seen in diabetes;
Shah et al. 2013). For this to be the case, circulating hyperglycaemia would have to translate
into elevated glucose levels in the brain, a process mediated by glucose transporter 1 (GLUT1),
the main glucose transporter expressed on endothelial cells in the BBB (Vannucci et al., 1998).
GLUT1 expression is changed to maintain normoglycaemia in the brain (during fasting-associated
hypoglycaemia; Fuente-Martin´ et al. 2012) so the hyperglycaemic state associated with HFD feed-
ing would be expected to decrease its expression levels. Indeed, this occurs as expected, though
the decrease is only transient and rather than maintaining brain glucose availability, is associated
with a reduction of cerebral glucose levels (Jais et al., 2016). This suggests that HFD-induced hy-
perglycaemia is not responsible for the reported increases in oxidative stress in the brain (at least
not within the first 3 weeks), but provides evidence of HFD-driven dysfunction in brain glucose
regulation. Reduced GLUT1 levels are associated with neuronal dysfunction and degeneration and
BBB integrity is mediated by GLUT1 (Winkler et al., 2015), indicating that the transient reduction
reported by Jais et al. (2016) may have long-lasting implications for neural processing.
Oxidative stress can also impact BDNF levels during HFD feeding. BDNF modulates synaptic
plasticity and its levels are decreased by HFD in both the hippocampus (Kishi et al., 2015; Molteni
et al., 2004; Camer et al., 2015) and cortex (Kaczmarczyk et al., 2013; Pistell et al., 2010; Camer
et al., 2015). A reduction in BDNF signalling, induced either by HFD feeding (Camer et al., 2015;
Kaczmarczyk et al., 2013; Pistell et al., 2010) or antagonism of the BDNF receptor tropomyosin
receptor kinase B (TrkB; Kishi et al. 2015), is associated with cognitive impairments. This could
be related to a loss of dendritic spines (Granholm et al., 2008; Arnold et al., 2014) that has been
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reported following HFD feeding, and changes in synapsin 1 and CREB, modulators of learning
and memory, correlate with HFD-induced reductions in hippocampal BDNF levels (Molteni et al.,
2004). A study by Wu et al. (2004a) showed that the HFD-induced decrease in BDNF levels was
associated with oxidative stress and could be rescued through treatment with the anti-oxidant vit-
amin E, implicating oxidative stress as the mediator of BDNF level changes. Oxidative stress could
reduce BDNF by diminishing the activity of activator protein-1 and CREB, or impairing NMDA
function (Wu et al., 2004a). Reductions in NMDA receptor binding densities are correlated with
reduced BDNF levels in the prefrontal cortex, but not the hippocampus, following HFD feeding
(Camer et al., 2015). Inflammation can also affect BDNF expression, where the intraperitoneal
injection of proinflammatory stimuli such as IL-1β or lipopolysaccharide (LPS) decreases BDNF
mRNA levels in the hippocampus (Lapchak et al., 1993) and protein levels in the hippocampus
and cortex (Guan and Fang, 2006), though this is likely partially mediated by inflammation-driven
oxidative stress.
1.1.3 Summary
In summary, HFD-induced inflammation could influence cognition through a number of mech-
anisms. Inflammatory cytokines are involved in supporting hippocampal-dependent learning and
LTP (Goshen et al., 2007), though when present in non-physiological levels can impair these pro-
cesses (reviewed in Lynch 2015). Inflammation can also induce neuronal resistance to both leptin
and insulin signalling, two pathways that likely influence hippocampal cognition through the mod-
ulation of synaptic plasticity and receptor trafficking (briefly reviewed in Cordner and Tamashiro
2015). Finally, oxidative stress has been linked to cognitive deficits in a number of HFD stud-
ies, and has also been implicated in the HFD-induced reduction of BDNF levels, a neurotrophin
involved in modulating synaptic plasticity. Oxidative stress can be driven by inflammation.
With regards to the rapid hippocampus-specific deficits observed by McLean et al. (2018)
and Kanoski and Davidson (2010), HFD induced oxidative stress has been reported in both the
hippocampus and cortex, with the latter reported after only a week (Kaczmarczyk et al., 2013),
and in contrast to the hippocampus-specific enrichment of leptin (Scott et al., 2009) and IL-1
receptors (reviewed in Parnet et al. 2002), insulin receptors are highly expressed in both regions
(Havrankova et al., 1978). Therefore, if inflammation-related changes in insulin signalling and
oxidative stress are related to the hippocampus-specific cognitive deficits, they must demonstrate
hippocampus-specific effects. In contrast, global inflammation could drive hippocampus-specific
changes given the hippocampal enrichment of the IL-1 and leptin receptors.
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Overall, studies suggest that HFD-induced inflammation occurs in a region and time-specific
manner, though studies that compare inflammation between regions in a single model are rare. The
only study so far, to my knowledge, that has directly compared early changes in cortical and hippo-
campal inflammation is Denver et al. (2018). They showed that HFD elevated microglial densities
in both the dentate gyrus and cortex after 18 days of feeding, which, given that HFD-induced
cognitive deficits remain hippocampus-specific for 30 days (Kanoski and Davidson, 2010), sug-
gests global inflammation has greater effects on hippocampal versus cortical processing. However,
Denver et al. (2018) did not assess hippocampus-specific cognition, instead using more cortically-
dependent novel object recognition and Morris water maze tests (HFD and its effects on behaviour
reviewed in Cordner and Tamashiro 2015). As such, a direct relation between early global inflam-
mation and hippocampus-specific deficits in behaviour during HFD feeding has yet to be made.
1.2 Vascular Mechanisms of HFD-Induced Cognitive Deficits
Other possible mechanisms involved in HFD-induced cognitive deficits relate to the vasculature.
As stated previously, obesity is a risk factor for cardiovascular and microvascular disease and is
linked to endothelial dysfunction and the development of atherosclerosis. The main role of the
vasculature in the brain is to supply oxygen and nutrients and remove carbon dioxide and meta-
bolic waste products, where dysfunction in this network disrupts its ability to support neuronal
metabolism and contributes to the development cerebromicrovascular disease (microvasculature
reviewed in Sorop et al. 2017). Blood supply for the brain comes from the internal carotid arter-
ies and the vertebral arteries, which branch and combine to form the cerebral arteries, the basilar
artery, and the circle of Willis, which likely improves the chances of brain regions continuing to be
supplied with blood in the event of a major artery becoming occluded. Neurons are more sensitive
to oxygen deprivation than other cell types, so any interruption in the supply of oxygen or glucose
leads to significant damage (Purves et al., 2001). Arteries and arterioles that supply neurons pen-
etrate into the parenchyma and form a network of capillaries, with individual neurons generally
within 20 µm of a capillary. Brain vessels are composed of endothelial cells connected via tight
and adherens junctions which limit paracellular transport into the brain, though other cell types are
also intimately associated with brain vessels. Astrocytes attach end-feet to microvessels that facil-
itate their role in transporting oxygen and glucose to neurons by regulating local blood flow, with a
similar role also existing for pericytes and vascular smooth muscle cells, vascular mural cells that
wrap around vessels and through their contraction also regulate changes in flow (brain microves-
sels described in Kolinko et al. 2014). Activity-dependent changes in the blood supply in the
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brain are mediated by neurovascular coupling, the mechanism whereby local changes in neuronal
activity are coupled to regional changes in blood flow. This occurs in capillaries, and precapillary
arterioles, via interactions and metabolic signalling between neurons, astrocytes, pericytes, and
endothelial cells, with evidence suggesting the initial change in flow occurs in capillaries before
propagating upstream to arterioles (Fouda et al., 2019; Sweeney et al., 2018).
In recent years evidence regarding the importance of vascular changes in various pathologies,
such as Alzheimer’s Disease (reviewed in de la Torre 2002) and ageing (briefly summarised in
Le Couteur and Lakatta 2010) has accumulated. Reductions in cerebral blood flow (CBF) are
reported in both vascular cognitive impairment and Alzheimer’s disease, and many vascular risk
factors are also risk factors for these conditions. Increases in the measures of small vessel dis-
ease in the brain precede cognitive decline, and dementias are widely associated with vascular
dysfunction and neurovascular uncoupling (the disruption of the relationship between neuronal
activity and changes in blood flow; Fouda et al. 2019). In obesity human subjects show reduced
levels of blood flow in the brain, impaired vascular responses to vasoactive molecules, and in-
dices of cerebral microvascular disease (such as microbleeds) are more common (Sorop et al.,
2017). Obesity-associated reductions in blood flow correlate with memory impairment (Birdsill
et al., 2013). In animal models both reductions (Estato et al., 2017; Obadia et al., 2017; Tucsek
et al., 2014b) and increases (Yamamoto et al., 2019; Yi et al., 2012) in microvascular density have
been observed. A common feature is that regardless of direction, changes in vascular density are
associated with cognitive deficits (Tucsek et al., 2014b; Coucha et al., 2019). HFD associated
reductions in vascular diameter have also been reported (He et al., 2016; Constantinescu et al.,
2011), as have reductions in CBF in HFD fed rats (Glaser et al., 2012; Obadia et al., 2017).
With regards to neurovascular coupling, rodent HFD feeding is associated with a reduction in the
vascular response to neuronal activity (Tucsek et al., 2014b; Li et al., 2013) and there is strong
evidence of impairment in vasodilatory capacity in models of obesity (Chantler et al., 2015; Phil-
lips et al., 2005; Schwaninger et al., 2003) and HFD feeding (Obadia et al., 2017). However,
studies that have looked at region-specific, and early, changes in vascular structure and function
in response to a HFD are notably lacking, making it difficult to evaluate their contribution to the
rapid hippocampus-specific cognitive impairments reported.
1.2.1 Blood-Brain Barrier Disruption
The BBB is a specialised barrier that essentially isolates the CNS from the rest of the body. It
is formed of specialised endothelial cells (Wolburg and Lippoldt, 2002) with tight junction pro-
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Figure 1.4: The Blood-Brain Barrier. The BBB is a specialised barrier that limits the movement of molecules
between the brain parenchyma and the vasculature. It consists of endothelial cells connected by specialised tight junc-
tions, which inhibit the paracellular movement of molecules. Pericytes sit on the abluminal surface of the vasculature,
and play important roles in the regulation of blood flow, capillary support, and BBB integrity. Astrocytic endfeet form
an additional component of the BBB. HFD feeding can reduce BBB integrity by diminishing the expression of tight
junctions, and has been shown to reduce pericyte coverage of the vasculature. Figure adapted from Aday et al. (2016)
and created with BioRender.com.
teins, such as occludin and the claudins, being the main structures involved in barrier integrity
(Huber et al., 2001). Paracellular transport between endothelial cells is restricted by the presence
of these tight junction proteins, whilst transocytosis at the BBB is reduced relative to the periphery
and is associated with a reduction in the number of endocytic vesicles. Alterations in the integ-
rity of the BBB are associated with cognitive decline (Nation et al., 2019) and decreased BBB
integrity can be both a cause and consequence of CNS pathologies (Hawkins and Davis, 2005).
Disruption in the BBB has been linked to the hippocampus-specific cognitive deficits associated
with HFD feeding (Cordner and Tamashiro, 2015; Davidson et al., 2019), where BBB breakdown
in a hippocampus-specific manner could permit the entry of a number of plasma-derived factors
that typically generate neurotoxic products and can compromise synaptic and neuronal functions
(Zlokovic, 2008), including proinflammatory circulating factors such as plasma derived immun-
oglobulin G (IgG), thrombin, and fibrinogen (Tucsek et al., 2014a; Carreño-Müller et al., 2003;
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Davalos et al., 2012).
Reports of HFD induced BBB breakdown are widespread (Davidson et al., 2012; Chang et al.,
2014; Pallebage-Gamarallage et al., 2012; Elahy et al., 2015) and seen across a variety of differ-
ent tracers and markers of integrity (e.g. endogenous IgG and albumin leakage, entry of sodium
fluorescein (NaF) and radio-labelled sucrose) with this breakdown linked to cognitive impairment
(Kanoski et al., 2010; Davidson et al., 2012, 2013). These changes also appear to be region and
time-specific. Hippocampus-specific BBB leakage has been reported in genetically obese and
HFD fed rats (Yoo et al., 2016; Kanoski et al., 2010; Davidson et al., 2012) consistent with reports
of decreases in the levels of claudin-5 and occludin in the hippocampus (Yamamoto et al., 2019)
but not parietal cortex (Li et al., 2016) after 16 weeks of HFD feeding. At the same timepoint
Salameh et al. (2019) showed that HFD elevated levels of radio-labelled sucrose in the hippocam-
pus and hypothalamus, but not at the whole brain level, whilst radio-labelled albumin was elevated
at the whole brain level and hypothalamus but not the hippocampus. These results suggest that
HFD induced reductions in BBB integrity could indeed be hippocampus-specific, but that this
may also depend on relative permeability to the molecules in question. For example, when look-
ing either exclusively at the hippocampus or across the entire brain, only the hippocampus was
permeable to sucrose (∼342.3Da). In contrast, the hippocampus showed no entry of the larger al-
bumin molecule, which was otherwise detected at the whole brain level(∼69kDa; molecular sizes
from Saunders et al. 2015). The route of entry likely mediates this effect, where HFD could affect
trans- or paracellular transport systems differentially. Salameh et al. (2019) make the point that
both sucrose and albumin can cross the BBB using either route, and that there is no method to
clearly distinguish between these two.
The mechanism linking HFD feeding to BBB breakdown seems most likely to be oxidative
stress. The protective effect of nicotine on HFD induced BBB breakdown has been suggested
to relate to its anti-oxidant activity (Elahy et al., 2015) and anti-oxidants prevented SFA asso-
ciated BBB breakdown whilst decreasing levels of central inflammation (Takechi et al., 2013).
Resveratrol, which also has antioxidant activity, attenuates HFD induced BBB disruption (Chang
et al., 2014) though this may also relate to the resveratrol-mediated reductions in the levels of total
cholesterol and low density lipoproteins, as well as the promotion of cytoskeletal polymerisation
and adenosine triphosphate (ATP) synthesis in cerebrovascular endothelial cells (Chang et al.,
2014). Finally, antagonism of the endothelial adenosine receptor 2a (Adora2a) prevented HFD
induced BBB breakdown (Yamamoto et al., 2019). Adora2a is upregulated in brain microvessels
following 16 weeks of HFD feeding, and is suggested to promote BBB leakage by eliciting NFκB
mediated down-regulation of tight junction proteins (Yamamoto et al., 2019).
17
Whilst there is evidence that changes in the BBB could be hippocampus-specific, the time-
course of these are important if they are to be related to cognitive effects. In what appears to be
the only study that looks at BBB changes within the first week of HFD feeding, Rijnsburger et al.
(2019) noted no increase in the permeability of the hypothalamic BBB to Evans blue dye, nor any
changes in the expression levels of the tight junction proteins zonula occludens-1 (ZO-1), claudin-
5, and occludin. Evans blue is widely stated to bind to plasma albumin (Saunders et al., 2015),
and so these results may indicate an absence of large-scale BBB disruption following a week of
dietary manipulation. However, Saunders et al. (2015) make the case that there are plenty of issues
surrounding the use and interpretation of Evans blue for the assessment of BBB integrity, so these
results should be viewed cautiously. Regardless, Rijnsburger et al. (2019) provide an assessment
of BBB integrity at what appears to be the earliest documented timepoint in HFD studies, and
though their Evans blue result should be viewed cautiously, the fact they detect no hypothalamic
changes in tight junction protein levels suggests an absence of HFD induced changes in paracellu-
lar transport across the BBB. Again, however, it is important to consider that HFD induced BBB
disruption may be both time and region specific, so extrapolating these results to the hippocampus
should be done with caution.
Besides reductions in integrity, HFD feeding is also associated with impairments in receptor
mediated transport across the BBB. HFD reduces brain endothelial cell insulin uptake (Gray et al.,
2017) suggesting it may do so at the BBB in vivo, and HFD-induced impairments in the transport
of leptin into brain appear after 6 weeks (Schuster et al., 2018). The latter can be induced by
elevated circulating triglyceride levels (Banks et al., 2004). The degree of BBB leptin uptake
correlates negatively with adiposity levels and appears to develop alongside obesity, where even
modest weight reduction can improve it (Banks and Farrell, 2003), making it unlikely that impaired
BBB transport of leptin plays a role in the early stages of HFD feeding.
1.2.2 Pericyte Dysfunction
Pericytes are vascular mural cells that are a key cellular component of the BBB and sit on the
abluminal surface of microvessels. They are embedded in a common basement membrane with
endothelial cells, and wrap their processes around the endothelium (Trost et al., 2016). In areas
where a basement membrane is absent, they make direct contact with endothelial cells (Winkler
et al., 2011). Reductions in pericyte coverage correlate with increased rates of both para- and tran-
scellular transport across the BBB, which are related to decreases in the expression of tight and
adherens junction proteins (Haddad-Tóvolli et al., 2017). Pericytic coverage of the vasculature is
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reduced by HFD (Yamamoto et al., 2019; Tucsek et al., 2014b) but treatment with an Adora2a
antagonist not only attenuated this effect, it also reduced the degree of HFD-induced BBB break-
down. Whilst Adora2a is expressed on both endothelial cells and pericytes, these results indicate
that HFD-induced BBB disruption could be mediated by dietary effects on pericytes (Yamamoto
et al., 2019). These effects could be related to oxidative stress, an insult that pericytes seem partic-
ularly susceptible to. Hyperglycaemia associated oxidative stress induces cerebral pericyte death
through apoptosis in vitro (Shah et al., 2013), whilst in a mouse model of diabetes treatment with
an anti-oxidant prevented the loss of pericytes (Price et al., 2012). Though not observed directly,
these results indicate that oxidative-stress induced pericyte dysfunction could lead to BBB break-
down during HFD feeding, and in doing so may trigger further downstream detrimental effects.
If this were to occur in a region-specific manner, pericyte dysfunction might be a key driver of
hippocampus-specific dietary effects.
Besides a role in maintaining the BBB, pericytes are also key players in the regulation of blood
flow (Hall et al., 2014) and preserving cerebral circulation. Pericyte dysfunction has been implic-
ated in a number of CNS pathologies such as stroke, where their constriction and subsequent death
contributes to the no-reflow phenomenon, reducing blood flow and likely contributing to continu-
ing neuronal damage, and in diabetes, where retinal pericyte loss, which can cause local oedema,
occurs early in disease progression due to inhibited endothelial to pericyte communication. Fi-
nally, pericyte loss coincides with a loss of BBB function in Alzheimer’s Disease (reviewed in
Cheng et al. 2018). Changes in vascular densities reported in HFD models (reductions; Estato
et al. 2017; Obadia et al. 2017; Tucsek et al. 2014b, increases; Yamamoto et al. 2019; Yi et al.
2012) have been associated with cognitive deficits (Tucsek et al., 2014b; Coucha et al., 2019) and
pericytes play key roles in both the formation of new blood vessels (in part through the Ephrin-
B2 signalling pathway; Sweeney et al. 2016) and support of existing vessels, where their loss or
aberrant constriction in hypertension has been linked to the development of cerebral capillary loss
(reviewed in Hirunpattarasilp et al. 2019). Inhibition of pericyte Ephrin-B2 prevented the aberrant
neovascularisation reported by Coucha et al. (2019), whilst the loss of vessels observed by Tucsek
et al. (2014b) was suggested to relate to the loss of pericytes they observed. Pericyte loss, and
associated capillary rarefaction, have been proposed to be mediated by mechanical and oxidative
stress (briefly reviewed in Hirunpattarasilp et al. 2019). Oxidative stress in ischaemia induces ab-
errant pericyte constriction (Yemisci et al., 2009), and given that HFD feeding has been reported
to reduce blood flow and perfusion in HFD fed rats (Glaser et al., 2012; Obadia et al., 2017), its
possible that such a mechanism is also at play.
HFD induced disruptions in neurovascular coupling (Tucsek et al., 2014b; Li et al., 2013) are
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thought to lead to cognitive deficits (Sorop et al., 2017), and pericytes have been implicated in this
(Gomez-Smith et al., 2018) as well, given the role they play in regulating blood flow (Hall et al.,
2014). Whilst pericytes sit on capillaries and have protruding cell bodies with thin longitudinal
processes, they reflect an end of a spectrum of vascular mural cells that begins with the coverage
of arteries and arterioles by smooth muscle cells, which have a ring shaped morphology (pericytes
reviewed in Armulik et al. 2011). Bridging the gap between smooth muscle cells and pericytes
are cells with features of both. Though smooth muscle cells are generally acknowledged as con-
tractile, the role of pericytes in controlling cerebral blood flow has been controversial. This partly
relates to a lack of agreement on how to define the transitional cell types (Grant et al., 2019), an im-
portant distinction given that they likely have different physiological roles, with evidence strongly
supporting a contractile role for ensheathing pericytes (located on proximal branches of penetrat-
ing arteriole offshoots; Hill et al. 2015; Fernández-Klett et al. 2010) whilst for capillary pericytes
this is a more inconsistent finding (in support: Hall et al. 2014; Peppiatt et al. 2006; Kisler et al.
2017, against: Fernández-Klett et al. 2010; Wei et al. 2016; Hill et al. 2015). Studies investigating
the effect of HFD feeding on pericyte function are lacking, but given the potential heterogeneity
of function between pericyte subtypes, this is an important factor that must be considered in future
work.
1.2.3 Basal Hippocampal Susceptibility
Pericyte-related or not, disruptions in hippocampal neurovascular coupling and vascular supply
seem promising candidates for the mechanisms driving HFD induced cognitive deficits. How-
ever, the increased susceptibility of the hippocampus to damage or pathology such as hypoxia (Ng
et al., 1989), Alzheimer’s Disease, and ageing (reviewed in Fjell et al. 2014), suggests that it may
be the hippocampus itself, rather than any region-specific dietary effects, that are responsible for
hippocampus-specific changes. Evidence indicates that the enhanced susceptibility of the hippo-
campus to early damage relates to its paucity of vascular support relative to other brain regions
such as the neocortex. This is supported by findings that consistently demonstrate a lower vessel
density in the hippocampus relative to cortex (Wu et al., 2004b; Patt et al., 1997; Zeller et al.,
1997) which seems to be the case across frontal (Bohn et al., 2016; Klein et al., 1986), visual,
and auditory cortices (Klein et al., 1986). Regional vessel density and local blood flow, as well
as glucose utilisation, are correlated (Klein et al., 1986), so one might expect this to be matched
by a relatively lower level of neuronal energy demand in the hippocampus. However, it appears
that its metabolic demands are at least similar to, if not greater than, those in the cortex. Neuronal
density is reduced in the parietal and visual cortices relative to hippocampal CA1 (reviewed in
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Keller et al. 2018), and both the uptake and utilisation of glucose is seen at similar levels in the
hippocampus and the cortex (Kleinridders et al., 2018; Zeller et al., 1997). This would suggest
that the hippocampus shows a degree of uncoupling between energy demand and supply relative to
other brain areas, and this may explain its enhanced susceptibility to the early effects of numerous
brain pathologies including HFD feeding.
1.2.4 Summary
HFD feeding is associated with dysfunctional changes in the ability of the vasculature to support
neuronal activity both in a functional and structural capacity. However, no studies have invest-
igated the extent of HFD-induced vascular changes at early timepoints, nor directly compared
them between regions in a single model, so how they might relate to early hippocampus-specific
cognitive changes is unclear. Region-specific BBB disruption has also been proposed to explain
cognitive changes, where HFD induced decreases in BBB integrity appear to be dependent on the
duration of manipulation, brain region, and route of entry into the brain. Again, no studies so far
have compared early changes between regions. Pericytes are affected by long-term HFD feeding
(Tucsek et al., 2014b; Yamamoto et al., 2019) and given their involvement in numerous aspects of
vascular physiology (functional and structural regulation of the capillary bed, maintenance of BBB
integrity), any dietary effects they suffer could have a widespread impact. Once more however,
early dietary effects in pericytes have not been investigated. Finally, the possibility that global di-
etary effects are translated into hippocampus-specific changes thanks to its relatively worse level
vascular support is apparent from the literature, though no studies have yet directly compared all
of vascular structure, function, and neuronal metabolism, between the hippocampus and cortex.
1.3 Aims and Hypotheses
So far no studies exist that have compared some of the numerous mechanisms proposed to mediate
the hippocampal cognitive impairment observed in short-term HFD feeding across multiple brain
regions, despite the fact that such work is necessary in order to determine what is driving these
rapid region-specific cognitive changes. The aim of my PhD was to address this, and to evaluate
hypotheses regarding whether inflammatory and vascular changes show region and time-specific
responses to a HFD. In my first experimental chapter I describe immunofluorescence imaging
studies I undertook in mice fed a HFD for 2 weeks. Here I imaged the hypothalamus, hippo-
campus, and cortex, evaluating diet-induced changes in vascular structure, BBB integrity, pericyte
coverage, and microglial activation (assessed by their density and morphology), with the aim of
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establishing whether the suggested mechanisms were affected in a global or region-specific man-
ner at a timepoint relevant to hippocampus-specific cognitive impairment. In the second and third
experimental chapters I describe in vivo timecourse imaging studies conducted in awake, behav-
ing mice where data were collected from both the hippocampus and cortex over an 8 week HFD
feeding protocol. In addition, the mice in these chapters were tested on a hippocampus-specific
behavioural task so that their performance could be correlated with in vivo data.
The second experimental chapter discusses my investigation of changes in microglial activ-
ation in vivo, using changes in their morphology as an index of this. The aims of this were to
evaluate whether neuroinflammatory responses to HFD occur in both a time and region-specific
manner, to test a hypothesis based on work in the first experimental chapter that suggested HFD
might prime, rather than overtly activate, microglial cells, and to see if microglial activation cor-
related with hippocampus-specific cognition. In my final experimental chapter I describe my
investigation of changes in blood flow, oxygenation, and neurovascular coupling in vivo. The aims
of this were to evaluate whether HFD induced changes in these measures showed region or time-
specific patterns, to test hypotheses regarding the lack of vascular support in the hippocampus
and whether vascular structural changes detected in my immunofluorescence data correlated with
changes in blood flow and vascular function in vivo, and to investigate if hippocampus-specific
cognition correlated with any of the measures taken.
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Chapter 2
Methods
2.1 Animals
Animal procedures were carried out in accordance with the guidelines of the UK Animals (Sci-
entific Procedures) Act 1986. Mice were housed individually in a temperature controlled room
(22 +/- 2°C) with a 12 hour light/dark cycle. Mice of varied age and both sexes were used. Body
weight was monitored daily.
All mice used were bred on a C57BL/6J background. Reporter mutations used were NG2DsRe-
dBAC (NG2: Neuron-Glial Antigen 2; Zhu et al. 2008) and Cx3CR1-GFP (Cx3CR1: C-X3-C
motif chemokine receptor 1; Jung et al. 2000). NG2-DsRed positive mice constitutively express
the fluorescent DsRed protein under the NG2 promoter, which labels vascular mural cells (peri-
cytes and vascular smooth muscle cells) as well as oligodendrocyte precursor cells, though these
can be distinguished morphologically and by their position in the parenchyma. Cx3CR1-GFP ex-
pression labels microglial cells, as well as circulating monocytes and subsets of natural killer and
T cells (Imai et al., 1997). All mice with this mutation were heterozygotes. The Cx3CR1-GFP
mutation involves the knockout of one allele of the Cx3CR1 gene, and its complete knockdown of
is associated with impairments in cognition and synaptic plasticity (Rogers et al., 2011), as well
as changes in the metabolic impact of HFD feeding (Shah et al., 2015).
2.2 Dietary Manipulations
Animals had ad libitum access to water and either a HFD or control diet. For all experiments
(except one of the three immunofluorescence studies) the same combination of diets were used.
The single study differed because it was the initial pilot immunofluorescence experiment, and was
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conducted using diets purchased by the lab prior to my arrival. Following this study new diets
supplemented with the anthelmintic Fenbendazole were sourced as at the time animals throughout
the animal unit were undergoing pinworm treatment. These Fenbendazole diets were then used
throughout all other work. These diets consisted of a HFD composed of 45% calories from fat
(4.72kcal/g, Research Diets D12451-150FBZ) and a control diet that contained 10% calories from
fat (3.84kcal/g, Research Diets D12450H-150FBZ). In Chapter 3 the single immunofluorescent
pilot study that differed used a HFD composed of 45% calories from fat (4.56kcal/g, Special Diet
Services 824018) and a control diet containing 11.5% calories from fat (3.9kcal/g, OpenSource
Diets D10001). Where diets differed in an analysis this was included as a factor. The percent-
age of calories derived from protein, carbohydrate, and fat sources for each diet are presented in
Table 2.1. The ingredients in each diet as a percent of total weight are presented in Table 2.2. Di-
ets composed of 45% rather than 60% (the other commonly used HFD percentage) of total calories
from fat were used given that prior to my project this fat percentage was shown to be associated
with hippocampus-specific cognitive impairments after two weeks of feeding in unpublished work
by my lab. In addition, 45% represents a less severe distortion of dietary fat content relative to
control diets and is therefore arguably a better model of obesogenic diets in humans (Speakman,
2019).
Fenbendazole was chosen as the anthelmintic given its lack of documented interactions and
large margin of safety (Pritchett and Johnston, 2002). In a comparison of standard rodent chow
to that supplemented with Fenbendazole, no difference in eating behaviour or weight gain was
detected, though rats did show preference for the standard chow (Vento et al., 2008). The drug did
also not affect the incidence or onset of diabetes in non-obese diabetic mice (Franke and Shirwan,
2006). It was also shown to have no effect on behavioural tests involving the relationship between
a stimulus and food (Keen et al., 2005). However, there is some evidence that it promotes more
severe detrimental effects when LPS is injected into the striatum (Hunter et al., 2007) and other
studies suggest it has a degree of influence on immune responses (Yu et al., 2014; Villar et al.,
2007; Ramp et al., 2010) though at baseline this appears to not be the case (Cray et al., 2008).
2.3 Novel Object-Context Recognition Task
In order to evaluate hippocampus-specific cognition a novel object-context recognition (NOCR)
task was used. This task is a modified version of the novel object recognition paradigm, which
measures the proportion of time an animal spends with novel rather than familiar objects given
that cognitively intact animals show preferences for novelty. Though the novel object task in-
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 D12451-150FBZ
High Fat Diet
 D12450H-150FBZ
Control Diet
 824018
Pilot High Fat 
Diet
 D10001
Pilot Control Diet
Percent of calories 
from fat 45% 10% 45% 11.5%
Percent of calories 
from carbohydrates 35% 70% 35% 67.7%
Percent of calories 
from protein 20% 20% 20% 20.8%
Calorie density 
(kcal/g)
4.72 3.84 4.56 3.90
Table 2.1: Diet Calories Percentages. Table demonstrating the percentage of calories derived from fats, carbohydrates,
and proteins, in the experimental diets. Codes indicate the diet model number. Pilot indicates the diets used in the first
immunofluorescence study.
volves hippocampal processing, the prefrontal and perirhinal cortices are also involved. Given
that tasks that rely on distributed processing (in comparison to those that depend more exclus-
ively on the hippocampus) show inconsistent dietary effects (HFD behaviour studies reviewed
in Cordner and Tamashiro 2015), and my primary interest was in investigating the mechanisms
underlying hippocampus-specific cognitive impairment following HFD feeding, I opted to use a
modified version of the novel object task that measures novel object-context recognition. In this
version animals are exposed to two distinct contexts associated with discrete pairs of objects.
On testing day one object is swapped between pairs so that each context contains an object that
though familiar, is novel in that particular context. Object-context recognition is more closely as-
sociated with hippocampal cognition than simple novel object recognition, given that permanent
hippocampal lesions impair novel object-context, but not novel object, recognition (Mumby et al.,
2002). The hippocampus-specific nature of the NOCR task is supported by work demonstrating
that long-term object-context memory is reduced by the infusion of a protein synthesis inhibitor
into the hippocampus, but not the perirhinal or insular cortices, or the amygdala (Balderas et al.,
2008). NOCR impairment has been seen following only 48 hours of HFD feeding, with other
hippocampus-specific tasks showing deficits after a single day (McLean et al., 2018). The same
study showed no evidence of impaired novel object recognition over two weeks of dietary manipu-
lation, highlighting the existence of rapidly-induced, hippocampus-specific, cognitive impairment
associated with HFD feeding previously demonstrated by Kanoski and Davidson (2010). Previous
unpublished work within my lab has shown a deficit in NOCR performance in mice fed a 45%
HFD for two weeks.
NOCR behavioural analysis was carried out in arenas (35 x 35cm with 35 cm high walls). Two
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% w/w
 D12451-150FBZ
High Fat Diet
 D12450H-150FBZ
Control Diet
 824018
Pilot High Fat 
Diet
 D10001
Pilot Control Diet
Casein 23.29% 18.94% 26.51% 20.00%
Choline Bitartate 0.23% 0.19% 0.30% 0.20%
L-Cystine 0.35% 0.28% 0.40% -
DL-Methionine - - - 0.30%
Lard 20.67% 1.89% 18.00% -
Rice Starch - - 18.43% -
Corn Starch 8.48% 42.83% - 15.00%
Cellulose 5.82% 4.74% 6.16% 5.00%
Soya Oil 2.68% 2.37% 4.32% -
Corn Oil - - - 5.00%
Sucrose 20.12% 16.37% 20.34% 50.00%
Maltodextrin 11.65% 7.10% - -
Table 2.2: Diet Ingredients. The ingredients for each diet as a percentage of total weight according to the manufac-
turer’s documentation. Codes indicate the diet model number. Pilot indicates the diets used in the first immunofluores-
cence study. Dashes indicate ingredients that were not present in the diet.
different contexts were used. Context 1 had a white floor and alternating white and black walls
and was paired with an almond scent. Context 2 had a metal grid placed over the floor and had
grey walls and was paired with a lemon scent. During all habituation, training, and testing stages,
white noise was played to avoid the interference of any outside sound. Objects in each context were
placed in the top left and bottom right corners of the arenas, 10cm from the nearest walls. The
object pairs used were white salt shakers and Christmas tree baubles. These two pairs of objects
were chosen as preliminary testing showed no difference in exploratory preference between them.
Behavioural tasks were performed during the light phase and mice were placed in the center of the
arenas.
On day 11 of dietary manipulation mice were habituated to the two contexts without objects.
On days 12 and 13 mice were trained to associate the two contexts with their associated objects.
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On day 14 mice were tested by placing them in each context with one object swapped between
contexts, so that each context now contained an object that was novel but only in that context. The
order of context exposure, object set paired with each context, odour association, and location of
novel object placement on test day, were balanced across diet groups. Exposure to the contexts
at all stages (habituation, training, and testing) occurred for 10 minutes in each context, with a 5
minute break in between exposures. During this break mice were returned to their home cages
and the contexts were cleaned with ethanol to remove debris and any odour marking. Behavioural
testing was performed on mice with hippocampal window implantations as well as naive mice.
Unfortunately, mice with window implantations appeared distinct to naive mice, and the difference
in colour and texture between HFD and control diets was clear. As such, performance of the
behavioural protocol was not blind to surgical status or diet group.
Analysis of NOCR performance was done manually using videos taken on test day by logging
the beginning and end time of each interaction mice had with the objects in their environment.
Care was taken to ensure that only legitimate exploration of objects was recorded, and interactions
where mice simply climbed on the objects were ignored. This analysis was done blind to dietary
manipulation and object novelty, though not surgical status, by having a colleague rename and
reorganise the recorded video files. NOCR performance was quantified by calculating a novelty
index (NI) that represents the difference in time spent exploring the novel and familiar objects as
a proportion of total exploration time;
Nt −Ft
Nt +Ft
where Nt represents the time spent exploring the novel object and Ft the familiar object.
2.4 Surgical Window Implantation Procedure
In vivo experiments were conducted in mice implanted with windows for imaging cortical V1 and
hippocampal CA1. Mice were anaesthetized in an induction chamber with 4% isoflurane until
their breathing rate reached ∼1.5Hz at which time the isoflurane percentage was decreased to 2%
and the induction chamber was flushed for 4 seconds. The animals were then placed in a ste-
reotactic frame and secured with a heat mount (Kopf). Reflexes were checked to ensure adequate
anaesthesia levels before subcutaneous injections of 0.9% saline (400 µL), the opioid analgesic
buprenorphine (1.2 µg, 0.3mg/ml, Vetergesic, Ceva), the anti-inflammatory steroid dexamethasone
(120 µg, 2mg/ml, Dexadreson, MSD Animal Health), and the non-steroidal anti-inflammatory
meloxicam (6.2 µg, 0.5mg/ml, Metacam, Boehringer Inglehim) were administered to reduce de-
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hydration, post-operative pain, and inflammation, respectively. Temperature was maintained at
37°C throughout using a homeothermic blanket (PhysioSuite, Kent Scientific Corporation).
Hair over the skull was first trimmed using scissors, before the remaining hair was removed
with hair removal cream (Veet, Reckitt Benckiser). The exposed skin was cleaned with saline and
then sterilised with ethanol and iodopovidone (Betadine, Mundipharma). The skin and periosteum
over the skull were cut away and removed with small spring scissors and forceps across the entire
dorsal skull surface. During this process, any bleeding was minimised using absorption spears
(Fine Science Tools). Following removal, the edges of the skin were sealed to the the skull with
surgical cyanoacrylate (Vetbond, 3M) before surgical calipers and a pen were used to mark a 3mm
circle overlaying the visual cortex or hippocampus. The skull, excluding the marked region, was
then roughened using a scalpel to create overlapping scores in perpendicular directions to aid in
cement and head plate adhesion, before being covered in surgical cyanoacrylate. The mouse was
then tilted on the head mount so that the area marked for the craniotomy laid flat. The roughened
area was covered with dental cement (Unifast TRAD, GC; previously mixed with black acrylic)
and a stainless steel head plate (designed and built in the University of Sussex workshop) was
placed over the (still wet) dental cement and left for a few minutes until dry.
Following this, a dental drill (OmniDrill 35, World Precision Instruments) was used to drill
around the edges of the marked area alternating between 0.5, 0.7, and 1mm drill bits as necessary
(diameter at the tip, Fine Science Tools) ensuring that regular breaks were taken and that the area
was frequently moistened with saline to prevent overheating of the brain. The area surrounding
this was also flattened. Once the skull was thin enough, the bone was moistened with saline for
a final time and then lifted off with forceps and a microprobe. Gelfoam (Pfizer) was used to stop
any bleeding of the brain. Once bleeding halted, forceps were used to remove the dura (if it hadn’t
been removed during the craniotomy).
For visual cortex surgeries, an optical window (made from two 3mm glass coverslips and a
5mm glass coverslip, Harvard Apparatus) was placed into the craniotomy and secured using a
glass rod whilst absorption spears were used to dry the liquid surrounding the window. The edges
of the glass window were then sealed to the skull, first with surgical cyanoacrylate, then with
dental cement. For hippocampal surgeries, ∼1.5mm of cortex was aspirated (New Askir 30, CA-
MI Srl) until the striations of the corpus callosum (just above CA1 hippocampus) were visualised
(see Dombeck et al. 2010 for detailed protocol). A 3mm round stainless-steel cannula (2.4mm
ID, 3mm OD, 1.5mm height, Coopers Needle Works Ltd) with a 3mm glass coverslip attached
(Harvard Apparatus) was inserted into the craniotomy and secured. Finally, for both surgery types,
2 rubber rings were secured on top of the head plate with dental cement to allow for two-photon
28
imaging using a water-based objective. Mice were removed from the head mount attached to
the isoflurane machine and placed into a heat box (37°C) to recover, before being singly-housed
in a recovery cage. For three days following the surgery mice were given daily 10 µg doses of
meloxicam mixed into wet food mash.
2.5 In Vivo Experimental Set-up
A week after surgery mice implanted with windows for in vivo imaging were moved into a reverse
light/dark cycle so that imaging during the day would not disrupt their circadian rhythms. In vivo
imaging sessions took place at least 3 weeks following the surgery to allow enough time for the
majority of reactive gliosis to subside (astrocytic and microglial responses to the surgery subside
within 30 and 7-10 days of V1 window surgery respectively; Holtmaat et al. 2009, and 20 days of
CA1 window surgery; Gu et al. 2014). Mice were gradually habituated to the two photon setup
to reduce not only the detrimental effect of excessive movement on image collection, but also
chronic restraint stress, given chronic stress can influence microglial morphology (Hinwood et al.,
2013). This typically took place during the 3 weeks following surgery. Mice were head-fixed
underneath a two-photon microscope (Scientifica) atop of a free-moving polystyrene cylinder that
allowed voluntarily running during imaging sessions. This was fitted with a rotary encoder (Ku-
bler) to measure locomotion. A combined laser doppler flowmetry/haemoglobin spectroscopy
probe (Oxy-CBF probe; VMS Oxy, Moor Instruments) was also available to record haemody-
namic parameters. In front of the mice were two computer screens (Asus) that were dark during
microglial data acquisition and displayed drifting gratings (PsychoPy; spatial frequency of 0.04
cycles per degree, temporal frequency of 2Hz, gratings angled at 315°, bars sized at 220 degrees
of visual space at a 17cm distance from the mouse) when collecting Oxy-CBF probe recordings
from V1 window mice. Immediately prior to most imaging sessions mice were intravenously in-
jected with 2.5% (w/v) Texas Red Dextran (70kDa, neutral, Invitrogen) to label blood plasma and
visualise the vasculature. This involved warming the mice in a heat box to 37°C for 10 minutes to
dilate blood vessels and increase their accessibility in the tail, before restraining and injecting the
dye into a tail vein using an insulin syringe (BD Microfine). Alternatively, vessels were labelled
through subcutaneous injection of 2.5% (w/v) Texas Red Dextran (3kDa, neutral, Invitrogen). A
schematic of the experimental setup is presented in Figure 2.1. In vivo imaging was conducted a
day before the beginning of dietary manipulation (D-1), and then at 2, 4, and 6 hours, as well as 1,
3, 7, 10, 14, 21, 30, 35, 42, 49, and 56 days, after the onset of diet manipulation. Oxy-CBF probe
recordings were not conducted at the 2, 4, and 6 hour timepoints given they temporarily bleached
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fluorescent signal.
Figure 2.1: Experimental Setup Schematic.
2.6 Lipopolysaccharide-Induced Microglial Activation
Mice used for in vivo imaging were given intraperitoneal (i.p.) injections of LPS (O111:B4;
Sigma-Aldrich) at a dosage of 4mg/kg in 0.9% saline to induce microglial activation at the end
of imaging on the 56th day of dietary manipulation. 24 hours post-injection, two photon image
stacks of microglia and Oxy-CBF probe recordings were collected. Microglia demonstrated pro-
found morphological changes indicating an inflammatory response. Following imaging mice were
culled using a terminal dose of i.p. sodium pentobarbital (Dolethal; Vétoquinol Ltd) at 120mg/kg
(diluted to 10% in saline).
2.7 Statistical Analysis
Analysis was done using linear mixed models (LMM). Unlike ANOVAs, LMMs do not depend
on limited assumptions about the variance-covariance matrix and can accommodate missing data,
as well as allowing for the inclusion of different grouping configurations e.g. nested groups,
partially crossed groups, and crossed groups. In an LMM variables are classified as fixed factors
or random factors. Generally speaking, fixed factors are factors of experimental interest whilst
random factors are factors that include a small sample of all possible levels e.g. subject ID or
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animal number would typically be included as random factors. Random factors can have both
random intercepts and random slopes specified, allowing for them to account for an interaction
between the random factor and a fixed factor (see Magezi 2015 for its description of LMMs).
Data are reported as estimated marginal means +/- 1 standard error of the mean unless other-
wise indicated. Estimated marginal means were extracted from the relevant LMM. The threshold
for statistical significance was set at p < 0.05, with the threshold for a trend effect set at p < 0.1.
All pairwise comparisons were done with a Bonferroni correction applied. All statistical analysis
was done in R (R Core Team, 2013) in the RStudio environment (R Studio Team, 2015).
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Chapter 3
Short-Term HFD-Induced Changes in
Microglial and Vascular Function
3.1 Introduction
HFD feeding induces deficits in hippocampus-dependent cognition after only 24 hours (McLean
et al., 2018) with impairments in hippocampus-independent non-spatial memory taking 30 days
to appear (Kanoski and Davidson, 2010). The mechanisms responsible for this region-specific
effect have yet to be established, with HFD either associated with unique hippocampal changes,
or the elevated susceptibility of the hippocampus to damage (hypoxia; Ng et al. 1989, Alzheimer’s
Disease and ageing; reviewed in Fjell et al. 2014) translating global dietary effects into region-
specific cognitive impairment. These deficits have been linked to both inflammatory and vascular
changes. Inflammation could alter hippocampal processing either directly through the action of
proinflammatory cytokines (Lynch, 2015; Barrientos et al., 2002; Goshen et al., 2007) or indir-
ectly by inducing leptin and insulin resistance (briefly reviewed in Cordner and Tamashiro 2015)
or promoting oxidative stress (microglia and oxidative stress reviewed in Lull and Block 2010).
Others have suggested that changes in the vasculature such as a loss of BBB integrity (Cordner
and Tamashiro, 2015), deficits in neurovascular coupling (Sorop et al., 2017), or pericyte dysfunc-
tion (Gomez-Smith et al., 2018), could mediate the effect of HFD on cognition. I evaluated the
effect of short-term HFD-feeding on vascular and immune measures in the cortex, hippocampus,
and hypothalamus, to assess their relative contributions to the reported early cognitive deficits
and determine if they occurred in a region-specific or global manner. In addition, I tested mice
on a hippocampus-specific test of cognitive function (NOCR) and correlated this with changes in
hippocampal protein expression.
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3.1.1 Hippocampus-Specific Novel Object-Context Recognition
Tests of hippocampal function run the gamut from the Morris water maze to conditioned inhibition
tasks, though some require more distributed neural processing than others. To test hippocampus-
specific cognition I opted to use a novel object-context recognition task. In this task animals are
tested on their recognition of an object that is novel in a given context, but not novel outright.
Whilst simple novel object recognition involves hippocampal, prefrontal and perirhinal cortical
processing (novel object recognition briefly reviewed in Cordner and Tamashiro 2015), permanent
hippocampal lesions impair novel object-context but not novel object recognition (Mumby et al.,
2002). In addition, long-term object-context memory is reduced by the infusion of a protein syn-
thesis inhibitor into the hippocampus, but not the perirhinal or insular cortices, or the amygdala
(Balderas et al., 2008). McLean et al. (2018) report that HFDimpairs NOCR performance after
only 48 hours of HFD feeding with other hippocampus-specific tasks showing deficits after 24
hours, though no impairment of simple novel object recognition was seen over the two weeks of
the study.
3.1.2 Microglia and Inflammation
Neuroinflammation is associated with a decline in memory and has been linked to the cognitive
deficits seen in overweight and obese individuals (reviewed in Miller and Spencer 2014). Mi-
croglia, the brain’s resident immune cells, respond to damage and injury by proliferating and
shifting their morphology from a resting, ramified phenotype, towards an amoeboid-like struc-
ture (Hanisch and Kettenmann, 2007). Their activation is usually accompanied by the production
of cytokines, such as IL-1β and IL-6, which can disrupt the mechanisms involved in cognition
and memory (Bellinger et al., 1995; Jankowsky and Patterson, 1999; Gemma and Bickford, 2007;
Lynch, 2015). Activated microglia can also act as sources of ROS and promote oxidative stress
(reviewed in Lull and Block 2010) which has been linked to impairments in hippocampal learning
and memory. This may relate to changes in neurogenesis and spine density (Huang et al., 2015).
Inflammation can also promote the development of leptin and insulin resistance (Romanatto et al.,
2007) with their signalling pathways thought to be involved in hippocampal-dependent learning
and memory (briefly reviewed in Cordner and Tamashiro 2015).
HFD feeding is associated with both central and peripheral inflammatory responses (reviewed
in Lumeng and Saltiel 2011) where the former is driven either through the signalling of peri-
pheral cytokines (Layé et al., 1994), the breakdown of the BBB and the entry of factors like IgG,
thrombin, and fibrinogen that are proinflammatory (Tucsek et al., 2014a; Carreño-Müller et al.,
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2003; Davalos et al., 2012), or, as appears to be the case in the hypothalamus, the stimulation
of microglial TLR4 by SFAs (Milanski et al., 2009) that show postprandial influx into the region
(Valdearcos et al., 2014). Changes in microglial morphology and density have been reported in
the hypothalamus, hippocampus, and cortex, across a range of HFD studies (Thaler et al., 2012;
Calvo-Ochoa et al., 2014; André et al., 2017; Zhou et al., 2018; Denver et al., 2018) and HFD-
induced increases in the levels of proinflammatory cytokines have also been recorded (Liu et al.,
2014; Thirumangalakudi et al., 2008; Pistell et al., 2010). However, there is also evidence for an
absence of changes in cytokine levels (Kaczmarczyk et al., 2013) or microglial activation (Knight
et al., 2014; Spencer et al., 2019; Baufeld et al., 2016; Bocarsly et al., 2015) within the first 8
weeks of HFD feeding.
3.1.3 The Blood-Brain Barrier
The BBB isolates the CNS from the rest of the body and is formed of specialised endothelial
cells (Wolburg and Lippoldt, 2002) and tight junction proteins that are involved in barrier integrity
(Huber et al., 2001). HFD-induced BBB breakdown has been associated with cognitive decline
(Davidson et al., 2012; Kanoski et al., 2010) and is a hallmark of a number of CNS pathologies (re-
viewed in Hawkins and Davis 2005). The detection of endogenous IgG in the brain has been used
to indicate BBB leakage (Saunders et al., 2015), and HFD-induced BBB breakdown has been seen
to occur in number of studies (Davidson et al., 2012; Chang et al., 2014; Pallebage-Gamarallage
et al., 2012; Elahy et al., 2015; Kanoski et al., 2010) with reports showing hippocampus-specific
decreases in BBB integrity (Davidson et al., 2012; Kanoski et al., 2010) and reductions in the ex-
pression of tight junction proteins (hippocampus; Yamamoto et al. (2019); but not parietal cortex;
Li et al. 2016).
Pericytes are vascular mural cells that not only regulate blood flow (Hall et al., 2014) but also
maintain the integrity of the BBB. Reductions in their coverage of the vasculature correlate with
increased rates of transport across the BBB and decreases in the expression of tight and adherens
junction proteins (BBB reviewed in Haddad-Tóvolli et al. 2017). Models of pericyte deficiency
clearly demonstrate the importance of pericytes in preventing neurodegeneration, with their loss
promoting neuronal damage either through BBB disruption or leading to dysregulation of blood
flow and the maintenance of normoxia (the role of pericytes in health and disease reviewed in
Winkler et al. 2011). HFD feeding reduces their vascular coverage (Yamamoto et al., 2019; Tucsek
et al., 2014b) and this correlates with the degree of cognitive impairment (Tucsek et al., 2014b).
GLUT1 plays a vital role in the transport of glucose into the brain and is situated at the BBB
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(Vannucci et al., 1998) where it also plays a role in the maintenance of BBB integrity (Wink-
ler et al., 2015). GLUT1 expression is altered to maintain constant levels of glucose availability
(Fuente-Martin´ et al., 2012) and it is sensitive to changes in oxygenation, with its levels increasing
in response to hypoxia (Harik et al., 1996). GLUT1 expression is transiently decreased by HFD
feeding, which correlates with a reduction in brain glucose levels (Jais et al., 2016). In a combined
HFD and stroke model, this transient GLUT1 reduction was proposed to compromise tissue viab-
ility and lead to elevated levels of cell death following ischaemia (Haley et al., 2019), suggesting
a HFD-induced and GLUT1-mediated increase in the susceptibility of neurons to damage could
play a role in HFD-induced cognitive deficits.
3.1.4 Blood Supply and the Cerebrovasculature
Recent years have seen the importance of the vascular changes underlying pathologies such as
Alzheimer’s Disease (reviewed in de la Torre 2002) and ageing (briefly summarised in Le Couteur
and Lakatta 2010) emphasised. Changes in the vasculature can impair the mechanisms that sup-
port neuronal metabolism through nutrient exchange and waste removal. HFD feeding has been
shown to reduce vascular diameters (He et al., 2016; Constantinescu et al., 2011) and levels of
blood flow (Glaser et al., 2012; Obadia et al., 2017), and though both increases and decreases
in vascular density have been reported (decreases; Estato et al. 2017; Obadia et al. 2017; Tuc-
sek et al. 2014b, increases; Yamamoto et al. 2019; Yi et al. 2012), they are both associated with
cognitive impairment (Tucsek et al., 2014b; Coucha et al., 2019). Whilst the latter likely leads to
cognitive impairment by reducing blood flow and metabolic support for neural signalling (Tucsek
et al., 2014b), the former could be linked to unorganised, poorly perfused, leaky new vessels (as
seen with upregulated vascular endothelial growth factor (VEGF) expression) that promote neur-
onal dysfunction (Coucha et al., 2019). HFD also impairs neurovascular coupling (Tucsek et al.,
2014b; Li et al., 2013) and the ability of the vasculature to dilate in response to vasoactive signals
(Obadia et al., 2017).
3.1.5 Aims, Hypotheses, and Experimental Approach
A number of mechanisms have been proposed to mediate the detrimental effect of HFD on cog-
nition. However, few studies exist that have investigated these mechanisms at early enough
timepoints in the hippocampus to be relevant to the rapid cognitive changes reported. As such,
a significant gap in our understanding of the early effects of HFD feeding exists. Though Calvo-
Ochoa et al. (2014) showed that HFD induces low levels of hippocampal inflammation after a
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week of feeding, this is still too delayed to relate to the cognitive deficits seen after only 24 hours
(McLean et al., 2018). Similarly, with regards to vascular changes, only GLUT1 expression has
been evaluated within the first few days of dietary manipulation (Jais et al., 2016), with studies
looking at changes in BBB integrity, pericyte coverage, and vascular structure and function within
the first two weeks of dietary manipulation notably scarce or absent entirely. The earliest time at
which BBB-related changes have been analysed appears to be one week, though this was limited
to the hypothalamus (Rijnsburger et al., 2019).
I had multiple aims with the work presented in this chapter. The first was to investigate in-
flammatory and vascular changes that could be responsible for HFD-related cognitive impairment
at an early timepoint in the hippocampus, in order to address the lack of studies that have looked
at early hippocampal changes. Secondly, by investigating the hypothalamus, hippocampus, and
cortex, I aimed to evaluate whether changes were taking place globally, or in a region-specific
manner. In this way I could establish whether HFD-induced hippocampus-specific cognitive de-
ficits were the result of hippocampus-specific dietary effects, or the translation of global effects
into hippocampus-specific neuronal dysfunction owing to its enhanced susceptibility to pathology.
Thirdly, I tested mice on the hippocampus-specific NOCR task with the aim of replicating previous
unpublished work in may lab showing a deficit induced by HFD feeding, and correlating behavi-
oural performance with protein levels from hippocampal lysates. Finally, I wanted to investigate if
the reporter mutation I planned to use in future in vivo experiments (heterozygous Cx3CR1-GFP
expression) influenced the effects of HFD feeding.
To achieve these aims I fed mice a HFD or control diet for two weeks. I chose the two week
timepoint given this was the duration of feeding used in previous unpublished work from my group
that showed a detrimental effect of HFD on NOCR, and this represents a time where cognitive
impairments are still hippocampus-specific (Kanoski and Davidson (2010) suggests that HFD-
induced cognitive impairments are hippocampus-specific for up to 30 days). This approach al-
lowed me to investigate the relative importance of diet-induced inflammatory and vascular changes
to early hippocampus-specific cognitive impairment. At the two week timepoint I tested mice on
the NOCR task before using their hippocampal lysates to investigate correlations between beha-
vioural performance and changes in the expression of a range of hippocampal proteins, including
proinflammatory cytokines. In addition, I carried out post-mortem brain slice immunofluorescent
analyses on three separate cohorts of mice to compare dietary effects between the cortex, hip-
pocampus, and hypothalamus. Microglial activation, BBB integrity, pericyte coverage, GLUT1
expression, and capillary structure were quantified. Microglial activation was assessed by cal-
culating their density and comparing their morphologies, and BBB integrity was determined by
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measuring the levels of extravasated endogenous IgG. Pericyte coverage was quantified by meas-
uring the distance between adjacent pericytes, and changes in the capillary bed were evaluated by
measuring capillary density, radius, radius variance, and the proportion of capillary length perfused
by a fluorescent gelatin perfusate. To address my final aim, I included a cohort of Cx3CR1-GFP
heterozygotes in my immunofluorescence experiments.
3.2 Methods
3.2.1 Animals, Dietary Manipulation, and Experimental Approach
Details of animal genotypes, diets used, and behavioural testing, are presented in the main meth-
ods (Chapter 2). Results from two separate cohorts of mice are discussed in this chapter. Im-
munofluorescence data were collected from NG2-DsRed, and joint NG2-DsRed / Cx3CR1-GFP
mutants. Where genotype differed in a given analysis it was included as a factor. The majority of
data were collected from NG2-DsRed mice, with the joint NG2-DsRed / Cx3CR1-GFP mutants
used in order to investigate the effect of the partial knockdown of the Cx3CR1 gene associated
with the Cx3CR1-GFP mutation on responses to HFD feeding. This was important as the in vivo
work described in the next two chapters is based on Cx3CR1-GFP mice, and prior to undertaking
the in vivo work I wanted to investigate whether this mutation was associated with differential
dietary effects.
Behavioural testing was conducted after I had completed my immunofluorescence experi-
ments. This was done on a cohort of wild type C57BL/6J mice as well as Cx3CR1-GFP mutants
that had received hippocampal window implantations and were being used for in vivo imaging
experiments. To relate behavioural performance to protein expression data, behavioural analysis
in this chapter was limited to 8 of the wild type mice that had hippocampal tissue collected for
protein expression analysis. This involved excluding one wild type mouse from analysis, the de-
tails of which are in the statistical analysis section. Mice were given ad libitum access to water
and either a HFD or control diet for two weeks and weighed daily, though the time of day at which
weights were taken varied. Summary statistics of age, sex, and genotype split between the im-
munofluorescence and protein array / behavioural cohorts are displayed in Table 3.1. The issues
regarding the use of mice varying in age, sex, and genotype, are described in the discussion.
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Protein Array / NOCR Cohort Immunofluorescence Cohort
Genotype 
(Wild Type / NG2-DsRed / Cx3CR1-GFP) 8/0/0 0/44/18
Count (HFD) 8 (4) 62 (31)
Male : Female 5 : 3 27 : 35
Mean Age +/- SD (Weeks) 12.36 +/- 2.04 16.20 +/- 9.32
Table 3.1: Summary Statistics of Mice Used in Chapter 3. Statistics are presented split by cohort. Genotype
indicates the number of mice of each genotype used, where Cx3CR1-GFP refers to joint NG2-DsReD/Cx3CR1-GFP
mutants. Count indicates the total number of mice with those fed a HFD denoted in parentheses. Male : Female
displays the ratio of male to female mice. Age represents age at the start of dietary manipulation, and is presented as
the mean +/- 1 SD in units of weeks.
3.2.2 Immunofluorescence Protocol
For immunofluorescence imaging, at the end of the two weeks of dietary manipulation animals
were i.p. injected with sodium pentobarbital (Dolethal; Vétoquinol Ltd) at 120mg/kg (diluted
to 10% in saline). Once unresponsive to noxious stimuli, the chest cavity was opened and a
needle was placed into the left ventricle. The right atrium was then cut before the animals were
transcardially perfused with ice cold 0.1M phosphate buffer saline (PBS) for 5 minutes at a flow
rate of 5ml/min (this flow rate was used for all perfusion steps).
Following the perfusion of ice cold PBS, animals were perfused with 75ml of ice cold 4%
paraformaldehyde (PFA; Sigma-Aldrich) in 0.1 M PBS before this was switched to 10ml of PBS
maintained at 30°C. This was followed by 15ml of a solution composed of 0.2% fluorescein iso-
thiocyanate (FITC) conjugated albumin (Sigma-Aldrich) in 5% gelatine (Sigma-Aldrich) in PBS
kept at 30°C. This was prepared according to the method in Lugo-Hernandez et al. (2017). Briefly,
gelatin powder was dissolved in 0.1M PBS at 60°C, before the solution was cooled to 40°C with
constant stirring. At this point the FITC-conjugated albumin was added before the solution was
filtered through filter paper (GE Whatman) and stored at 30°C to prevent setting. After FITC-
conjugated albumin perfusion, animals were placed head down on ice for 30 minutes to allow the
gelatin solution to set. After setting brains were extracted and fixed in 4% PFA at 4°C overnight.
Brains were then rinsed with PBS before being stored in a 30% sucrose and 0.1% sodium azide
(Sigma-Aldrich) solution at 4°C for 48 hours. Coronal brain slices were then cut at 200 µm thick-
ness using a vibrotome (Leica). This thickness was chosen to preserve the labelled vascular net-
work within each slice.
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All following steps were performed with gentle agitation with slices free-floating in 24 well
plates. Slices were washed in PBS for three cycles at 10 minutes per cycle, before they were
incubated in a blocking / permeabilisation solution (10% normal goat serum (Vector Laboratories),
0.05% Triton X-100 (Sigma-Aldrich), and 0.2M glycine (Sigma-Aldrich) in PBS) for 3 hours at
room temperature. Following this, they were incubated with primary antibodies at appropriate
dilutions in the blocking / permeabilisation solution overnight at room temperature before being
washed in PBS for three cycles at 10 minutes per cycle. Incubation of slices with secondary
antibodies diluted appropriately in PBS then took place at room temperature for 4 hours, before
a final wash with PBS for three cycles at 10 minutes per cycle. Slices were mounted on slides
(SuperFrost, Thermo Scientific) with coverslips (Menzel 24 x 60 mm 0.13 - 0.16mm, Thermo
Scientific) using HardSet Vectashield (Vector Laboratories). Slides were modified with buffers
made of 200 µm thick double sided tape (FiveSeasonStuff Limited) to minimise compression and
distortion of the slices by coverslips.
Differences Between Immunofluorescence Studies
The immunofluorescence protocol for the first 14 mice analysed differed slightly. In this case, per-
fusion proceeded directly from ice cold PBS to FITC-conjugated albumin. Immediately after the
gelatin had set, instead of incubating brains in PFA, they were extracted and sliced on the vibro-
tome prior to the slices being incubated free-floating in 500 µL of 4% PFA for 30 minutes before
being washed three times for ten minutes per wash with PBS. At this point the slices were subjec-
ted to the same washing, blocking/permeabilisation, and antibody incubation steps. Additionally,
the slides used for imaging did not have the 200 µm buffers. These methodological differences
were accounted for in the statistical analysis of results.
The protocol also differed slightly for the NG2-DsRed/Cx3CR1-GFP mice, given the overlap
in emission spectra between FITC and GFP. These mice had their brains collected and stored in
PFA immediately after termination of the PFA perfusion step, and were not perfused with the
FITC-conjugate solution.
3.2.3 Antibodies
Primary antibodies used were rabbit anti-Iba1 (1:1000, Synaptic Systems, 234 003; 1:500, WAKO,
019-19741), biotinylated horse anti-mouse IgG (1:500, Vector Laboratories, BA-2000), and rabbit
anti-GLUT1 (1:500, Abcam, ab15309). Secondary antibodies used were goat anti-rabbit Alex
Fluor 405, 647, 633 (1:1000, Invitrogen; A31556, A21245, A21071), and streptavidin Alexa Fluor
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647 (1:500, Invitrogen, S32357).
3.2.4 Immunofluorescence Image Capture
All imaging was done blind to mouse identity and dietary manipulation. Images were taken using
a 20X objective (HC PL APO CS2 20X/0.75, Leica Microsystems) on an inverted Leica SP8
TCS confocal microscope (Leica Microsystems). Continuous wave lasers with 405, 488, 561,
and 633 nm excitation wavelengths were used. Images were collected using a 1024 x 1024 pixel
matrix with line averaging of 16, and a depth of 8-bit. Images were collected in z-stacks with a z
distance of 0.69 µm, and pixel sizes in the x and y directions of 0.57 µm. All image analysis was
done using the Fiji distribution of ImageJ (Schindelin et al., 2012). Given results are presented as
a combination of three separate immunofluorescence studies, different levels of laser power and
photodetector gain were used. This was accounted for in the statistical analysis of results.
Three z-stacks were taken for each brain region (hippocampus, cortex, and hypothalamus)
for each animal, with each region only being imaged a single time per slice. Generally, imaging
and analysis was restricted to hippocampal CA1, cortical V1, and the hypothalamic ARC, though
occasionally adjacent subregions were included.
Pericyte coverage was quantified in NG2-DsRed mice. Microglial density and morphology
was quantified using Iba1 staining of slices, or through the endogenous expression of Cx3CR1-
GFP. GLUT1 and IgG staining intensity were analysed in slices incubated with anti-GLUT1 and
anti-mouse IgG antibodies. Vascular morphology was assessed in slices where vessels had been
labelled through the perfusion of FITC-conjugated albumin.
3.2.5 Immunofluorescence Image Quantification
Image analysis was done blind to mouse identity and dietary manipulation. NG2-labelled pericytes
were identified by their distinct morphology and association with blood vessels, and assessed using
the criteria outlined in Grant et al. (2019). Pericyte coverage was quantified by measuring the
inter-soma distance (ISD) between adjacent pericytes. This was only done for NG2 positive cells
present on vessel branches that were two or more branches from penetrating arterioles in order
to restrict analysis to the capillary bed. The ISD was calculated in composite z-stacks by tracing
along vessels between pericyte cell bodies, and distance was calculated in 2D.
Vessel length and radius were calculated by taking maximum z projections of the composite
z-stacks before thresholding the FITC signal manually. A region of interest (ROI) was then drawn
40
on the image to exclude vessels that were less than two branches away from penetrating arterioles.
The length of FITC labelled vessels within the ROI was calculated by skeletonising the image,
with the length of the skeleton taken as a measure of vessel length in 2D. To calculate vessel
radius and vessel radius variance a Euclidean distance map of the image was computed and the
associated skeleton was used as a ROI to measure the mean grey value and its standard deviation
along the centre of the vessels in the Euclidean distance map. The grey value along the skeleton
represents the 2D radius of the vessels.
Microglia were counted as Iba1 or Cx3CR1 labelled cells using the cell counter plugin in
ImageJ, and microglial morphology was quantified by tracing microglial cells using the Simple
Neurite Tracer plugin (Longair et al., 2011) for ImageJ. Microglial density was calculated by
dividing the number of microglia by the volume of tissue analysed, whilst microglial morphology
was quantified by measuring the number of processes at varying distances from the centre of the
microglial soma. These values were binned by 1 µm.
GLUT1 and IgG staining intensity analyses were limited to vascular ROIs drawn using FITC
signal as a mask. This was done as GLUT1 is vessel associated (Vannucci et al., 1998) and IgG
staining was seen mainly on vessels. Mean intensity values were computed, before having the
average mean grey value of no-primary stained control slices subtracted in an animal and region-
specific manner. These background corrected values were then used in analysis.
FITC signal showed incomplete perfusion of the vascular bed, with segments of non-perfused
vasculature situated between perfused areas. As such, 2D traces of these non-perfused segments
were added on to the measure of vessel length obtained through FITC thresholding to calculate a
total vessel length. The orientation of pericyte processes, as well as the use of z-stacks, enabled
identification and tracing of these segments. Total vessel length was normalised to the volume of
tissue analysed. The proportion of this total vessel length that was perfused was also computed.
The distribution of the proportion of total vessel length perfused showed more of a bimodal
than normal distribution. To facilitate analysis of this data using logistic regression, perfusion
proportions of less than 50% were classified as "low perfusion", whilst proportions greater than or
equal to 50% were classified as "high perfusion".
3.2.6 Protein Profiler Array
Hippocampi were collected from wild type mice following the completion of NOCR behavioural
testing and processed for use with the Mouse Cytokine Array C1000 kit (AAM-CYT-3, Ray Bi-
otech). Briefly, brains were removed and hippocampi were dissected out following cervical dislo-
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cation. These were weighed and then homogenised in homogenisation buffer composed of 0.1M
PBS with 10 µg/ml of protease inhibitors (Protease Inhibitor Cocktail, Abcam, ab65621). After ho-
mogenisation, Triton X-100 was added to a final concentration of 1%, before samples were frozen
at -80°C. Following this, samples were thawed, centrifuged at 10,000g for 5 minutes, and pro-
tein concentrations were quantified using a bicinchoninic acid (BCA) assay (Pierce BCA Protein
Assay Kit, Life Technologies). The protein array was then performed according to the manufac-
turer’s instructions and arrays were loaded with 500 µg of protein. Blot images were analysed in
ImageJ, where the intensity of the signal for each spot had local background values subtracted.
The background corrected values were then normalised to the value of the positive control spots
on the same array. The assay, and image analysis, was performed blinded to mouse identity and
dietary manipulation.
3.2.7 Statistical Analysis
As stated in the main methods chapter, all analyses were run using LMMs, and all plotted values
represent the estimated marginal mean +/- 1 SEM derived from the appropriate LMM, unless
otherwise indicated. Images were used as subjects in the analysis of the immunofluorescence
data. Mice were used as subjects in the analysis of weight gain and behavioural data. Individual
protein level readings were used as subjects in the protein array analysis. Where mice weren’t
used as subjects this was accounted for by including a random effect structure in the statistical
model that grouped measurements by animal in the relevant LMMs.
For the analysis of weight changes, to control for differences in starting weight, the weight of
mice as a proportion of their starting weight was compared over the two week dietary timecourse.
Here fixed effects were specified as diet, day, and their interaction. Sex and age, and their full
interactions with diet and day, were included. Random intercepts were included to account for
different levels of dataset (i.e. immunofluorescence or protein array / behavioural cohorts), study
(i.e. immunofluorescence study 1, 2, or 3), and animals within each study. An autoregressive order
1 model was included to account for the correlation in values between adjacent time points.
Analysis of immunofluorescence results was done using diet and region, and their interaction,
as fixed effects. A random intercept for different studies, and animals nested within study, was
included. In addition, a random slope for region was included to account for variation in the rela-
tionship between regions across studies and animals. A compound symmetry correlation structure
was used to account for the repeated measures of different brain regions within an animal. Sex,
age, and weight gain, and their interactions with diet, were included as factors. For measures
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where mice differed by genotype or diet pairings, their main effects, and interactions with diet,
were also included. Images were used as subjects in the analysis.
NOCR performance was analysed with diet as a fixed effect, and with the main effects of sex
and age, and their interactions with diet, included. A random intercept for animal was included.
Changes in protein levels measured using the protein array were analysed by including diet,
NOCR performance, and their interaction, as fixed effects. NOCR performance was included
to investigate the relationship between protein expression levels and cognitive performance. A
random intercept for animal was included. Given the number of proteins analysed (62) the p values
of the effects of diet, NOCR performance, and their interaction, derived from the LMMs, were
adjusted using the Bonferroni correction for multiple comparisons. Each protein array provided
duplicate measurements of protein levels. Each replicate was used as a subject in the analysis.
After quantifying total vessel length, images where the proportion of this that was labelled
(i.e. perfused) by FITC was less than 50% were classified as "low perfusion", with those showing
greater than 50% perfusion classified as "high perfusion". This distribution was analysed using
logistic regression. Diet, region, and their interaction, were included as fixed factors, as were
the main effects of sex, age, and weight change. The predict function in R was used to calculate
classification probabilities.
In order to reduce the dimensionality of the microglial morphology data, the approach taken in
Heindl et al. (2018) was used. A principle component analysis (PCA) with centering and scaling
of features was run on the morphology measurements. The first principal component, which by
definition reflects the greatest level of variability in the data, was used as a single value reflecting a
’morphology index’, and this was analysed with an LMM as in the immunofluorescence analysis
description.
One animal was excluded from analysis in order to link protein array results (n = 8) to beha-
vioural results (n = 9; n = 8 with exclusion). This meant that this animal was also excluded from
the analysis of weight changes. As the NOCR experiment was run with uneven groups (n = 5 for
control, n = 4 for HFD), the excluded mouse was a control diet subject that had the lowest NI in
the control group, which fell outside the mean +/- SD for control animals (mean = 0.178, SD =
0.061, excluded value = 0.0758).
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Figure 3.1: Two Weeks of HFD Increases Weight. (A) Weight normalised to starting values showed a trend level
increase after two weeks of HFD feeding in the combined analysis, and the rate of weight gain was significantly
increased by HFD. (B) Restricting analysis to the mice used in immunofluorescence experiments showed a persistent
effect of HFD on rate of weight gain, though here the increased weight at day 14 no longer reached trend level. (C)
The mice used in the protein array / NOCR behavioural test showed none of the effects of diet seen in the combined or
immunofluorescence analyses (’ indicates p < 0.1. Combined analysis n = 70 mice (n = 35 HFD), immunofluorescence
cohort n = 62 mice (n = 31 HFD), protein array cohort n = 8 mice (n = 4 HFD)).
3.3 Results
3.3.1 Two Weeks of HFD Increases Weight Gain and the Rate of Weight Gain
HFD feeding promotes weight gain, though cognitive impairments associated with HFD feeding
in rodents have been reported both with and without significant changes in weight. To assess the
effect of diet on weight gain in my model, mice were weighed daily. To control for differences in
starting weight, weight was normalised to its starting value and compared over the two week time-
course (Fig 3.1). Analysis of the timecourse revealed a significant positive correlation between
time and weight gain (F(13,788) = 6.74, p = < 0.001). Additionally, there was a significant inter-
action between time and diet whereby HFD mice gained weight at a greater rate than control mice
(F(13,788) = 3.01, p = 0.004). Corrected pairwise comparisons revealed a trend level increase in
the weight of HFD animals at day 14 (Fig 3.1 A; t(61) = 2.81, p = 0.094).
Given the data in this chapter are split between mice used for immunofluorescence and those
used in protein array / behavioural analyses, the effect of diet on weight gain in each group was
analysed. In the immunofluorescence cohort (Fig 3.1 B) the significant effects of time (F(13,696)
= 6.14, p = < 0.001) and diet by time (F(13,696) = 2.72, p = < 0.001) were present. However,
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the trend level increase in weight seen in the HFD group at day 14 in the combined dataset was no
longer present (though this was near trend level; t(54) = 2.80, p = 0.101).
The protein array / behavioural cohort (Fig 3.1 C) also showed a significant effect of time
(F(13,27) = 3.04, p = 0.007). However, the interaction between time and diet was not significant.
As in the immunofluorescence analysis, weight did not significantly differ between dietary groups
at any timepoint in either dataset.
Results therefore suggest that weight increased over the timecourse of dietary manipulation,
but whilst HFD feeding induced an increased rate of weight gain in the animals used in the im-
munofluorescence experiments, this was not the case in the protein array / behavioural cohort of
mice. A chi-squared test was carried out comparing the distribution of sexes between the protein
/ behavioural and immunofluorescence cohorts to see if this could account for the lack of a diet
by time interaction in the former. This was non-significant X2(1, N = 70) = 0.39, p = 0.534.
Similarly, age did not vary significantly between the two cohorts (F(1,2) = 0.00, p = 0.963).
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Figure 3.2: HFD Impairs NOCR Performance. (A) Mice fed a HFD for two weeks and tested on NOCR showed a
trend level decrease in NI, indicating impaired hippocampal cognition. (B) The task involved mice learning to associate
object pairs with contexts (Exposure) before one object from each pair was swapped and the time mice spent exploring
objects that were novel in a given context (Test) was analysed (number on brackets indicates p value of the main effect
of diet on NI, n = 8 mice (n = 4 HFD)).
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3.3.2 HFD Mice Trended Towards Impaired Hippocampal Cognition
Short-term HFD feeding is associated with hippocampus-specific cognitive deficits (McLean et al.,
2018; Kanoski and Davidson, 2010). In order to investigate this in my model and correlate it
with changes detected in the immunofluorescence data, I tested mice on NOCR performance.
The hippocampal-specific nature of the NOCR task is described briefly in the introduction to this
chapter, and the assessment of performance using a novelty index (NI) is described in the main
methods chapter. Results showed that HFD animals trended towards a lower NI (Fig 3.2 A, F(1,1)
= 147.01, p = 0.052) than control animals.
3.3.3 Short-Term HFD Does Not Alter Hippocampal Protein Expression
Hippocampal inflammatory cytokine levels in HFD studies have been demonstrated to both cor-
relate with (Liu et al., 2014), and show no correlation with (Kaczmarczyk et al., 2013), cognitive
impairment. To investigate this I collected hippocampal lysates from mice that had undergone
NOCR behavioural testing, and analysed them using a protein array to look at changes in ex-
pression across a broad range of proteins, inflammatory cytokines included. NOCR performance
values (NI) were included as a factor in the analysis of protein changes to investigate any pos-
sible correlation. After correcting for multiple comparisons there were no significant effects of
diet, NOCR performance, nor their interaction, on the levels of hippocampal protein expression
(Table 3.2). This may reflect an underpowered experiment rather than an experimental effect how-
ever, given that there were only four mice per diet group, but the absence of any change in such
a broad range of proteins, many of them inflammation-related, suggests a lack of diet-induced
inflammation in the hippocampus.
3.3.4 Microglial Cell Density was Increased by HFD
Microglial proliferation is a key component of the damage response in the brain and is widely doc-
umented in HFD research (Thaler et al., 2012; André et al., 2017; Zhou et al., 2018). I calculated
the density of microglial cells by dividing their number by the volume of tissue analysed. Two
weeks of HFD induced a significant increase in microglial density (Fig 3.3 C; F(1,33) = 4.40, p =
0.044). Given the inclusion of data from NG2-DsRed/Cx3CR1-GFP mice in the analysis (in order
to investigate the effect of heterozygous Cx3CR1-GFP expression given this mutation was to be
used in future in vivo work), genotype was included as a factor. This showed a significant effect on
microglial density (F(1,33) = 7.05, p = 0.012) where NG2-DsRed/Cx3CR1-GFP mice had greater
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IGFBP-5 
IGFBP-6 
IL-1 Alpha 
IL-1 Beta 
IL-10 
IL-12 p40/p70 
IL-12 p70 
IL-13 
IL-17A 
IL-2 
IL-3 
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0.359 
0.570 
0.904 
0.544 
0.490 
0.177 
0.458 
0.378 
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0.750 
0.294 
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0.595 
0.201 
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0.587 
Novelty Index 
0.995     
0.976     
0.874     
0.307     
0.489     
0.882     
0.084     
0.251     
0.200     
0.792     
0.455     
0.900     
0.336     
0.832     
0.917      
0.343     
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0.084
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0.182 
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0.496 
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0.209 
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0.990 
0.899 
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IL-9 
KC 
LSelectin
Leptln
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Ltn 
M-CSF
MCP-1 
MCP-5 
MIG 
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MIP-1 Gamma 
MIP-2 
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PF-4 
RANTES 
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TMP-1 
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VEGF-A 
Novelty Index Diet Dlet:Novelty Index
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0.360 
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0.451 
0.554 
0.138 
0.521 
0.393 
0.579 
0.401 
0.816 
0.211 
0.545 
0.421 
0.668 
0.984 
0.922 
0.262 
0.372 
0.384 
0.562 
0.640 
0.835 
0.540 
0.863 
0.506 
0.493 
0.280 
0.348 
0.695 
0.673 
0.669 
0.381 
0.328 
0.945 
0.548 0.793 
0256 0.741 
0.341  0.263 
0.370 0.925 
0.726 0.156 
0.308 0.579 
0.469 0.606 
0.478 0.921 
0.530 0.921 
0.178 0.854 
0.757 0.681 
0.340 0.745 
0.728 0.773 
0.142 
0.979 
0.533 
0.424 
0 .275 
0.333 
0.542 
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0.743 
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0.996 
0.973 
0.938 
0.480 
0.582 
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0202 
0.836 
0.342 
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0.319 
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Table 3.2: Hippocampal Protein Levels are Unaffected by HFD. Unadjusted p values for each measured protein for
NI, diet, and the interaction between diet and NI (Diet:Novelty Index) are listed. Once adjusted for multiple compar-
isons no effects reached significance (Darker shading indicates larger values. Red text indicates p < .05. Green text
indicates p < 0.1. Analysis used n = 16 readings per protein (n = 8 HFD) where readings were taken in duplicate for
each mouse; n = 8 mice (n = 4 HFD))
microglial densities than NG2-DsRed animals. This is likely the result of clearer microglial la-
belling by endogenous GFP expression in the NG2-DsRed/Cx3CR1-GFP mice compared to the
use of the Iba1 antibody in NG2-DsRed animals. Results of the statistical analysis of diet, region,
and their interaction, are presented in Table 3.3.
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Figure 3.3: Short-Term HFD Increases Microglial Density. (A, B, D) Cx3CR1-GFP labelled microglial cells in the
hippocampus, cortex, and hypothalamus respectively, with red lines denoting hippocampal CA1 and the third ventricle.
(C) Microglial density was elevated globally by HFD feeding. Though the effect of diet appeared to differ in strength
between regions, the interaction between diet and region was not significant in the overall model (numbers on brackets
indicate pairwise corrected dietary comparisons, analysis used n = 571 images (n = 218 cortex, n = 243 hippocampus,
n = 110 hypothalamus; n = 303 HFD) that were taken over n = 46 mice (n = 24 HFD)).
numDF 
1 
2 
2 
denDF 
33 
521 
521 
F-value
4.40 
1.53 
1.74 
P-value 
0.044
0.218 
0.176
Factor 
Diet 
Region 
Diet:Reglon
Sig 
•
Table 3.3: Short-Term HFD Microglial Density Statistics. The effects of diet, region, and their interaction, on
microglial density were analysed using an LMM (numDF and denDF refer to degrees of freedom. F and p values are
rounded to 4 decimal places. Red text indicates significance. Green text indicates trend level. Background shading
indicates size of p value where darker is larger. Sig shows significance indicator. Factor indicates factors in the model).
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3.3.5 Using Dimensionality Reduction to Create a Compound Morphology Score
Microglial activation correlates not only with changes in proliferation and cell density, but also
in morphological changes. Cell morphology was quantified by counting the number of branches
at increasing distances from the centre of the cell soma. Not surprisingly these values showed
a high degree of multicolinearity given their adjacency in space (Fig 3.4 F). As a result, the ap-
proach used by Heindl et al. (2018) was taken, where the dimensionality of microglial morphology
measurements was reduced by using the first PC (PC1) of a PCA run on the data as a compound
morphology score. The first two PCs explained 74.6% of the total variance in the data, and the PC1
essentially reflected the mean number of branches (Fig 3.4 C) with a significant Pearson’s correl-
ation between them r(265) = 0.99, p = < 0.001. As a result, the PC1 was used as a compound
measure of morphology.
3.3.6 Short-Term HFD Does Not Alter Microglial Morphology
Microglia shift their phenotype from a ramified to an amoeboid shape in response to injury, which
correlates with the extent of microglial activation (Hanisch and Kettenmann, 2007). An analysis of
the compound morphology score (Fig 3.4 B), which correlated with the mean number of branches
on a microglial cell (Fig 3.4 C), showed no effect of diet (F(1,20) = 0.07, p = 0.799) nor region
(F(2,234) = 1.89, p = 0.154) on morphology.
3.3.7 HFD Did Not Effect BBB Integrity and GLUT1 Expression
GLUT1 is involved in glucose uptake into the brain as well as BBB integrity, and has been shown
to be transiently downregulated by short-term HFD feeding (Jais et al., 2016). A change in GLUT1
expression could make neurons more susceptible to the other detrimental effects of a HFD, and
indeed HFD feeding associated GLUT1 changes are implicated in the enhanced susceptibility of
HFD animals to ischaemic damage (Haley et al., 2019). GLUT1 expression levels, as assessed
by the intensity of GLUT1 staining, were unaffected by diet (Fig 3.5 C; F(1,3) = < 0.01, p =
0.997) and showed no diet by region interaction (F(2, 67) = 0.46, p = 0.635) though did vary
significantly by region (F(2,67) = 5.63, p = 0.006) where corrected pairwise tests revealed greater
GLUT1 staining in the hypothalamus relative to the hippocampus (t(67) = 3.13, p = 0.008) and
the cortex (at trend level; t(67) = 2.39, p = 0.059). Results of the statistical analysis of diet, region,
and their interaction, are presented in Table 3.4.
The detection of endogenous plasma proteins in the brain, including IgG, has been used to
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Figure 3.4 Legend on the following page. .
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numDF 
1 
2 
2 
denDF 
3 
67 
67 
F-value
0.00
5.63
0.46 
P-value
0.997 
0.006
0.635
Factor 
Diet 
Region 
Diet:Reglon
Sig 
Table 3.4: Short-Term HFD GLUT1 Intensity Statistics. The effects of diet, region, and their interaction, on GLUT1
intensity were analysed using an LMM (numDF and denDF refer to degrees of freedom. F and p values are rounded
to 4 decimal places. Red text indicates significance. Green text indicates trend level. Background shading indicates
size of p value where darker is larger. Sig shows significance indicator. Factor indicates factors in the model).
evaluate changes in BBB integrity (Saunders et al., 2015), with HFD-induced BBB disruption
being suggested to mediate its detrimental cognitive effects (cognitive effects of HFD reviewed in
Cordner and Tamashiro 2015). IgG staining intensity (Fig 3.6) was greatest on vessels so analysis
was conducted within vessel ROIs. This was interpreted as reflecting extravasated IgG molecules,
given the vascular lumen had been cleared by perfusion. There was no effect of diet (F(1,4) =
3.37, p = 0.140), region (F(2,90) = 2.22, p = 0.114), nor any interaction between the two (F(2,90)
= 0.68, p = 0.511) on the levels of IgG staining intensity. Results of the statistical analysis of
diet, region, and their interaction, are presented in Table 3.5. IgG staining intensity in the brain
parencyhma was also analysed (excluding vessels). This showed no effect of diet, region, or any
interaction between the two (data not shown).
Figure 3.4 (preceding page): Microglial Morphology is Resistant to Short-Term Dietary Effects. (A) Microglial
morphology was quantified by counting the number of processes at increasing distances from the centre of the mi-
croglial soma. (B) These measurements showed a high degree of multicolinearity, so a PCA was used to reduce their
dimensionality and the PC1 was used as a compound morphology score. This showed no effect of diet or region.
(C) The compound morphology score showed an incredibly strong correlation with the mean number of branches on
microglial cells. (D, E) Illustrative images of microglial morphology showing cells that had a low number of mean
branches and a negative PC1 value, compared to cells with a high mean number of branches and a positive PC1 value.
Numbers on the images refer to numbers in C. (F) The correlation matrix of raw morphology measurements (blue
indicates a correlation of 1, red of -1, distance from soma centre increases from top left outwards (A solid line indicates
mean, dashed line indicates SD. B numbers indicate p values of corrected pairwise dietary comparisons. C text shows
correlation values. Analysis used n = 267 cells (n = 71 cortex, n = 121 hippocampus, n = 75 hypothalamus; n = 134
HFD) that were taken from n = 29 mice (n = 15 HFD))
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Figure 3.5: GLUT1 Expression is Unaffected Following Two Weeks of HFD. (A, B, D) GLUT1 labelling in the hip-
pocampus, cortex, and hypothalamus respectively, with blue lines denoting hippocampal CA1. (C) GLUT1 intensity
was unaffected by diet but varied between regions (numbers on brackets indicate pairwise corrected dietary comparis-
ons, analysis used n = 82 images (n = 25 cortex, n = 27 hippocampus, n = 30 hypothalamus; n = 56 HFD) that were
taken over n = 11 mice (n = 7 HFD)).
numDF 
1 
2 
2 
denDF 
4 
90 
90 
F-value
3.37 
2.22
0.68 
P-value 
0.140 
0.114
0.511 
Factor 
Diet 
Region 
Diet:Reglon
Sig 
Table 3.5: Short-Term HFD IgG Intensity Statistics. The effects of diet, region, and their interaction, on vessel-
associated IgG intensity were analysed using an LMM (numDF and denDF refer to degrees of freedom. F and p values
are rounded to 4 decimal places. Red text indicates significance. Green text indicates trend level. Background
shading indicates size of p value where darker is larger. Sig shows significance indicator. Factor indicates factors in
the model).
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Figure 3.6: HFD Did Not Affect BBB Integrity. (A, B, D) IgG labelling in the hippocampus, cortex, and hypo-
thalamus respectively, with red lines denoting hippocampal CA1. (C) Vessel-associated IgG intensity did not differ by
brain region or dietary manipulation (numbers on brackets indicate pairwise corrected dietary comparisons, analysis
used n = 107 images (n = 30 cortex, n = 41 hippocampus, n = 36 hypothalamus; n = 65 HFD) that were taken over n =
13 mice (n = 8 HFD)).
3.3.8 Pericyte Coverage is Smallest in the Hippocampus and Resistant to Short-
Term HFD
Pericytes are vascular mural cells that are involved in regulating blood flow, maintaining BBB
integrity, and stabilising newly formed capillaries. Hippocampal pericytes have been observed to
occupy less volume and cover less of the vascular area during long-term HFD feeding (Yamamoto
et al., 2019; Tucsek et al., 2014b), with this implicated in cognitive deficits. Pericyte coverage in
my data was assessed by measuring the distance between adjacent NG2-DsRed labelled pericyte
somas (Fig 3.7 A Inset). The advantage of using inter-soma distance (ISD) rather than pericyte
cell density or number to investigate changes in pericytes is that it is independent of differences
in vascular density. Pericytes were only measured on capillaries (vessels that were two or more
branches away from penetrating arterioles) and identified by their distinct ’bump on a log’ mor-
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phology using NG2 labelling. Care was taken to avoid including ensheathing pericytes, smooth
muscle cells, and oligodendrocyte precursor cells, all of which also express NG2 but are morpho-
logically distinct from capillary pericytes. Pericyte subtypes are described in Grant et al. (2019).
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Figure 3.7: Pericyte Spacing is Greatest in the Hippocampus. (A, B, D) NG2-DsRed labelled pericytes in the
hippocampus, cortex, and hypothalamus respectively, with blue lines denoting hippocampal CA1. (A Inset) Example
of ISD measurement inset with 50 µm scale bar. (C) The ISD between capillary pericytes was unaffected by diet, but
varied significantly by region with the hippocampus showing the greatest ISD value (analysis of coverage was restricted
to capillary pericytes. Numbers on brackets indicate pairwise corrected dietary comparisons. Capillary pericytes are
indicated by green (thin-strand pericytes) and magenta (mesh pericytes) arrows. Red arrows indicate ensheathing
pericytes on pre-capillary arterioles. Open red arrow indicates a smooth muscle cell on a penetrating arteriole. Cyan
arrow indicates an NG2 positive oligodendrocyte precursor cell, seen predominantly in hippocampal CA1. Pericyte
subtypes defined as in Grant et al. (2019). Analysis used n = 569 images (n = 183 cortex, n = 205 hippocampus, n =
181 hypothalamus; n = 300 HFD) that were taken over n = 45 mice (n = 23 HFD)).
Pericyte ISD, which increases as coverage decreases, was unaffected by diet (Fig 3.7 C;
F(1,32) = 0.065, p = 0.801) but varied significantly by region (F(2,520) = 4.67, p = 0.010) where
the hippocampus had the greatest pericyte ISD (Hippocampus: 123 +/- 10 µm, Cortex: 112 +/-
7 µm, Hypothalamus: 116 +/- 20 µm). Pairwise comparisons between regions adjusted with the
Bonferroni correction showed that the hippocampus had a significantly greater pericyte ISD than
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the cortex (t(520) = 2.86, p = 0.013) with no other regional comparisons approaching significance.
Results of the statistical analysis of diet, region, and their interaction, are presented in Table 3.6.
Given pericyte data was analysed across mice with different genotypes, this was included as a
factor in the statistical model. Data from different genotypes were pooled in order to evaluate the
effect of the Cx3CR1-GFP mutation on dietary changes, given that this mutation was to be used in
future in vivo work. There was a trend level effect of genotype on ISD (F(1,32) = 3.83, p = 0.059)
where NG2-DsRed animals had a greater ISD (126 +/- 12.1 µm) than NG2-DsRed/Cx3CR1-GFP
animals (108 +/- 12.7 µm). This may be a reflection of age-related effects given that as age in-
creased so did ISD (F(1,43) = 30.59, p = < 0.001) and the NG2-DsRed/Cx3CR1-GFP animals
had a significantly greater age than the NG2-DsRed animals (t(18.906) = 5.88, p = < 0.001).
Pericyte data was also analysed across different diet combinations (the first immunofluores-
cence study I conducted was a pilot experiment, and used a slightly different combination of high
fat and control diets). To account for this, diet combination was included as a factor in the analysis
(diet combinations are described in the main methods chapter). A trend level effect of diet type
was present (F(1,1) = 90.68, p = 0.067) where the ISD in animals fed the combination of diets
supplemented with Fenbendazole (i.e. the diets used for all work except the pilot immunofluor-
escence study) was larger. As with genotype, age was significantly greater in the Fenbendazole
group (t(31.266) = 5.55, p = < 0.001), suggesting the effect of diet type may be a reflection of
differences in age.
3.3.9 Capillary Perfusion Showed a Trend Level Reduction by HFD
The length of capillaries was assessed by measuring the length of vessels labelled with a perfusion
of a FITC-gelatin. However, this labelling was not complete (Fig 3.8), with non-perfused sections
appearing in-between perfused segments (Fig 3.8 A, B; Inset). As such, the length of these non-
perfused segments was added to the length of the perfused capillaries to calculate total capillary
length. These non-perfused segments were not the result of methodological issues, as animals that
showed reduced perfusion in one region of the brain had near complete perfusion in others (Fig 3.8
A and D illustrate the hippocampus and hypothalamus from the same mouse). The proportion of
total capillary length that was perfused was analysed to investigate if this was affected by diet, with
this proposed to reflect an increase in resistance to blood flow in capillaries. Here there was a trend
level decrease in the HFD group (F(1,16) = 3.39, p = 0.084) but this did not vary significantly by
region (F(2,346) = 1.01, p = 0.367), suggesting that capillaries in the HFD group may provide
more resistance to flow.
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HFD Increases the Odds of Poor Capillary Perfusion
The distribution of capillary length perfusion proportions showed more of a bimodal than normal
distribution, and so a logistic regression was carried out to look at the probability of having a capil-
lary perfusion percentage below 50%. This revealed that HFD was associated with a significantly
greater chance of having poor capillary perfusion (Fig 3.8 E; F(1,375) = 41.54, p = < 0.001). The
probability of having poor perfusion was 0.20% in the HFD group, and 0.012% in the control diet
group. There was a trend level effect of region (F(2,373) = 5.41, p = 0.067), where the probability
of poor perfusion in the hypothalamus was 0.05%, whilst it was 0.13% in the cortex and 0.14% in
the hippocampus.
numDF 
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denDF 
32 
520 
520 
F-value
0.06 
4.67 
0.85 
P-value
0.801 
0.010 
0.430
Factor 
Diet 
Region 
Diet:Reglon
Sig 
Table 3.6: Short-Term HFD ISD Statistics. The effects of diet, region, and their interaction, on the ISD between
capillary pericytes were analysed using an LMM (numDF and denDF refer to degrees of freedom. F and p values are
rounded to 4 decimal places. Red text indicates significance. Green text indicates trend level. Background shading
indicates size of p value where darker is larger. Sig shows significance indicator. Factor indicates factors in the model).
numDF 
1 
2 
2 
denDF 
16 
346 
346 
F-value
3.39 
1.01 
0.84 
P-value
0.084 
0.367 
0.432 
Factor 
Diet 
Region 
Diet:Reglon
Sig 
Table 3.7: Short-Term HFD Perfusion Statistics. The effects of diet, region, and their interaction, on the proportion
of total capillary length perfused by FITC were analysed using an LMM (numDF and denDF refer to degrees of
freedom. F and p values are rounded to 4 decimal places. Red text indicates significance. Green text indicates trend
level. Background shading indicates size of p value where darker is larger. Sig shows significance indicator. Factor
indicates factors in the model).
3.3.10 The Hippocampus had the Smallest Capillary Radii, and Lowest Radius
Variance and Capillary Density, with Radius and Radius Variance Decreased
by Short-Term HFD
A reduction in CBF is reported in the cortex in obesity, which correlates with memory impair-
ment (Birdsill et al., 2013), and obstructions of cerebral microvascular lumina have been observed
following HFD feeding (He et al., 2016; Constantinescu et al., 2011). To evaluate changes in
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Figure 3.8: Short-Term HFD Reduces Capillary Perfusion. (A, B, D) FITC perfused vessels in the hippocam-
pus, cortex, and hypothalamus respectively. (A Inset) Example of a non perfused segment situated between perfused
segments indicated by magenta arrow. (B Inset) Example of non perfused segment associated with pericyte process
indicated by cyan arrow. (C) Analysis of the proportion of the total capillary length perfused showed a a trend level
reduction by HFD feeding. (E) Mosaic plot illustrating the proportion of images classified as low and high perfusion
split by brain region and diet group. Numbers indicate the percentage of low and high perfusion images from control
and HFD mice (numbers in C indicate pairwise corrected dietary comparisons. Scale bars in A and B insets indicate
50 µm. Analysis used n = 377 images (n = 124 cortex, n = 135 hippocampus, n = 118 hypothalamus; n = 213 HFD) that
were taken over n = 27 mice (n = 15 HFD)).
57
capillary radii, which could be linked to a reduction in blood flow, I analysed measurements of
luminal capillary radii. These showed a significant reduction in the HFD group (Fig 3.9 F; F(1,18)
= 7.70, p = 0.013) and varied significantly by region (F(2, 392) = 5.77, p = 0.003) where radius
was greatest in the hypothalamus (2.27 +/- 0.49 µm), followed by the cortex (2.24 +/- 0.84 µm)
and then the hippocampus (2.11 +/- 0.68 µm).
The ability of the capillary bed to locally dilate is important in neurovascular coupling, the
mechanism whereby blood flow is redirected to regions of greater neuronal activity. HFD-induced
impairments in neurovascular coupling are suggested to lead to cognitive impairment (Sorop et al.,
2017). Changes in this ability can be reflected in reductions in the variation of radius measure-
ments. The effects here mimicked those on radius, where the radius SD was significantly reduced
by HFD (Fig 3.9 G; F(1,18) = 22.14, p = < 0.001) and varied by region (F(2,382) = 3.19, p =
0.042) where pairwise Bonferroni corrected comparisons revealed a significantly smaller radius
SD in the hippocampus compared to the hypothalamus. Overall, the hippocampus had the smal-
lest radius standard deviation (0.893 +/- 0.042 µm) relative to the cortex (0.901 +/- 0.084 µm) and
the hypothalamus (0.989 +/- 0.026 µm). An analysis of proportional variance, i.e. the SD as a
proportion of the mean, revealed no effect of diet or region.
HFD feeding and obesity are associated with changes in cerebrovascular density. This has
been seen as both a pathological increase (Coucha et al., 2019) and decrease (Tucsek et al., 2014b)
that correlated with impaired cognitive performance. Analysis of the length of capillaries normal-
ised to tissue volume (Fig 3.9 E) revealed no effect of diet, but there was significant variance by
region (F(2,339) = 2.35, p = < 0.001) where pairwise Bonferroni corrected comparisons revealed
that the cortex had significantly greater capillary length density than the hippocampus. The hippo-
campus had the smallest capillary length density (0.00299 +/- 0.00083 mm/mm2) followed by the
hypothalamus (0.00303 +/- 0.00051 mm/mm2) and the cortex (0.00629 +/- 0.00170 mm/mm2).
There was no effect of diet.
3.4 Discussion
3.4.1 HFD Increased the Rate of Weight Gain, with Differences in Weight Emer-
ging Shortly After Beginning HFD Feeding
Weight was analysed relative to starting values to control for differences in weight at baseline,
with two weeks of HFD feeding leading to an increase in the rate of weight gain and a trend to
increased weight in HFD animals at day 14 in the combined analysis. Given the split between
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Figure 3.9 Legend on the following page.
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numDF denDF F-value P-value Factor Slg Measure 
1 16 2.35 0.145 Diet Density 
2 339 9.02 0.000 Region
••• 
2 339 0.38 0.681 Dlet:Region 
1 18 7.70 0.013 Diet • Radius 
2 392 5.77 0.003 Region 
2 392 0.71 0.492 Diet:Region 
1 18 22.05 0.000 Diet ••• Radius Variation
2 382 3.19 0.042 Region • 
2 382 0.48 0.622 Dlet:Reglon 
Table 3.8: Short-Term HFD Vessel Statistics. The effects of diet, region, and their interaction, on capillary density,
radius, and radius variance, were analysed using an LMM (numDF and denDF refer to degrees of freedom. F and p
values are rounded to 4 decimal places. Red text indicates significance. Green text indicates trend level. Background
shading indicates size of p value where darker is larger. Sig shows significance indicator. Factor indicates factors in
the model. Measure indicates the measurement analysed).
immunofluorescent and protein array / behavioural experiments in this chapter, weight analyses
split by cohort were conducted, where mice in the immunofluorescence cohort demonstrated the
same effects as were present the grouped analysis, though the effect of diet at day 14 was no
longer present (albeit near trend level). The protein array / behavioural cohort only demonstrated
an increase in weight over time with no effects of diet. These results contribute to the established
body of literature demonstrating that a switch to a HFD promotes rapid increases in weight gain,
but also highlight that the immunofluorescence results presented in this chapter must be interpreted
differently from the protein array and behavioural data, given the former is associated with HFD-
induced weight gain (and its associated metabolic effects) whilst the latter is not.
In the combined analysis the trend level increase in weight at day 14 appears to reflect the
imminent onset of diet-induced weight gain following two weeks of HFD feeding, though non-
Figure 3.9 (preceding page): Capillary Density, Radius, and Radius Variance, are Lowest in the Hippocampus
and Radius and Radius Variance are Reduced by HFD. (A, B, C) FITC perfused vessels in the hippocampus, cortex,
and hypothalamus respectively. Hippocampal CA1 indicated by magenta lines. (D Top Left) Skeleton of B in yellow
overlaid on Euclidean distance map in cyan. (Bottom Left) Thresholded image in red. (Top Right) Thresholded
image in green, skeleton overlaid in magenta. (Main Panel) Raw signal in green merged with threshold in red. Yellow
indicates overlapping signal. Skeleton in magenta. (E) Diet had no effect on capillary density though it was lowest in
the hippocampus. (F) Capillary radii were diminished by HFD feeding, and were lowest overall in the hippocampus.
(G) The variation in capillary radii was reduced by HFD, and was smallest in the hippocampus (p values of within
region dietary comparisons are indicated on brackets. Analysis of length density / radius / radius variation used n =
370/425/415 images (n = 121/152/147 cortex, n = 132/150/145 hippocampus, n = 117/123/123 hypothalamus; n =
206/233/225 HFD) taken over n = 27/29/29 mice (n = 15/16/16 HFD)).
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significant differences in mean weight (relative to starting weight) were apparent between diet
groups from one day of feeding onwards. This timecourse fits with other studies, where male
C57BL/6J mice fed a 45% HFD (the same percentage used in my experiments) showed a differ-
ence in weight after a week, and significant weight increases from four weeks onwards (Ouyang
et al., 2014). Similarly, a 60% HFD used by Jais et al. (2016) was associated with significant
weight increases after 3 days, and though only significant after 5 weeks, Kim et al. (2008) showed
non-significant HFD-induced increases in weight after a week of feeding. In addition, McLean
et al. (2018) used a 60% HFD with weight increasing from the second day onwards, and reaching
significance by day 3. In rats, a 60% HFD has been associated with significant increases in weight
after one week (Calvo-Ochoa et al., 2014; Posey et al., 2009; Thaler et al., 2012). Since a positive
relationship exists in both rats and mice between dietary fat content and body weight or fat gain
(reviewed in Hariri and Thibault 2010), an accelerated onset of diet-induced weight gain with a
60% diet is to be expected. Overall, my results agree with other published studies showing an
effect of HFD feeding on weight gain beginning shortly after the start of dietary manipulation,
with the fact that I used a large sample size (n = 70 mice) and saw no significant effect on weight
within 2 weeks of HFD likely down to the use of a 45% rather than 60% HFD.
It also important to consider the fact that the mice I analysed varied both in sex and age.
HFD-induced weight gain has previously been shown to be mediated by sex, with males more
susceptible to diet-induced weight gain (Hwang et al., 2010), and old mice seen to be more sus-
ceptible to the metabolic effects of HFD feeding (Nunes-Souza et al., 2016), with a significant
difference in weight only detected in aged (54-56 weeks old) mice from 8 weeks onwards during
60% HFD feeding, something that was not detected over 14 weeks in young (6-8 weeks old) mice,
though young mice did show reduced glucose tolerance, hyperlipidaemia, and elevated abdom-
inal fat levels (Nunes-Souza et al., 2016). However, in my statistical analysis neither sex nor age
significantly affected weight gain, perhaps owing to the short duration of dietary manipulation
used, given that Hwang et al. (2010) only showed significant differences in diet-induced weight
gain between sexes from 4 weeks onwards, and the restricted range of ages incorporated in my
experiments (relative to Nunes-Souza et al. 2016), given the mean and standard deviation of this
was 15.76 +/- 8.87 weeks.
Cohort Differences
The difference in dietary effects between the immunofluorescence and behavioural cohorts in my
results was not down to any sex or age-related effects, as a chi-squared test revealed no difference
in the distribution of sexes, and mean age did not vary significantly between them. It may be
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the case that genotype played a role, as the protein array / behavioural cohort were wild type
C57BL/6J mice, whereas transgenic animals were used in the immunofluorescence experiments.
Additionally, the behavioural cohort were handled to a greater extent, so it is possible that this
was associated with levels of stress that interacted either with dietary effects or overall feeding
behaviour.
The mice used in the immunofluorescence experiments had either one, or both, of two re-
porter mutations. These were the NG2-DsRed mutation that labels pericytes, oligodendrocyte
precursor cells, and smooth muscle cells, and the Cx3CR1-GFP mutation, which labels microglial
cells, as well as circulating monocytes and subsets of natural killer and T cells (Imai et al., 1997).
Only mice heterozygous for this latter mutation were used, given it involves the knockout of the
Cx3CR1 gene, with its complete knockdown associated with impairments in cognition and syn-
aptic plasticity (Rogers et al., 2011). Cx3CR1 and its ligand are important in neuroinflammation
and are involved in signalling between neurons and microglia, and impaired Cx3CR1 signalling
is associated with age-related macular degeneration and neurodegeneration in mouse models of
Parkinson’s disease and amyotrophic lateral sclerosis (Lee et al. (2010) introduce the effects of
Cx3CR1 dysfunction). Whilst it is possible that genotype effects are responsible for the different
trajectory of HFD-induced weight gain in wild type versus transgenic animals, the results I present
are in the opposite direction of what would be expected.
Polymorphisms in the Cx3CR1 gene are associated with obesity and metabolic traits (Sirois-
Gagnon et al. 2011 cited by Shah et al. 2015), and results from work on diet-induced obesity show
that complete Cx3CR1 deficiency protects against obesity and the inflammation of visceral adipose
tissue (Polyák et al., 2014), with partial deficiency also associated with resistance to diet-induced
weight gain and cognitive impairment (Cope et al., 2018). However, work by Shah et al. (2015)
showed no effect of complete Cx3Cr1 deficiency on diet-induced weight gain, fat content, feeding,
or energy expenditure at any point over 24 weeks, in HFD fed mice, though these mice did show
attenuated glucose-intolerance at baseline and after 12 weeks, and improved insulin sensitivity
after 24 weeks of HFD. Indeed, looking more closely at the work by Polyák et al. (2014), they
showed that weight gain on a HFD is only significantly reduced by complete Cx3CR1 deficiency
after 8 weeks, with the inflammatory changes they report only investigated after 10 weeks. These
results support the possibility that Cx3CR1 deficiency is associated more with altered dietary
effects after long-term rather than short-term HFD feeding. In contrast Cope et al. (2018) show
a significant HFD-induced increase in weight after 2 weeks in wild type mice, with the same
effect only seen after 5 weeks in partially Cx3CR1 deficient mice. In addition, partially Cx3CR1
deficient mice were also resistant to diet-induced cognitive deficits after 12 weeks of HFD feeding.
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The reason for discrepancies between studies are unclear, given they all used male mice with ages
ranging from 7-10 weeks at the start of a 45% HFD (though Polyák et al. (2014) used a 2:1 mixture
of standard chow and lard). If anything it appears that partial (as in Cope et al. 2018) rather than
complete Cx3CR1 deficiency is associated with the modulation of short-term dietary effects.
Ultimately then there is some evidence that Cx3CR1-GFP mutants may be resistant to short-
term diet-induced weight gain on a HFD. However, the partially Cx3CR1 deficient mice I used
were included in my immunofluorescence cohort, which showed elevated, rather than reduced,
susceptibility to diet-induced weight gain relative to wild-type behavioural animals. These mice
were in the minority of the immunofluorescence cohort, so their presence may have dampened the
effect of HFD on the overall cohort, though genotype did not significantly affect weight gain, or the
rate of weight gain, in my statistical analysis. An alternative explanation for differences between
cohorts relates to the extra degree of handling, and perhaps stress, associated with behavioural
testing. However, behavioural testing and training only began at day 11 of dietary manipulation,
so an effect of HFD on weight would be expected prior to this if this was an influencing factor, with
no such effect present. As such, the question of why the cohorts differ in terms of susceptibility to
diet-induced weight gain remains unanswered. It is possible that the NG2-DsRed mutation present
in the immunofluorescence cohort could play a role in this, but to my knowledge no studies have
yet looked at the effect of this mutation on HFD-induced weight gain.
3.4.2 HFD Treatment Impairs Hippocampal Cognition
HFD feeding was associated with a trend level deficit in NOCR. Though not significant, in light
of the small sample size used (n = 4 mice per diet group), this suggests the presence of a dietary
impairment in hippocampus-specific cognition following short-term HFD feeding. The NOCR
task relies not only on hippocampus-dependent (Mumby et al., 2002), but also hippocampus-
specific (Balderas et al., 2008) cognitive processes, though the medial frontal cortex also appears
to be involved given that when damaged, object-context recognition is impaired (Spanswick and
Dyck, 2012). McLean et al. (2018) demonstrated an impairment in NOCR after only 48 hours of
HFD feeding, as well as impairments in hippocampus-specific tests of object-place-context and
object-place recognition after a single day of HFD feeding (using a sample size of 48 mice), with
their results representing the earliest time at which HFD-induced cognitive impairments have been
investigated.
My results support the work by both McLean et al. (2018) and Kanoski and Davidson (2010)
that demonstrate hippocampus-specific deficits in cognition following short-term HFD feeding.
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Whilst finding HFD-induced cognitive deficits at large appears inconsistent, tasks that measure
hippocampus-dependent cognition show impairment more reliably than those that utilise non-
hippocampal, or more distributed, processes (HFD and cognition reviewed in Cordner and Tamashiro
2015). The fact that the deficits I report are detected in mice that showed no effect of HFD
on their weight or rate of weight gain fits with other studies cited in a review by Cordner and
Tamashiro (2015) that demonstrate hippocampal deficits in the absence of weight gain, particu-
larly given that the rapid deficits reported by McLean et al. (2018) and Kanoski and Davidson
(2010) aren’t associated with significant weight increases. The fact that Kanoski and Davidson
(2010) report non-spatial cognitive deficits taking 30 days to appear (when animals show signific-
ant increases in weight) suggests that hippocampus-independent cognition deficits could be driven
via obesity-related mechanisms, whilst hippocampus-dependent deficits may not rely on the pres-
ence of obesity. Whilst other studies that have used more hippocampus-specific variants of the
novel object recognition task report a link between deficits and weight gain (Heyward et al., 2012;
Valladolid-Acebes et al., 2013), this is likely a result of the length of dietary manipulation used (27
and 8 weeks respectively) rather than a causative factor, as hippocampus-specific deficits persist
beyond the onset of significant weight gain (McLean et al., 2018; Kanoski and Davidson, 2010).
It is important to note that HFD associated cognitive deficits are likely not the result of altered
locomotive activity, given that Heyward et al. (2012) report no difference in the distance travelled
or time spent in the center of an open field task in diet-induced obese HFD fed mice, though these
mice did show elevated signs of anxiety which it was suggested could confound anxiety-evoking
tests of memory. Rats fed a HFD for 6 weeks showed no effect on locomotion in an elevated plus
maze (Aslani et al., 2015), with spontaneous locomotor activity not affected after 9 weeks (Chia-
Ying et al., 2017). With regards to motivation, 3 weeks of a HFD in rats did not affect responding
to a sucrose reinforcer on a progressive ratio schedule (Tracy et al., 2015), demonstrating that at
least in terms of food rewards, short-term HFD feeding doesn’t influence motivation.
A final point to make concerns the age of mice tested, given Valladolid-Acebes et al. (2013)
show cognitive deficits in mice aged 5 weeks at the start of dietary manipulation, but not those
aged 8 weeks, though the reason for this is unclear given that hippocampus-specific deficits have
been reported in 12 week old mice (Heyward et al., 2012; McLean et al., 2018). The detection of
differences appears unrelated to sample size, with Heyward et al. (2012) using 5-8 mice per diet
group, McLean et al. (2018) using 24 per group, and Valladolid-Acebes et al. (2013) using 15 and
12 mice per group in their 8 and 5-week experiments respectively. All three studies used male
mice exclusively. With regards to my own results, no effect of age or sex was seen on behavioural
performance, though the sample size used was likely too small to detect any effects of these factors,
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with age only ranging from 8 to 14 weeks. In summary, evidence suggests that hippocampus-
specific cognitive impairments induced by HFD feeding are independent of increases in weight
or the presence of diet-induced obesity, fitting with my results, and that deficits aren’t related to
changes in locomotive or motivational behaviour.
Mechanisms of Early HFD Induced Hippocampal Deficits
Two mechanisms proposed to underlie HFD-induced hippocampal cognitive deficits include gluc-
ose intolerance, which develops after only three days (McLean et al., 2018), and resistance to
leptin and insulin signalling. Both the leptin and insulin receptors are highly expressed in the
hippocampus, with evidence suggesting that they play a role in hippocampal-dependent learning
and memory via the regulation of receptor trafficking and synaptic plasticity (briefly reviewed in
Cordner and Tamashiro 2015).
Diet induced obesity leads to impaired central responses to peripheral leptin throughout the
brain (Morabito et al., 2017) though reductions in sensitivity to peripherally administered leptin
appear to take a long time to develop, with no evidence of it after 16 days of HFD feeding (Van
Heek et al., 1997) though it is reported after 8 weeks (Van Heek et al., 1997; Lin et al., 2000).
Resistance to centrally administered leptin seems to take even longer to manifest, with it only
beginning to appear after 15 (El-Haschimi et al., 2000) and 19 (Lin et al., 2000) weeks. Leptin
resistance therefore seems an unlikely mechanism for mediating the early effect of HFD feeding
on hippocampal cognition. This is supported by my protein array data that demonstrated no effect
of two weeks of HFD feeding on the hippocampal levels of leptin or its receptor. In contrast to
leptin, central insulin resistance appears after only three days of HFD feeding in rats independent
of changes in weight or adiposity (Clegg et al., 2011), and changes in the hippocampal insulin
signalling pathway have been reported after a week of HFD feeding (Calvo-Ochoa et al., 2014),
making it a much more likely candidate mechanism, and one that is relevant to my model given
the absence of dietary effects on weight I observed in the behavioural cohort of mice.
Besides a potential role for insulin resistance, evidence exists that supports roles for oxidative
stress, BBB impairment, inflammation, and changes in BDNF levels, in diet induced hippocam-
pal deficits (briefly reviewed in Cordner and Tamashiro 2015). HFD induced increases in the
level of oxidative stress in the hippocampus (Xia et al., 2015; Kishi et al., 2015; Liu et al., 2014;
Molteni et al., 2004; Cui et al., 2012) and cortex (Liu et al., 2014) are associated with cognitive
deficits, although the earliest that this has been demonstrated is 8 weeks making the relevance of
HFD-induced oxidative stress to early cognitive deficits unclear. HFD also induces BBB disrup-
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tion (Davidson et al., 2012; Chang et al., 2014; Pallebage-Gamarallage et al., 2012; Elahy et al.,
2015) that is associated with cognitive impairment (Kanoski et al., 2010; Davidson et al., 2012,
2013). However, as well as seeing no effect of HFD on BBB integrity in my model, the evidence
that hippocampal BBB disruption only occurs in obese mice (Davidson et al., 2012, 2013) makes
it likely unrelated to the behavioural changes I report. Elevated levels of inflammatory cytokines
(Liu et al., 2014; Thirumangalakudi et al., 2008; Pistell et al., 2010) have also been linked to HFD-
related cognitive impairment, although there is evidence for this in the absence of cytokine changes
as well (Kaczmarczyk et al., 2013). Given that HFD feeding had no effect on the expression of
hippocampal inflammatory cytokines in my model, the latter study seems most relevant, espe-
cially given that Kaczmarczyk et al. (2013) demonstrated behavioural changes after only a week
of HFD feeding. Kaczmarczyk et al. (2013) link their results to decreased levels of BDNF, which
modulates synaptic plasticity and is decreased in models of HFD feeding in both the hippocampus
(Molteni et al., 2002; Stranahan et al., 2008; Kishi et al., 2015; Molteni et al., 2004; Camer et al.,
2015) and cortex (Xia et al., 2015; Kaczmarczyk et al., 2013; Pistell et al., 2010; Camer et al.,
2015). It may therefore be the case that HFD induced alterations in BDNF-related synaptic plas-
ticity are what underlie the cognitive deficits in my model, although Kaczmarczyk et al. (2013)
reported no change in hippocampal BDNF levels. This doesn’t rule BDNF out entirely however,
given that transient and biphasic dietary effects have been documented (Thaler et al., 2012; Jais
et al., 2016) so it is possible that BDNF levels in the hippocampus could be downregulated prior
to one week before returning to basal levels, and that this is partly responsible for the hippocampal
cognitive deficits..
3.4.3 Hippocampal Protein Levels were Unaffected by HFD and Did Not Correlate
with Behavioural Performance
Analysis of protein array data revealed that two weeks of HFD feeding had no effect on the hip-
pocampal expression of a selection of proteins. Additionally, neither NOCR performance nor its
interaction with diet showed significant effects on protein expression. The array included meas-
urements of proinflammatory cytokines (for a full list see Table 3.2), with results indicating the
absence of an inflammatory response. It should be noted that the protein array experiment was
exploratory and severely underpowered. Using the levels of IL-1β as an example, the experiment
achieved a 12.1% power level, where 80% power would have required 21 animals per group (com-
pared to the 4 per group used). In addition, given 62 proteins were measured, changes would have
needed to be highly significant to pass a correction for multiple comparisons. As such, the ab-
sence of significant changes I report is not surprising, and likely more related to the study design
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than real dietary effects. However, the unadjusted p values show a lack of change in the vast ma-
jority inflammation-related proteins in response to dietary manipulation, which could indicate a
lack of hippocampal inflammation. With the study limitations in mind, an appropriately powered
follow-up experiment is needed to confirm this.
Detecting a HFD-induced deficit in cognitive performance without a concurrent elevation in
hippocampal cytokine levels fits with work by Kaczmarczyk et al. (2013), and this relationship
seems to be associated with short-term HFD feeding (Kaczmarczyk et al. (2013) used a week of
HFD) given that studies where cytokine elevations and cognitive deficits correlated used longer
manipulations (e.g. Liu et al. (2014) used 16 weeks of HFD). Since the early effects of HFD
include hypothalamic inflammation (after 24 hours; Thaler et al. 2012) and reactive gliosis in the
hippocampus (after a week; Calvo-Ochoa et al. 2014) an absence of early changes in the levels of
hippocampal cytokines is surprising. This could be related to time-specific dietary effects, given
that HFD induces a biphasic inflammatory response in the hypothalamus where proinflammatory
cytokine mRNA levels are elevated before returning to baseline after a week of HFD feeding only
to show increases again after four weeks (Thaler et al., 2012). Whilst it may appear strange that
I opted to investigate hippocampal inflammation following two weeks of dietary manipulation in
light of this, it seemed likely that any phasic hippocampal inflammatory changes would follow
a different timecourse to that in the hypothalamus given the lack of any close association of the
hippocampus to a CVO. The mechanisms underlying the biphasic response in the hypothalamus
are unclear, but Mendes et al. (2018) make the point that a biphasic pattern is seen in inflammatory
responses in other tissues, and suggest that the initial peak is driven by microglia, but their gradual
replacement by bone-marrow derived myeloid cells (Valdearcos et al., 2017) alters proinflammat-
ory cytokine expression levels. In general, investigation of whether inflammation follows a phasic
pattern in the hippocampus is lacking, with existing evidence being inconsistent and drawn from
multiple studies looking at individual timepoints. At later timepoints there have been reports of
both increases and an absence of changes in cytokine levels (no changes; Boitard et al. 2014;
Sobesky et al. 2014, increases; Thirumangalakudi et al. 2008; Liu et al. 2014), whilst no changes
were detected after 1 or 3 weeks (Kaczmarczyk et al., 2013). Evidence seems to suggest that rather
than showing phasic cytokine changes in response to HFD feeding, the hippocampus is resistant
to HFD-induced changes in proinflammatory cytokine levels.
Sobesky et al. (2016) suggest that HFD induced increases in the expression of proinflammat-
ory cytokines in the brain relies on the presence of a substantial sugar component in the HFD
regimen, and that HFDs without this component require a secondary insult to induce an elevation
of proinflammatory cytokines or memory impairments. Though there is evidence against the ne-
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cessity of cytokine production for the development of cognitive impairment, their suggestion that
HFD primes rather than activates microglial cells, and thereby does not promote cytokine produc-
tion, could explain my results. Primed microglia show signs of activation such as proliferation
(priming reviewed in Li et al. 2018), though they show less distinct morphological changes (they
remain highly ramified despite showing larger and less-round somata than resting cells; Torres-
Platas et al. 2014) and do not produce inflammatory cytokines (Perry and Holmes (2014) cited by
Hoogland et al. 2018). They also show an elevated degree of cytokine production in response to a
secondary inflammatory stimulus (microglial priming reviewed in Perry and Holmes 2014). Given
my data showed an increase in microglial cell density, no change in microglial ramification, nor
any increase in proinflammatory cytokine levels, the priming rather than activation of microglia
in my model seems a possible explanation. The fact that HFD induced priming is detected in the
hippocampus (Sobesky et al., 2016) and hypothalamus (Souza et al., 2019) after only 3 days of
feeding suggests that early HFD may prime microglia.
With regards to models that lack a substantial sugar component and still demonstrate elevated
cytokine levels or cognitive impairment (such as my own), Sobesky et al. (2016) suggest that this
is the result of a secondary insult. In my model this secondary insult may have been the stress
of behavioural testing, which involved ∼90 minutes in total of handling, context exposure, and
testing. This duration is most relevant to measures of acute stress, which are associated with
upregulated hippocampal IL-1β and signs of microglial reactivity (Piskunov et al., 2016; Chen
et al., 2016). The fact that acute stress increases cytokine expression however doesn’t fit with my
detection of cognitive impairment in the absence of cytokine changes.
Ultimately, it seems that whilst HFD-induced hippocampal priming of microglia can explain
my results, there is no evidence that a secondary insult occurred (a necessary factor for the de-
tection of cognitive impairment according to the suggestions of Sobesky et al. 2016) given that
the effects of acute stress on cytokine expression don’t match my data. In addition, other work
provides evidence that the activation of primed microglia is not necessary to induce early cognitive
impairment (Kaczmarczyk et al., 2013). This leads to a number of suggestions, either that primed
microglia could affect hippocampal processing in a cytokine-independent manner, that hippocam-
pal inflammatory changes are irrelevant to early HFD-induced cognitive deficits, or that microglial
activation occurs in a transient manner, with an early increase in proinflammatory cytokine levels
mediating the behavioural effects of inflammation. No studies so far have looked at hippocam-
pal changes earlier than 1 week, so future work should investigate inflammatory changes in the
hippocampus prior to this in order to evaluate this latter hypothesis. In addition, it would interest-
ing to use a specific marker of circulating monocytes such as chemokine receptor type 2 (CCR2;
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Saederup et al. 2010) to evaluate the presence of hippocampal myeloid cell infiltration following
short-term HFD feeding, given this is the mechanism proposed to mediate phasic hypothalamic
inflammation and has been seen to occur after only a week (Valdearcos et al., 2017). It is pos-
sible that the increased microglial cell density I report could be down to immune cell infiltration
rather than resident microglial proliferation given the immune cell markers used in my experiments
(Iba1 and Cx3CR1) are unable to distinguish between resident and infiltrating inflammatory cells
(Greter et al., 2015). Lastly, it is important to note that my microglial analysis was conducted in
different mice to those that were used in the protein array, with both cohorts showing differential
effects of diet on weight gain. As such, the simultaneous presence of microglial proliferation in
the absence of cytokine or morphology changes cannot be confirmed in my model, so future work
should attempt to address this.
3.4.4 Microglial Cell Density was Increased by HFD, Though Morphology was Un-
changed
Whilst no changes in hippocampal protein levels were detected, HFD was associated with an in-
creased microglial cell density across the cortex, hypothalamus, and hippocampus. This indicates
microglial activation and is usually accompanied by morphological shifts from a ramified to an
amoeboid shape, an additional indicator of activation (microglia reviewed in Kettenmann et al.
(2011) and Hanisch and Kettenmann 2007). Though morphological changes were absent in my
model, Sobesky et al. (2016) suggest that HFD studies that demonstrate elevated markers of mi-
croglial activation without simultaneous increases in the levels of proinflammatory cytokines are
the result of HFD-induced microglial priming (as previously discussed). As an alternative to the
priming theory, it may be the case that transient microglial activation in the hippocampus prior
to the two week timepoint leads to proliferation of microglial cells and morphological changes,
though the latter are reversed when this transient elevation subsides, leading to the results I ob-
serve at the two week point. Transient early dietary effects have been reported previously (Thaler
et al., 2012; Jais et al., 2016), though evidence from Kaczmarczyk et al. (2013) shows no change
in hippocampal inflammation after 1 or 3 weeks. However, no studies have yet looked prior to 1
week, so this theory cannot be disregarded. Such a mechanism could follow a similar pattern to
the phasic hypothalamic inflammation reported by Thaler et al. (2012), where inflammatory cy-
tokine levels return to baseline following a peak at one and three days, only to peak again at four
weeks. This coincided with an elevated microglial cell density at one, three, seven, and 14 days,
providing evidence that increases in microglial cell density persist beyond transient decreases in
proinflammatory cytokine expression.
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Mendes et al. (2018) have proposed that the infiltration of the hypothalamus by circulating
monocytes (Valdearcos et al., 2017) mediates the phasic hypothalamic inflammatory changes re-
ported by Thaler et al. (2012), given this infiltration has been reported after only a week (Valdear-
cos et al., 2017), though whether these infiltrating cells potentiate or inhibit existing inflammatory
processes in the hypothalamus has not yet been studied. Circulating monocytes can cross the BBB
during inflammation (reviewed in Ashhurst et al. 2014) and though Valdearcos et al. (2017) make
the point that previous evidence regarding HFD induced monocyte infiltration appears inconsist-
ent (for Buckman et al. 2014; Morari et al. 2014, against Baufeld et al. 2016), these studies were
confounded by the effect of irradiation on BBB integrity, a confound Valdearcos et al. (2017) over-
came by using head/neck lead shielding - though they also observed infiltration in mice that never
underwent irradiation (Valdearcos et al., 2017).
No studies have looked at hippocampal monocyte infiltration following short-term HFD feed-
ing, so whether this plays a role is still uncertain. The potential for the presence of activated,
proinflammatory resident microglia, coupled with resting ramified infiltrating cells, or vice versa,
could explain the increased microglial cell density I observe, given that neither Iba1 nor Cx3CR1
(the microglial markers used in my studies) are able to distinguish between resident and infiltrating
inflammatory cells (microglial and myeloid markers reviewed in Greter et al. 2015). Future work
should track hippocampal inflammatory changes over the first two weeks of dietary manipulation,
and investigate the presence of infiltrating monocytes (using a marker such as CCR2) as well as
any differential inflammatory phenotype between resident and infiltrating immune cells.
It is important to note that some of the mice used in the microglial analyses carried the
Cx3CR1-GFP mutation, which evidence suggests could impart resistance to the effects of HFD
feeding on microglial activation (Cope et al., 2018). Of the 46 mice used in microglial cell density
analysis, 12 carried the Cx3CR1-GFP mutation, and of those analysed for morphology, none were
Cx3CR1-GFP mutants. Genotype did not significantly affect microglial cell density in my ana-
lysis, suggesting that my microglial results are unaffected by the the inclusion of Cx3CR1-GFP
mice.
3.4.5 Short-Term HFD Did Not Affect BBB Integrity
The BBB isolates the CNS from the rest of the body is formed of specialised endothelial cells,
pericytes, and astrocytic endfeet. Disruptions in its integrity are associated with cognitive decline
and can be both a cause and consequence of CNS pathologies (reviewed in Hawkins and Davis
2005). My results showed no effect of diet or region-specific dietary effects on IgG leakage (either
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looking at vessel-associated extravasated IgG, or IgG signal in the parenchyma), though both di-
etary and regional differences have been reported (Yamamoto et al., 2019; Pallebage-Gamarallage
et al., 2012; Elahy et al., 2015). However, this is likely down to the short timecourse I used relative
to other studies. The earliest time at which HFD-induced impairments in BBB integrity have been
investigated is 1 week, where Rijnsburger et al. (2019) showed no effect of HFD on hypothalamic
BBB integrity, though by 8 weeks, evidence of decreased integrity in the cortex exists (Chang
et al., 2014), with the earliest documented HFD-induced leakage of IgG seen after 12 weeks in
the cortex, brainstem, and hippocampus (Elahy et al., 2015; Pallebage-Gamarallage et al., 2012).
Though no early hippocampal studies exist, evidence suggests that HFD-induced BBB impairment
is the result of long-term dietary manipulations, rather than an early effect. In conjunction with my
behavioural results, this suggests that BBB breakdown, and any associated neurotoxic and proin-
flammatory effects it may have, does not play a role in early HFD hippocampus-specific deficits.
However, it should be noted that Rijnsburger et al. (2019) used Evans blue to interrogate BBB
integrity, a tracer with documented issues regarding the evaluation of BBB integrity (reviewed in
Saunders et al. 2015), and my own work used IgG, a relatively large molecule compared to other
plasma constituents such as albumin (∼155kDa vs 69kDa) so early reductions in BBB integrity
may be detectable through the use of alternative markers. Finally, work by Salameh et al. (2019)
illustrates that HFD could have time and region-specific effects on BBB integrity, and also may
exert differential effects on the mode of transport across the BBB. Future studies should therefore
look at a timecourse of early HFD-related changes in the integrity of hippocampal BBB para-
and transcellular transport with regards to physiologically relevant molecules smaller than IgG,
such as albumin, in order to fully establish whether it plays a role in the development of early
HFD-induced cognitive impairment. However, current evidence suggests this is not the case.
In addition to the absence of early HFD studies on BBB integrity, the mechanisms proposed
to mediate dietary changes have generally not been investigated at early timepoints. Oxidative
stress has been suggested to link HFD feeding to BBB breakdown, given that anti-oxidant treat-
ment has been reported to attenuate HFD-induced impairments in BBB integrity (Elahy et al.,
2015; Takechi et al., 2013; Chang et al., 2014), though the earliest this has been investigated is
8 weeks (Chang et al., 2014). In addition, antagonism of Adora2a, a receptor expressed on both
endothelial cells and pericytes, prevents HFD induced BBB breakdown (Yamamoto et al., 2019),
an effect proposed to result from Adora2a-mediated upregulation of NFκB activity leading to the
downregulation of tight junction proteins (Yamamoto et al., 2019). However, this was only in-
vestigated after 16 weeks of HFD feeding. In contrast to these delayed studies, evidence of early
peripheral inflammation (3 days of HFD elevated inflammatory markers in the spleen and liver
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Souza et al. 2019) suggests that peripheral cytokine mediated BBB breakdown (Fung et al. (2012)
review mechanisms of peripheral inflammation leading to central inflammation) could occur at an
early timepoint in HFD feeding. However it may also be the case that more chronic peripheral
inflammation is necessary to induce BBB changes. In summary, BBB integrity can be comprom-
ised through a number of mechanisms, and short-term HFD studies looking at changes in BBB
integrity to small molecules, oxidative stress, and NFκB activity, will go a long way to improving
our understanding of the early effects of HFD.
3.4.6 The Distance Between Capillary Pericytes is Greatest in the Hippocampus
and Unaffected By HFD
Pericytes are vascular mural cells that play a role in the regulation of capillary blood flow (Hall
et al., 2014), maintain BBB integrity (Haddad-Tóvolli et al., 2017), and provide support to ca-
pillaries (where their loss leads to a loss of capillary density; reviewed in Hirunpattarasilp et al.
2019). My results demonstrate that short-term HFD feeding does not influence their spacing on
the vasculature. Although this is not a direct measure of pericyte function, the absence of a di-
etary effect on spacing suggests a lack of pericyte loss which may indicate their physiological
roles are similarly unaffected. Though confirming this requires more work, this suggests that the
HFD-induced reduction in capillary radius seen in my vascular results may be more likely medi-
ated by dietary effects on endothelial cells, or the physical obstruction of the capillary lumen, than
through pericyte dysfunction (aberrant pericyte constriction is observed in a model of Alzheimer’s
disease; Nortley et al. (2019), and pericyte constriction and death occurs in ischaemia; Hall et al.
2014). Similarly, my results showed a reduction in radius variation, a measure suggested to reflect
the ability of the capillary bed to vary its radii in order to support neurovascular coupling, which
therefore also appears to be independent of pericyte dysfunction. Future work should investig-
ate HFD-induced functional pericyte changes, and determine whether short-term HFD leads to
pericyte constriction to confirm these suggestions.
Other studies have shown that hippocampal pericytes occupy less volume and cover less of
the vessel area following HFD feeding (Yamamoto et al., 2019; Tucsek et al., 2014b), though this
was with much longer dietary durations (16 and 20 weeks respectively). Pericytes are sensitive to
oxidative stress, so the promotion of this by HFD feeding could be responsible for the loss of their
coverage seen in long-term dietary studies. Pericyte loss could lead not only to microvascular rar-
efaction as seen in Tucsek et al. (2014b), but also BBB disruption and neurovascular uncoupling.
An important consideration is that I quantified the effect of diet on pericytes by measuring their
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ISD, whilst Yamamoto et al. (2019) and Tucsek et al. (2014b) quantified the proportion of labelled
vasculature they covered. This likely enabled the detection of more subtle changes, so it remains
possible that short-term HFD feeding affects pericytes but my methodology lacked the sensitivity
to detect this. In addition, a slight difference in the timecourse of dietary effects on pericytes seen
by Yamamoto et al. (2019) and Tucsek et al. (2014b) suggests that HFD-induced pericyte effects
may be time-specific. Though Yamamoto et al. (2019) saw deficits after 16 weeks of HFD in 8
week old mice, 20 weeks was insufficient to induce a reduction in pericyte coverage in mice of
the same age in Tucsek et al. (2014b) (who instead report coverage deficits in 19 month old mice).
This could not be attributed to differences in genotype, sex, HFD composition, or pericyte subtype
analysed (using the definitions outlines by Grant et al. 2019), so may relate to potential variation in
control diet sucrose content, microscopic technique used, or phasic effects of dietary manipulation
on pericyte coverage. An interesting direction for future work would be to quantify the timecourse
of early HFD induced changes in pericyte coverage, perhaps using electron microscopy as in
Yamamoto et al. (2019) to detect any time-specific dietary effects with a high degree of precision.
It is important to note that in my own results neither age nor sex modulated the effect of diet on
pericyte spacing, though overall pericyte spacing did increase with age.
The effect of age on pericytes has previously been reported as a decrease in numbers, degener-
ation and loss, and a reduction in their cross-sectional area (reviewed in Erdö et al. (2017), cited by
Berthiaume et al. 2018), with 21 month old female mice demonstrating cortical and CA1 pericyte
loss and loss of coverage relative to 4 month old mice (Soto et al. (2015), cited by Berthiaume
et al. 2018). However, another study found no difference in pericyte coverage or pericyte number
in primary somatosensory cortex, hippocampus, or posterior thalamus, between mice aged either
4-6, 12-16, or 36-48 weeks old (Nikolakopoulou et al., 2017). Reasons for these discrepancies
could come down to ages used (as the oldest animals in the Soto et al. (2015) study were more
than twice the age of the oldest in Nikolakopoulou et al. 2017), the inclusion of males in Nikolako-
poulou et al. (2017), differences in genetic background (C57BL/6J or 129S1/SvlmJ in Soto et al.
(2015) and Nikolakopoulou et al. (2017) respectively), methodological differences (e.g. CD13
labelled pericytes on lectin labelled vessels, PDGFRB pericytes and laminin vessels, in Nikolako-
poulou et al. (2017) and Soto et al. (2015) respectively), or subtypes of pericytes included in the
analysis (Soto et al. (2015) looked at microvessels, though did not define what this meant, and
Nikolakopoulou et al. (2017) looked at vessels with a diameter of 6 microns or less). My data in-
cluded males, looked at a small age range, and attempted to restrict analysis to capillary pericytes,
similar to Nikolakopoulou et al. (2017), though used mice on a C56BL/6J background and found
an effect of age, as in Soto et al. (2015). Furthermore, I did not characterise pericyte number or
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vessel coverage in the same way as either study, making it very difficult to pinpoint where the
variation in results originates from.
Though my results showed no dietary effects on pericyte ISD they did show that the hippo-
campus had the largest ISD in comparison to the cortex and hypothalamus, a novel finding since
no other work has investigated regional differences in capillary pericyte spacing to my know-
ledge. Given that ISD is independent of capillary density, this suggests that the hippocampal
vasculature has a poorer level of support by pericytes, which could result in the hippocampal BBB
being more vulnerable to disruption, vessels being more susceptible to rarefaction, and a relat-
ively worse regulation of local blood flow changes. When considered in combination with my
other data, which showed that capillary radii and density were lowest in the hippocampus, this
could explain why the hippocampus is more susceptible to pathology associated with hypoxia
(Ng et al., 1989), Alzheimer’s Disease, and ageing (reviewed in Fjell et al. 2014). This may be
how global HFD-induced deficits in vascular structure are translated into hippocampus-specific
cognitive impairment.
3.4.7 GLUT1 Levels are Unaffected by Two Weeks of HFD
GLUT1 is involved in glucose transport into the brain and the maintenance of BBB integrity, with
HFD induced reductions in GLUT1 implicated in the enhanced susceptibility of HFD animals
to ischaemic damage (Haley et al., 2019). As such, changes in GLUT1 expression could play a
role in cognitive impairment by enhancing neuronal susceptibility to damage by reducing glucose
availability. My results showed no effect of diet on GLUT1 expression as assessed by the intensity
of GLUT1 staining, something also observed at the two week timepoint in the cortex by Jais et al.
(2016), who demonstrate that HFD feeding initially decreases the expression of GLUT1 following
three, five, and seven days of HFD feeding, but that its expression recovers to control levels by two
weeks. Other studies also corroborate this profile of GLUT1 changes, where three days of HFD
feeding was associated with its downregulation in cortex (Haley et al., 2019), seven days of a diet
supplemented with a sucrose solution and saturated fat showed no change in GLUT1 expression
in the hypothalamus (Rijnsburger et al., 2019), and a high-fat high-cholesterol diet for six months
showed no effect on GLUT1 levels in the hippocampus (Freeman and Granholm, 2012). My
results add to this body of work, showing that hippocampal, hypothalamic, and cortical GLUT1
expression is unchanged by two weeks of HFD.
Whilst it is possible that early decreases in GLUT1 expression, and the associated reduction
in glucose uptake (Jais et al., 2016), could drive the genesis of hippocampal cognitive deficits
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by promoting greater tissue vulnerability to damage (Haley et al., 2019), Jais et al. (2016) did
not observe early reductions in glucose uptake in the hippocampus, casting doubt on this the-
ory. However, it must be considered that hippocampal effects could exist prior to the 72 hour
timepoint investigated in Jais et al. (2016), given that McLean et al. (2018) reported hippocampus-
dependent cognitive deficits after a day of HFD. In addition, though Jais et al. (2016) looked at
glucose uptake in multiple brain areas, they only investigated cortical changes in GLUT1 levels,
so the phasic nature of dietary effects on its expression in the hippocampus still remains to be
investigated. Future work should track GLUT1 and glucose uptake changes after a day of HFD
feeding, and investigate whether inducing transient decreases in GLUT1 expression can lead to
rapid hippocampus-specific cognitive impairments.
Jais et al. (2016) noted that in their model the recovery of GLUT1 levels was associated with
elevated serum vascular endothelial growth factor (VEGF), which they suggest is derived from
CD206 positive macrophages that were present in greater numbers and showed increased VEGF
expression in the perivascular space in HFD animals. In addition, they demonstrated that the
ablation of macrophage derived VEGF attenuated serum VEGF increases and reduced GLUT1
expression following 6 months of HFD feeding. Though I did not measure serum VEGF levels
in my model, my protein array data showed no effect of diet on VEGF levels in the hippocam-
pus, although the underpowered nature of my protein array must be reiterated. This could relate
to region-specific effects of HFD, given that the results reported by Jais et al. (2016) are based
on cortical tissue, or perhaps the sparse distribution of perivascular macrophages apparent in Jais
et al. (2016) meant their contribution to total hippocampal VEGF levels was below the sensit-
ivity level of the protein array I used. As well as investigating the timecourse of hippocampal
GLUT1 changes, it would be interesting to look at VEGF expression in the hippocampus using
immunofluorescent labelling as done in Jais et al. (2016) to see if their findings are region-specific.
An additional point to consider regarding the effect of HFD feeding on GLUT1 expression is
the HFD fat percentage used. Work by Lizarbe et al. (2019) suggests that the metabolic effects
of long-term HFD feeding vary depending on the percentage of fat content used. Though it is
unclear how relevant this is to short-term effects, that fact that both Jais et al. (2016) and Haley
et al. (2019) used a 60% HFD and observed effects of HFD on GLUT1, whilst Freeman and
Granholm (2012) and Rijnsburger et al. (2019) showed no changes and used a 45% HFD, and a
lard and sucrose supplemented chow diet, respectively, suggests this could be important. Whilst
the differences between these studies could also be accounted for in a number of other ways -
either the timecourse of changes proposed by Jais et al. (2016), or regional differences in dietary
effects - this is a point worth considering, especially since the HFDs I used were 45%, which may
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also explain the lack of hippocampal VEGF changes I detect.
My results showed regional differences in GLUT1 expression driven by the greater GLUT1
staining intensity in the hypothalamus. Zeller et al. (1997) looked a regional differences in GLUT1
and demonstrated that the density of staining shows regional heterogeneity, whilst Takimoto and
Hamada (2014) showed that exercise leads to region-specific changes in GLUT1 levels. Whilst
these studies suggest that GLUT1 expression may be modulated in a region-specific manner, it
appears no studies that have directly compared regional levels of baseline GLUT1 expression, and
included the hypothalamus, exist. Though regional differences in GLUT1 expression appear to
be well founded, the fact that the hypothalamus showed the greatest level of GLUT1 staining in
my results is unusual. Areas with leaky BBBs, such as the hypothalamus, showed no GLUT1
staining in work by Rahner-Welsch et al. (1995), and though the absolute nature of this deficiency
is not supported by other studies that demonstrate hypothalamic GLUT1 staining (e.g. Rijnsburger
et al. 2019), the suggestion that its levels are reduced in areas with lower BBB integrity conflicts
with my results. Revisiting these findings when more work has been done investigating basal
differences in GLUT1 expression between brain regions will help with the interpretation of these
inconsistencies.
3.4.8 HFD Increases Capillary Bed Resistance
The primary function of the microcirculation (arterioles, capillaries, and venules) in the brain is to
supply oxygen and nutrients and remove carbon dioxide and waste products. Cerebral microvas-
cular disease is associated with microbleeds, lacunas, and microlacunas (Kalaria, 2012), which are
seen more commonly in obese individuals with insulin resistance and dyslipidaemia (microvascu-
lature in obesity reviewed by Sorop et al. 2017). Additionally, cerebral small vessel disease is
associated with visceral fat accumulation (Yamashiro et al., 2014). My results demonstrated that
short-term HFD decreases the luminal radius, and variance of the luminal radius in the capillary
bed. Additionally, HFD feeding led to a reduction in the proportion of capillary length that was
perfused by FITC-conjugated albumin. Together, these results suggest that HFD feeding not only
decreases capillary volume and therefore increases resistance to flow, but also impairs the ability
of the capillary bed to regulate local changes in diameter. This latter implication suggests that
HFD impairs neurovascular coupling, whilst the former may be related to an overall decrease in
the ability of the capillary bed to perform vital functions like nutrient delivery and waste removal.
76
3.4.9 Short-Term HFD Does Not Affect Capillary Density
Though my results indicate that short-term HFD has no effect on capillary density, models of
obesity are associated with a reduction in microvascular density (reviewed in Sorop et al. 2017),
whilst long-term HFD feeding in rodents also leads to decreases in vascular density (Estato et al.,
2017; Obadia et al., 2017), the extent of which in hippocampal CA1 has been correlated with the
learning index of animals on an elevated plus maze (Tucsek et al., 2014b), a measure the authors
claim correlates with hippocampal function (Tucsek et al. 2014a cited by Tucsek et al. 2014b).
Microvasular rarefaction can induce non-uniform blood flow distributions, and affects spatial hae-
modynamics of flow (Chantler et al., 2015), changes which could underlie cognitive deficits as-
sociated with long-term dietary manipulations. Tucsek et al. (2014b) suggest the microvascular
rarefaction they report is related to the loss of pericyte coverage they observe (pericyte loss or ab-
errant constriction in hypertension may mediate capillary loss; reviewed in Hirunpattarasilp et al.
2019). As well as capillary rarefaction, there is also evidence demonstrating that long-term HFD
feeding leads to the opposite effect, i.e. a HFD associated increase in capillary length density. This
has been seen in the hippocampus after 12 and 16 weeks (Yamamoto et al., 2019), and in the ARC
after 18 weeks (Yi et al., 2012), of HFD feeding. Coucha et al. (2019) demonstrated a correlation
between aberrant angiogenesis and cognitive impairment, where inhibiting pericyte Ephrin-B2 ex-
pression attenuated the angiogenesis and rescued behavioural performance. The absence of both
pericyte dysfunction and changes in capillary density in my model supports a role for pericytes in
mediating the effect of HFD on capillary stability.
3.4.10 HFD Decreases Capillary Luminal Radii
As previously described, HFD led to a decrease in the radii of capillaries in all brain regions
analysed, which likely has detrimental effects on blood flow and therefore nutrient exchange. De-
termining the cause of the HFD induced capillary radius reduction I observe is difficult, given
that studies investigating the effects of HFD feeding on cerebral capillary structure are limited,
though a few exist that look at the microcirculation in general. Ten weeks of HFD decreased the
size of the lumen of the cerebral microvasculature through the binding together of collagen fibres
(which may be related to the HFD-induced elevation of collagen 1 expression; Deutsch et al. 2009)
and microvessel lumina showed more microvilli, indentations, vacuoles, and wider gaps between
endothelial cells (He et al., 2016). In addition, endothelial surfaces were rougher, which it was sug-
gested could result in haemodynamic changes and increase the risk of microcirculatory blood clots
(He et al., 2016). Six months of a HFD in hamsters led to enlarged endothelial cells, irregularly
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shaped vessels with large perivascular spaces, and some lumina filled with lipoprotein particles
(Constantinescu et al., 2011). This same duration of HFD in rats led to changes in myofibrils
in smooth muscle cells, the thinning of endothelial cells, and the enlargement of subendothelial
spaces (Mato et al., 1996). Endothelial pathology and the exposure of subendothelial connective
tissue, as is documented in these cited studies, can increase the likelihood of blood flow retarda-
tion and platelet aggregation (blood flow control reviewed in Itoh and Suzuki 2012) and ultimately
thrombosis (He et al., 2016), another potential mechanism for reducing the size of capillary lu-
mina.
3.4.11 Capillary Radius Variation is Reduced by HFD
In the brain, regional changes in neuronal activity require changes in blood flow distribution to fa-
cilitate region-specific nutrient exchange and removal of waste products. My results demonstrated
a reduction in the variation of radii in the capillary bed, suggesting an impaired ability of the ves-
sels to regionally vary their diameter. This is typically stimulated through metabolic vasodilatory
signalling, and given that deficits in the ability of the vasculature to respond to vasodilatory signals
has been documented in a model of HFD feeding (Obadia et al., 2017), such an impairment could
be behind the decreased radius variance I report. However, dietary effects on vasodilatory capacity
have not been investigated following short-term HFD feeding. My results, suggesting a reduction
in the dilatory capacity of the capillary bed, may be associated with deficits in neurovascular coup-
ling in vivo, as is reported by Tucsek et al. (2014b) and Li et al. (2013) following longer periods
of HFD feeding.
3.4.12 Two Weeks of HFD Decreases Capillary Perfusion
Capillary perfusion by FITC-conjugated albumin was associated with the presence of non-perfused
gaps between perfused segments of the vasculature. A comparison of the proportion of total ca-
pillary length perfused revealed a trend level effect of diet, where HFD animals showed reduced
vascular perfusion levels. In addition, given the data appeared to have more of a bimodal than nor-
mal distribution, a logistic regression was conducted. This showed that the probability of having
a perfusion percentage below 50% of total capillary length was significantly increased in the HFD
group.
As for what may cause this incomplete perfusion, it is possible that the endothelial pathology
seen in longer term HFD feeding (He et al., 2016; Constantinescu et al., 2011) occurs early as
well, and in doing so may promote platelet aggregation, and ultimately thrombosis (He et al.,
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2016), where the presence of aggregates could underlie the appearance of non-perfused vascular
segments. An alternate source of capillary lumen blockage or obstruction could relate to leuko-
cytes, as leukocyte adhesion to endothelial cells could plug capillaries and disturb flow (del Zoppo
et al., 1991). Indeed, Obadia et al. (2017) observed a significant increase in the number of rolling
and adherent leukocytes in HFD fed animals, although this was in post-capillary venules, and
again, has only been looked at after long-term HFD feeding.
The fact that these non-perfused segments occur in-between perfused regions of the vascu-
lature make it unlikely that they are due to total blockages of the capillary bed, unless there was
a degree of retrograde movement of perfusate from venous circulation back into the capillaries.
Assuming this is not the case, it therefore seems that as the FITC-conjugated albumin / gelatin per-
fusate begins to set, parts of the capillary bed exert enough pressure to force out the semi-solidified
gelatin once the positive pressure of the perfusion has ceased. These regions of increased pressure
could be areas of platelet aggregation or leukocyte adhesion, or may be parts of the capillary bed
where bound collagen fibres or lipoprotein particles partially obstruct the luminal radius. Another
possibility is that these proposed high-resistance areas of the capillary bed are areas where peri-
cytes have constricted, as they do in a model of Alzheimer’s disease (Nortley et al., 2019), or
where they have constricted and then died, as they do in ischaemia (Hall et al., 2014). Though my
results suggest an absence of early dietary effects on pericytes, I only evaluated changes in ISD, so
early HFD induced pericyte constriction remains a possible mechanism. This could also explain
both the perfusion results, and the overall capillary radius reductions.
To investigate the mechanisms underpinning the perfusion reduction observed in my model,
experiments should look at the prevalence of rolling and adherent leukocytes in the capillary bed,
as well as the detection of platelet aggregates, thromboses, lipoprotein particles, and bound colla-
gen fibres, following short-term HFD feeding. An analysis of pericyte death in the capillary bed,
as well as the distribution of capillary radii at the points where pericytes are located, could help
reveal if their constriction (and possible death) are involved.
3.4.13 The Hippocampus has a Poorer Ratio of Vascular Supply to Metabolic De-
mand than the Cortex
Capillary length density was lowest in the hippocampus, followed by the hypothalamus and then
the cortex. These results fit with work by Todorov et al. (2019), who demonstrated (in a pre-
print) that vessel density was greater in visual cortex than the arcuate hypothalamic area in mice,
and Klein et al. (1986), who reported a significantly lower vessel segment density between the
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hippocampus and all of frontal, visual, and auditory cortices in rats. In Wu et al. (2004b) vessel
density was estimated using MRI, and the value in the cerebral cortex was almost twice that in the
hippocampus, whilst Bohn et al. (2016) demonstrated an elevated vessel density in frontal cortex
relative to hippocampus in both rats and mice. Both Patt et al. (1997) and Zeller et al. (1997)
showed greater vessel number density in the cortex compared to the hippocampus. Results also
showed that capillary radius, and radius variance, were lowest in the hippocampus, followed by
the cortex and then the hypothalamus. Studies looking at regional differences in vessel radius
are rare, though Todorov et al. (2019) demonstrate heterogeneity in vascular radii between brain
regions, and showed reduced vessel radii in the hypothalamus compared to the cortex - although
this was not significant. Weiss et al. (1982) found no significant differences between rat brain
regions in terms of vessel diameter, though they note this was not a measure of lumen exclusively
as it also included endothelial walls. There appear to be no other studies that have reported their
vessel radius data by region, or made it available to interrogate personally or by vessel type, so it
is hard to say if my results fit with the literature. Overall however, the lack of vascular support in
the hippocampus (assessed as capillary density, radius, and radius variance) relative to the cortex
suggests it has reduced blood volume and blood flow, which could make it more sensitive to the
effects of HFD, and in doing so, underlie the fact that HFD feeding leads to hippocampus-specific
deficits. Indeed, in rats blood volume and blood flow in the hippocampus is reduced relative to the
cortex (somatosensory, visual, auditory, and frontal; Cremer and Seville 1983).
Given the correlation between regional vessel density, local blood flow, and glucose utilisa-
tion (Klein et al., 1986), my results suggest that the hippocampus receives less vascular support
in terms of energy/nutrient supply and metabolic waste removal than the cortex. Though this also
suggests vascular support is proportional to energy demand, evidence indicates that the hippocam-
pus has equal, if not greater, neuronal metabolic demands than the cortex. Neuronal density in
the parietal and visual cortices (regions of the neocortex imaged in my data; 150,000 +/- 100,000
and 164,000 +/- 50,000 cells/mm3) is reduced relative to that of hippocampal CA1 (the primary
hippocampal subfield imaged; 307,000 +/- 200,000 in dorsal, 180,500 cell/mm3 in ventral) in mice
(numbers taken from Keller et al. 2018). In addition, the uptake of glucose, as indexed using mass
spectrometry by the relative abundance of the distribution of hexose phosphate (Kleinridders et al.,
2018) appears similar between the hypothalamus (∼140), hippocampus (∼145) and cortex (∼110)
in mice, with Zeller et al. (1997) reporting a similar degree of glucose utilisation in cortical V1 and
hippocampal CA1. Together these findings suggest that the metabolic requirements are similar, if
not greater, in the hippocampus relative to the cortex, which when considered with regional dif-
ferences in vascular support, demonstrates the uncoupling of hippocampal vascular supply from
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metabolic demand. This is likely what underlies the elevated susceptibility of the hippocampus
to damage in a number of pathologies, and could translate global HFD-induced changes (such as
microglial proliferation, reductions in capillary radius, radius variance, and perfusion extent) into
hippocampus-specific cognitive deficits.
3.5 Conclusion
To conclude, two weeks of HFD feeding was associated with the imminent onset of diet induced
weight gain, though in the cohort of mice that displayed hippocampus-specific cognitive defi-
cits HFD feeding had no effect on weight, supporting the evidence that HFD can induce early
hippocampus-specific cognitive impairment through weight-gain independent mechanisms. This
may be through effects on insulin signalling or BDNF expression. Analysis of hippocampal
proteins and proinflammatory cytokines revealed no diet induced changes, nor any correlation
between protein levels and behavioural performance. When considered with the evidence of diet-
induced microglial proliferation in the absence of morphological changes, these results suggested
that short-term HFD feeding may prime, rather than activate, hippocampal microglia. A mechan-
ism linking microglial priming to HFD-induced cognitive deficits is unclear, though the inflam-
matory results reported may also be driven by the infiltration of circulating monocytes. Short-term
HFD did not affect BBB integrity, though more work needs to be done in order to evaluate hippo-
campal changes using smaller molecules, and neither the distance between capillary pericytes, nor
levels of GLUT1 expression, were affected by diet. HFD feeding was associated with numerous
detrimental effects on the capillaries themselves, including a reduction in the radius of capillary
lumina and a reduction in the length of the capillaries that were perfused by a gelatin solution.
These changes likely reflect diet induced capillary obstruction or blockage by platelet aggregates,
adherent leukocytes, collagen fibres, lipoprotein particles, or constricted (and potentially dead)
pericytes. Finally, regional differences support the suggestion that the hippocampus suffers from
a relative uncoupling of blood supply from metabolic demand due to its reduced capillary density
and smaller average capillary radius relative to regions such as the cortex. My results therefore
support the evidence that short-term HFD feeding is associated with hippocampus-specific cognit-
ive deficits, and suggest this could result from global dietary effects having a greater detrimental
effect on hippocampal processing relative to other brain regions due to the enhanced vulnerability
of its neurons to damage given their paucity of vascular support.
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Chapter 4
In Vivo Microglial Changes
4.1 Introduction
Short-term exposure to a HFD is associated with hippocampus-specific cognitive deficits (McLean
et al., 2018; Kanoski and Davidson, 2010), though the mechanisms behind this remain poorly
investigated. In the previous chapter I demonstrated that this is likely the result of global HFD-
induced detrimental changes, such as microglial proliferation and capillary bed structural impair-
ments, that are translated into hippocampus-specific deficits as a result of its poor vascular support
system leading to enhanced neuronal susceptibility to damage. However, I only investigated this
after two weeks of HFD feeding, given this was the time at which my group previously demon-
strated HFD-induced impairments in the hippocampus-specific NOCR task in unpublished work.
I was therefore unable to determine whether microglial changes contribute to the genesis of early
cognitive deficits given they appear within 24 hours (McLean et al., 2018). In addition, I hypo-
thesised that microglia may be primed, rather than activated, by short-term HFD feeding, given I
observed evidence of their proliferation in the absence of morphological or cytokine level changes.
As an alternative theory, a transient peak in microglial activation that subsides within the first two
weeks of HFD could promote initial proliferation and morphological and cytokine changes, with
the only persistent evidence of this being an increased microglial density once it has subsided.
Whilst phasic inflammatory changes have been documented in the hypothalamus (Thaler et al.,
2012) their existence has not been investigated in the hippocampus and cortex. To answer these
questions I used in vivo timecourse imaging of mice implanted with cranial windows over cortical
V1 and hippocampal CA1 to investigate microglial changes starting at the very beginning of di-
etary treatment and lasting for 8 weeks. At the end of this timecourse mice were injected with
LPS to induce an inflammatory response. This served as a positive control in order to confirm my
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analyses were able to detect inflammatory microglial changes, but also allowed me to evaluate the
microglial priming theory.
4.1.1 Microglial Priming
Results from the previous chapter demonstrated cognitive impairment without any concurrent el-
evation of hippocampal proinflammatory cytokines, something that has been shown previously
after short-term HFD (Kaczmarczyk et al., 2013). Though this suggests an absence of inflammat-
ory changes, microglia were present in greater numbers, a sign of microglial activation. However,
this was not coupled with any change in microglial morphology, an additional marker of activation
(microglia reviewed in Kettenmann et al. 2011). An explanation for microglial proliferation in the
absence of either cytokine or morphological changes is that these cells were primed rather than
activated.
Microglial priming is widely observed with age and in neurodegenerative diseases (reviewed
in Tay et al. 2017; Norden and Godbout 2013; Perry and Holmes 2014). Like activated microglia,
primed cells proliferate (priming reviewed in Li et al. 2018) and their somas increase in size
(Torres-Platas et al., 2014). However, they are highly ramified like resting microglia (Torres-Platas
et al., 2014) and do not produce inflammatory mediators (Perry and Holmes 2014 in Hoogland
et al. 2018). They also produce an exaggerated inflammatory response following a proinflam-
matory stimulus, and aged (and therefore likely primed) microglia demonstrate reduced process
motility (reported in the outer plexiform layer of the retina; Damani et al. 2011). There is evid-
ence that obesity is associated with altered responses to immune challenge that might be associated
with inflammatory priming, where obese individuals have impaired wound healing, and alongside
obese rodents, are more susceptible to infections (Wilson and Clark, 2004; Falagas and Kompoti,
2006; Smith et al., 2007). With regards to HFD feeding, Sobesky et al. (2016) and (Souza et al.,
2019) both demonstrated evidence of microglial priming after only 3 days of HFD, and after 8
weeks diet-induced obese rats showed greater LPS induced elevations in levels of hypothalamic
IL-1β , IL-6, and SOCS3 mRNA (Pohl et al., 2009). However, after 16 weeks of HFD isolated
hypothalamic microglia demonstrated no evidence of priming (Baufeld et al., 2016), illustrating
that HFD-induced priming may be an inconsistent dietary effect.
4.1.2 Phasic Inflammatory Changes
The uncoupling of microglial proliferation from morphological and cytokine changes could relate
to phasic patterns of HFD-induced inflammation. Thaler et al. (2012) showed that proinflammat-
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ory cytokine mRNA levels in the hypothalamus are elevated after 1 and 3 days of HFD, but return
to basal levels by 7 days. They are then elevated again after four weeks. If a similar pattern of
inflammation occurs throughout the brain, it is possible that its initial peak drives microglial pro-
liferation and morphological changes, before the latter returns to baseline as cytokine production
falls at the end of the first week of HFD feeding. This would result in an environment at the two
week point where microglial cells that proliferated at an earlier timepoint are still present, but have
returned to a resting morphology. In addition, basal levels of cytokines would be detected. With
regards to the associated cognitive deficits, inflammation could drive the genesis of behavioural
impairment during the initial cytokine peak, with the results of this persisting beyond the transient
activation.
Though demonstrated in the hypothalamus (Thaler et al., 2012), evidence for similar phasic
changes in the hippocampus is mixed, though admittedly not well studied. Within 1 and 3 weeks of
HFD feeding there are no signs of hippocampal inflammation (Kaczmarczyk et al., 2013), though
this would fit with the timecourse established by Thaler et al. (2012), whilst long-term studies
show both increases (Thirumangalakudi et al., 2008; Liu et al., 2014) and no change (Boitard et al.,
2014; Sobesky et al., 2014) in hippocampal cytokine levels. What underlies the biphasic cytokine
response to HFD reported by Thaler et al. (2012) remains unclear, though Mendes et al. (2018)
suggest that it could be due to the HFD induced infiltration of circulating monocytes (Valdearcos
et al., 2017). However, this has thus far only been reported in the hypothalamus, where it took
place after a week (Valdearcos et al., 2017).
4.1.3 Aims, Hypotheses, and Experimental Approach
Thus far no work has looked at inflammatory changes in the hippocampus or cortex at any timepoint
prior to one week of HFD feeding. In addition, no studies have tracked inflammatory changes over
time in the hippocampus or cortex, so it remains unclear if phasic inflammatory responses to HFD
occur in these regions as they do in the hypothalamus (Thaler et al., 2012). Finally, no studies
have looked at the effect of HFD on microglia in vivo, and have also therefore not been able to
correlate cognitive performance with cellular measures within the same animal. I hypothesised
that hippocampal inflammation would show a phasic pattern, with it being detected initially but
returning to baseline by the two week timepoint, before becoming elevated again at a later time.
The initial peak would be responsible for driving mechanisms involved in hippocampal cognitive
impairment, and therefore mice undergoing cognitive testing at any point during the inflammatory
return to baseline would show no correlation between behaviour and microglial activation. Al-
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ternatively, I hypothesised that no changes in microglial activation would be detected until later
in the dietary manipulation, and that microglia would show evidence of priming instead of phasic
patterns of activation.
My aims with the work presented in this chapter were to to investigate whether microglial
changes contribute to the genesis of early cognitive deficits resulting from HFD feeding by invest-
igating them at multiple timepoints within the first week of manipulation, to look at microglial
changes at multiple points over a timecourse to evaluate the presence of phasic inflammatory
changes in the cortex and hippocampus, to combine in vivo microglial imaging with hippocampus-
specific NOCR behavioural testing in order to correlate changes in microglia with cognitive per-
formance, to evaluate whether hippocampal window surgery affected behavioural performance
relative to naive mice (mice that had not undergone any surgery), and to determine whether HFD
feeding primed microglia.
To address these aims I used two photon microscopy to conduct in vivo timecourse imaging
of awake, behaving, mice with fluorescently labelled microglia (using the Cx3CR1-GFP mutation
that labels microglia and circulating monocytes; Imai et al. 1997) implanted with cranial windows
over cortical V1 and hippocampal CA1 to image microglia starting at the very beginning of dietary
treatment and lasting for 8 weeks. At the end of this timecourse mice were injected with LPS
to induce an inflammatory response. By imaging both cortex and the hippocampus I was able
to determine whether HFD-induced inflammatory changes showed any region-specific effects at
multiple timepoints, since the global effects I detected in my previous chapter were only related to
dietary changes following two weeks of feeding, and taking an in vivo approach allowed me to not
only quantify changes in microglial activation (by analysing changes in their morphology, with this
being a widely accepted metric of inflammatory microglial changes; Kettenmann et al. 2011), but
also to look at microglial process motility. Microglia extend and retract their processes in order
to survey their environment and continuously interact with surrounding elements (Nimmerjahn
et al. 2005 cited in Hierro-Bujalance et al. 2018). This process is ATP dependent (Davalos et al.,
2005) and the extent of their motility varies with neuronal activity (in a preprint; Nebeling et al.
2019). Inflammation induced by systemic administration of LPS decreased process motility (Paris
et al., 2018), which would suggest that proinflammatory HFD exposure should do the same. The
effect of HFD treatment on process motility however has thus far not been published, with the most
relevant work conducted by Madore et al. (2014) (cited in Paolicelli and Ferretti 2017) who looked
at the effects of n-3 polyunsaturated fatty acid (PUFA) deficiency, and noted a change in motility at
postnatal day 21 in mice raised by mothers that were fed PUFA deficient diets throughout gestation
and lactation.
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By looking at timepoints that span from within the first week of dietary manipulation to up to
2 months, I was able to both evaluate microglial activation at the very beginning of dietary treat-
ment, thereby shedding light on the contribution of inflammatory changes to the genesis of early
HFD-induced cognitive impairment, as well as investigate the presence of a phasic inflammatory
response to HFD feeding over an 8 week period. In addition, the systemic administration of LPS,
which induces central inflammation through stimulation of microglia TLR4 at CVOs (Laflamme
and Rivest, 2001), allowed me to evaluate whether hippocampal and cortical microglia are primed
by 8 weeks of HFD feeding given that primed microglia produce a greater inflammatory response
after a secondary immune challenge (microglial priming reviewed in Perry and Holmes 2014).
This also served as a positive control, allowing me to confirm that my analyses were able to detect
signs of microglial activation. Finally, hippocampal window mice were tested on hippocampus-
specific NOCR at the two week timepoint in parallel with the wild type mice described in the
previous chapter. Besides correlating cognition with microglial changes, this allowed me to eval-
uate the effect of surgery on baseline hippocampal cognition and diet induced cognitive deficits.
I elected to perform behavioural testing after two weeks of HFD feeding as this was the duration
used in the HFD induced deficits reported previously in unpublished work in my lab. The fact
that my imaging was conducted in awake mice is important, as arousal state can influence mi-
croglial morphology and process motility, with microglia in awake mice demonstrating reduced
ramification and increased levels of process motility relative to anaesthetised animals (in a pre-
print; Stowell et al. 2019). Additionally, during development, the contact of microglial processes
with dendrites induced the formation of new spines, but only in awake mice (Miyamoto et al.,
2016).
4.2 Methods
4.2.1 Animals, Dietary Manipulation, and Experimental Approach
Details of animal genotypes, diets used, behavioural testing, window implantation surgeries, and
imaging setup, are presented in the main methods (Chapter 2). All in vivo imaging data were
collected from Cx3CR1-GFP heterozygotes that had undergone either cortical, or hippocampal,
window implantation. These mice were housed in a reverse light-dark cycle to minimise the
impact of imaging sessions on circadian rhythms, and fed either a HFD or control diet for 57 days.
In some cases, window implanted mice had to be culled prior to 57 days for welfare purposes.
After imaging on day 56, window implanted mice were injected with LPS to induce microglial
activation and then imaged again 24 hours later. Following this, mice were either culled using
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cervical dislocation or given a terminal dose of i.p. sodium pentobarbital (Dolethal; Vétoquinol
Ltd) at 120mg/kg (diluted to 10% in saline). Behavioural testing was run on hippocampal window
mice alongside a cohort of wild type C57BL/6J naive mice in order to evaluate the effect of surgery,
and dietary manipulation, on hippocampal functioning. As with the in vivo mice, these wild type
animals were fed either a HFD or control diet. The behavioural protocol began on day 11 of
dietary manipulation, and ran until day 14, the day on which testing took place. After testing wild
type mice were culled using cervical dislocation. Mice were weighed daily, though not always at
the same time of day. A summary of mice used is presented in Table 4.1. The mice used in this
chapter and the chapter following (Chapter 5) were the same.
Table 4.1: Summary Statistics of Mice Used in Chapters 4 and 5. Mouse information split by surgery status.
Genotype indicates the genotype of mice used. Count indicates the total number of mice with those fed a HFD
denoted in parentheses. Male : Female displays the ratio of male to female mice. Age represents age at the start of
dietary manipulation, and is presented as the mean +/- 1 SD in units of weeks.
4.2.2 Two-Photon Microscopy
High-resolution imaging of vessels and microglia was performed with a commercial two-photon
microscope (SP5, Leica), a high numerical aperture water-dipping objective (Olympus 20X
XLUMPLFLN20XW; Nikon 16X N16XLWD-PF), and a mode-locked Ti-sapphire multiphoton
laser (Chameleon, Coherent). Tissue was excited at a 940nm wavelength, and the emitted light was
filtered to collect red and green light from Texas Red Dextran (vessel lumina) and Cx3CR1-GFP
(microglia). Imaging sessions were recorded in the SciScan software (Scientifica). Laser power
at the objective was kept below 25mW to minimize photodamage. Laser power and photodetector
gain was kept relatively constant between imaging sessions to prevent drastic variations in the
signal to noise ratio of images. Stacks sampling 100 µm of tissue were collected for microglial
morphology analysis from a depth below the window of 50 µm down to 150 µm. These were
acquired at a resolution of 512 x 512 pixels with a voxel size of 580 x 580 x 1000nm (XYZ). Six
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frames were taken at each imaging plane. These parameters were based on work by Kozlowski and
Weimer (2012). Likewise, the stacks used for microglial process motility quantification sampled
50 µm of tissue from a depth of 75 µm down to 125 µm below the window. These were captured
at 512 x 512 pixels with a voxel resolution of 270 x 270 x 2000nm (XYZ). Fourteen frames
were taken per plane, and six motility stacks, 386 seconds apart, were recorded per animal per
timepoint to create a timelapse of z-stacks. These parameters were chosen given they provided
a good balance between quick stack acquisition and a high enough frame count, as frames that
were contaminated by motion had to be removed. Capturing 14 frames per plane provided a
good likelihood that at least one frame would be unaffected by motion, allowing me to recompile
the stack after motion correction. Given the clear difference in appearance between control and
high fat pellets, imaging was not blinded to dietary manipulation. Additionally, imaging was not
blind to timepoint or window placement, as cortical and hippocampal windows required the use
of different objectives.
4.2.3 Image Processing
Images were processed and analysed using the Fiji distribution of ImageJ (Schindelin et al., 2012).
Custom scripts were written to detect and remove motion-contaminated frames. First, contrast
levels within a stack were normalised using the Stack Contrast Adjustment plug-in (Cˇapek et al.,
2006) before a Laplacian of Gaussian filter was applied to the images and the maximum pixel grey
value was used as a measure of distortion, where higher values represent more distorted images.
The frame from each plane that had the lowest maximum grey value was selected, and the selected
frames were recompiled into a z-stack. Stacks were then registered with the MuliStackReg plug-in
(Thévenaz et al., 1998). In the case of stacks acquired for process motility analysis, these were
registered across time by registering them to the previously acquired z-stack. Following frame
selection and registration, stacks were inspected for the quality of preprocessing. Where this
wasn’t satisfactory, manually selected frames were recompiled and registered. If this was still not
adequate, images were excluded from further analysis. Image processing was done blind to diet
group, window placement, timepoint, and mouse identity.
4.2.4 Image Quantification
All image quantification was done blind to diet group, window placement, timepoint, and mouse
identity.
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Microglial Morphology
The methodology used to semi-automatically generate microglial cell masks from two-photon
image stacks is based on the work of Kozlowski and Weimer (2012). 100 µm deep z-stacks were
split into three 10 µm stacks separated by 20 µm, where this separation would prevent the same
cells being sampled in multiple 10 µm sub-stacks. A mean intensity projection was taken of each
sub-stack and these were used for quantification. Cell locations were marked manually on these
projections and a 120 x 120 µm ROI was drawn around each cell. Otsu’s method (Otsu, 1979),
which minimizes the interclass pixel intensity variance between the two pixel classes (’on’ or
’off’) within the image (Kozlowski and Weimer, 2012), was used to compute an initial grey value
for thresholding. This was applied in the Find Connected Regions plug-in, where all pixels that
fell above this threshold and were in contact with the marked cell location were used to form a cell
mask. The area of this mask was calculated and then compared to a user defined target area. If
the area of the mask fell within these values (+/- a user defined range), the mask was considered
complete and mask generation moved onto the next cell location. Otherwise, iterative thresholding
was used whereby the applied threshold value was adjusted until either the cell area fell within the
desired range, or the cell area stabilised for three consecutive iterations. The formula used to
determine the threshold for the next iteration
TIT+1 = TIT +TIT
AIT −TCA
n(TCA)
relates the threshold for the next iteration (TIT+1) to the current threshold (TIT ), the area of the
current threshold (AIT ), the target cell area (TCA), and the number of iterations thus far (n).
Cell masks were excluded from further analysis if an accepted mask contacted the edge of the
120 x 120 µm ROI. For accepted masks, masks of the cell soma were generated using automated
thresholding and particle detection, where particles that were smaller than 20µm2 and had a cir-
cularity value of less than 0.6 were excluded.
An analysis of different target cell area (TCA) values (200 - 800µm2) was conducted to select
the value that provided the best discrimination between resting and LPS-induced activated mi-
croglia in control diet fed animals. This was done based on the size of the effect of LPS treatment
on a composite morphology index I dubbed an ’inflammation index’ (Fig 4.6). The calculation of
this index is outlined in the statistical analysis section. A TCA of 500µm2 with a range of 100µm2
not only provided good discrimination between resting and activated cells, but was also used by
Kozlowski and Weimer (2012), so was selected as the value to use for all future analyses.
Automatically generated cell and soma masks were inspected manually. Cell masks were
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excluded if they contained more than one cell, clearly misrepresented the cell at the indicated
location, or represented cells that were not positioned within the imaged volume. Soma masks
were redrawn manually if the automated generation was inadequate, and were excluded from
analysis if their associated cell mask has been excluded.
Finally, cell and soma masks that passed inspection were quantified. Multiple parameters
were calculated. This involved the use of a sholl analysis (Ferreira et al. 2014; Fig 4.1 B, C, D),
quantification of simple shape descriptors (Fig 4.1 A), skeletonisation of the mask, and the use
of a fractal and hull and circularity morphometrics analysis using FracLac for ImageJ (Karperien
2013; Fig 4.1 A). A full list of measures is presented in Table 4.2.
Microglial Motility
The analysis of microglial process motility was based on work by Sipe et al. (2016). After im-
age stack preprocessing, ROIs were drawn around cells in z-stacks before these were manually
thresholded. Within each ROI, overlays were created for each pair of adjacent timepoints and
pixels were classified as either retraction (present in the first time point, but absent in the second),
extension (absent in the first but present in the second) or stable (present at both timepoints).
These classifications were used to calculate a motility index (MI; sum of extension and retrac-
tion pixels / the number of stable pixels), a retraction index (RI; the number of retraction pixels /
the number of stable pixels), an extension index (EI; the number of extension pixels / the number
of stable pixels), a stability index (SI; the proportion of pixels that were classified as extension that
became stable pixels at the subsequent timepoint), and an instability index (II; the proportion of
stable pixels that were classified as retraction at the subsequent timepoint). These classifications
and indices were calculated separately for each z plane. Figure 4.2 illustrates how two-photon
images were thresholded and used to create timepoint overlays that were used to classify pixels
for the calculation of various motility indices.
4.2.5 Statistical Analysis
As stated in the main methods chapter, all analyses were run using LMMs and all plotted values
represent the estimated marginal mean +/- 1 SEM derived from the appropriate LMM, unless oth-
erwise indicated. The use of cells or mice as subjects in an analysis is indicated in the appropriate
figure legends. Where cells were used as subjects this was accounted for by including a random
effect structure in the appropriate statistical model that grouped measurements by animal.
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Figure 4.1: Example of Automated Morphology Measure Generation. (A) Semi-automated generation of mi-
croglial cell masks was involved in quantifying parameters such as cell perimeter (green outline), soma area (magenta
outline), and cell spread (red lines). Hull and circle morphometrics were based on analysis of the convex hull (cyan
outline) and bounding circle (green circle). (B) A sholl analysis performed on the cell mask counted the number of
branches at varying distances from the cell soma. The analysis began from a distance equal to the circular radius of
the soma (white circle in the mask centre) from the centre of the cell soma (black dot). Coloured rings indicate the
number of branches at increasing distances. Coloured spots on branches are colour coded by number of branches at
that distance. Colour scale indicates colour coding. (C) A linear sholl analysis was used to compute values such as the
mean, median, and sum of branches (here called intersections), as well as the centroid (red dot, the mean position of
all plotted points). Values were derived for both the sample data, and data based on the best fit polynomial (blue line).
(D) A log-log sholl analysis. For both semi-log and log-log analyses, the numbers of intersections are normalised to the
area of the mask, then plotted either against distance or the log of the distance respectively. Plotting a linear regression
(blue line) can be used to derive a regression coefficient (k) and intercept. This can also be calculated for data within
the 10th to 90th percentiles (red line). Plots C, D were output by the sholl analysis plug-in in ImageJ.
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Table 4.2: Automatically Generated Microglia Morphology Measures. A wide range of parameters were used to
quantify microglial morphology. These were from five different analyses. Yellow; simple shape descriptors. Green;
measures based on the cell mask skeleton. Purple; parameters derived from sholl analyses. Intersections refer to
processes. Fit and sampled refer to measures derived from the polynomial fit or raw data of linear sholl analyses
respectively. Semi-log and log-log refer to values derived from the semi-log and log-log sholl analyses. [P10-P90]
refers to values derived from data within the 10th to 90th percentiles, rather than all the data. Red; indicates hull and
circularity morphometrics. Blue; fractal analysis. Orange; branching density is calculated by dividing the skeleton
area by the convex hull area.
The impact of diet and time on weight gain was analysed by normalising weights for each
animal to their weight at the beginning of dietary manipulation. This was done to control for
differences in starting weight, given the use of mice of both sexes and varied age. On occasion
mice were not weighed everyday throughout the 8 week dietary manipulation. To account for
this. missing weight readings were filled in for each animal using linear regression predictions.
The number of missing weights by day (and percent by diet group) are presented in Table 4.3.
Separate analyses were done for in vivo imaging mice and behaviourally tested mice (these mice
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Figure 4.2: Calculation of Indices of Process Motility. Two-Photon Image; Process motility indices were calcu-
lated by thresholding stacks of microglial cells obtained with two-photon microscopy. Thresholded Image; Adjacent
timepoints were compared between manually thresholded stacks. Overlay Timelapse; Pixels were classified either as
extension (green), retraction (red) or stable (yellow), depending on whether they appeared, disappeared, or remained,
from one timepoint to the next. Process Motility Indices; The MI, EI, and RI were calculated within each timepoint
comparison i.e. within C1, C2, or C3. The SI and II were calculated across timepoint comparisons i.e. using both C1
and C2, or C2 and C3. SI was calculated using the number of extension pixels in a previous comparison that became
stable pixels in the next. This was divided by the number of extension pixels in the previous comparison. II was cal-
culated using the number stable pixels in a previous comparison that became retraction pixels in the next. This was
divided by the number of stable pixels in the previous comparison.
also included the hippocampal window in vivo mice). Fixed effects were specified as diet, day
and surgery status (cortical window, hippocampal window, or naive), as well as their interactions.
The main effects of sex and age were also included as factors. Random intercepts were included
for each animal with random slopes for the relationship between days. An autoregressive order 1
model for the correlation between days was included.
NOCR performance was analysed with NI as the dependent variable, and fixed effects were
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Table 4.3: Record of Missing In Vivo Weights. The number of missing weight recordings by day and diet group for
in vivo imaging mice, with the percentage of weights missing by day and diet group indicated in brackets.
specified as diet, surgery status, and their interaction. The main effects of sex, age, and weight
change (relative to baseline) were included. A random intercept for animal was included.
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Microglial Statistical Analysis
Microglial morphology changes were analysed using a similar technique to that of Heindl et al.
(2018). This involved first identifying the morphological measures that were best able to distin-
guish LPS-activated from resting microglial cells (i.e. cells imaged at day 57 of dietary manipula-
tion, 24 hours after LPS injection, compared to cells imaged at day 56) in control diet fed, cortical
window mice. This was done to avoid the influence of dietary manipulation and tissue aspiration
on the ability of morphological measures to distinguish between the conditions. The discriminat-
ory ability of the measures was quantified using receiver operating characteristic (ROC) analysis.
ROC curves plot the false positive and true positive rates of binary classification against one an-
other at differing thresholds, with the area under the curve (AUC) of the plot used to quantify
the accuracy of the binary classifier (examples are demonstrated in Fig 4.5). A PCA with feature
centering and scaling was run on the measures that had the best AUC values to further reduce
the dimensionality of the dataset, and the PC1 was used as an index of inflammation-related mor-
phology changes. This is what is referred to in this chapter as an ’inflammation index’. When
selecting measures based on ROC performance, measures that were present in variant forms were
compared with one another and the poorest performing variant was dropped. Variants existed for
sholl parameters derived from all, or a percentile of the data, as well as from sampled or fitted data,
and from hull and circle morphometrics based on the bounding circle centre or centre of mass.
Microglia motility indices were averaged across all z-depths. Each index was analysed sep-
arately, as was a combined motility index constructed using a PCA with feature centering and
scaling run on all calculated motility indices. This compound index is referred to in this chapter
as the compound motility score.
The main effects of sex, age, and weight change were included for all the following described
models, except for those used for TCA selection. Cells were used as subjects in all analyses. For all
analyses, except those looking exclusively at changes at the two week timepoint, an autoregressive
order 1 model for the correlation between days was included. Data at the 49 day timepoint was
excluded from morphology analysis as no hippocampal HFD cells passed manual checking.
Analysis of timecourse data for morphology and motility measurements was done specifying
timepoint, diet, region (cortex or hippocampus), and their interactions, as fixed effects. A random
intercept for each animal was specified, with a random slope for the relationship between days.
A separate analysis was run to look at the effects of LPS, where LPS treatment, diet, region,
and their interactions, were specified as fixed effects. A random intercept for animal was specified
with a random slope for LPS condition.
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In addition, an analysis of behaviourally tested hippocampal window mice was run to look at
changes at the two week timepoint and correlate them with performance. Here diet and NI and
their interaction were specified as fixed effects. A random intercept for animal was included. As
well as this, analysis of changes at two weeks across all in vivo mice was conducted. This analysis
included diet and region and their interaction as fixed effects, with a random intercept for animal.
For TCA selection, the analysis was restricted to animals fed a control diet with cortical win-
dows. The effect of LPS treatment, with no covariates specified, on the inflammation index at
different TCA values was analysed. A random slope for LPS condition, and a random intercept
for animal, were included.
4.3 Results
4.3.1 HFD Did Not Significantly Affect Weight Gain of In Vivo Mice
In order to evaluate the effect of HFD feeding on weight gain, weights were compared. These
were normalised to their value at the beginning of dietary manipulation to control for differences in
starting weight, and the effect of diet on this value in in vivo imaging mice (that were heterozygous
Cx3CR1-GFP mutants) was analysed using an LMM (Fig 4.3). From here on, this value will be
referred to as weight. The following results are relevant to Chapter 5 as well given the results
presented there are based on the same mice. As time passed weight increased (F(56,983) = 5.49,
p = < 0.001), and though HFD appeared associated with greater weights and a greater rate of
weight gain, it did not reach significance. There was a significant interaction between surgery type
(cortical or hippocampal) and time (F(56,983) = 1.70, p = < 0.001). This effect was driven by
seemingly greater weights in the hippocampal window mice from days 40 to 42, although these
differences were not significant.
In order to directly correlate the results of behavioural testing with dietary effects on weight,
a separate analysis was limited to behaviourally tested mice (Fig 4.3 Inset). This included both
naive wild type, and hippocampal window Cx3CR1-GFP mice. As in the previous analysis, there
was a significant increase in weight with time (F(14, 175) = 4.08, p = < 0.001), however no other
factors significantly affected weight.
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Figure 4.3: HFD Did Not Affect In Vivo Weight Gain. Weight relative to its value at the start of dietary manipulation
(day 1) increased with time, but was resistant to the effect of HFD both in mice used for in vivo imaging, and those
involved in behavioural testing (Inset). Day 57 indicates the 56th day of dietary manipulation. In vivo Cx3CR1-
GFP heterozygotes n = 29 mice (n = 14 HFD), behavioural (combination of wild type C57BL/6J and Cx3CR1-GFP
heterozygotes) n = 21 mice (n = 9 wild type C57BL/6J where n = 4 HFD; n = 12 Cx3CR1-GFP where n = 6 HFD).
4.3.2 NOCR Performance was Unaffected by Diet or Surgery
Short-term HFD feeding is associated with hippocampal deficits. To investigate the effect of hip-
pocampal window surgery, and diet, on hippocampus-specific cognition, and to correlate cognit-
ive performance with in vivo microglial data, the performance of wild type mice that had not
undergone surgery, and Cx3CR1-GFP heterozygote hippocampus window implanted mice, on
a hippocampus-specific NOCR task following two weeks of dietary manipulation was assessed
(Fig 4.4). Performance was quantified using the calculation of a NI. Though the NI was reduced
in HFD mice (Fig 4.4 A; mean +/- SEM = 0.102 +/- 0.042, control = 0.187 +/- 0.039), this differ-
ence was not significant (F(1,13) = 0.96, p = 0.346). There was also no difference in NI between
hippocampal window Cx3CR1-GFP mice (Fig 4.4 A Left) and naive wild type animals (Fig 4.4
A Right; F(1,13) = 0.06, p = 0.807), nor did this interact with the effect of diet (F(1,13) = 0.29,
p = 0.60).
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Figure 4.4: NOCR Performance Was Resistant to the Effects of HFD and Hippocampal Window Surgery. (A)
NOCR performance was assessed by calculating a novelty index (NI), which represents the difference in the proportion
of time mice spent exploring novel versus familiar objects. This was unaffected by diet or surgery status (Left; hippo-
campal surgery, Right; no surgery). There was also no surgery and diet interaction (p value of corrected within-surgery
status diet comparisons indicated on brackets; dotted line at 0 represents no discrimination between novel and familiar
objects). (B) The NOCR behavioural protocol took place over three days. On the first day mice were habituated to two
different contexts with no associated objects, before being exposed to the two contexts with their associated object pairs
for the next two days (Exposure). On the third day, mice were tested by placing them in each context with a single
object swapped between object pairs such that the swapped object was novel in the given context (Test; n = 20 mice (n
= 10 HFD; n = 11 hippocampal surgery)).
4.3.3 Semi-Automated Quantification of Activation-Induced Microglial Morpholo-
gical Changes
In order to process the large number of microglial cells imaged, I took a semi-automated ap-
proach to quantifying microglial morphology. In order to ensure that this approach was sensitive
to changes in morphology, mice that had reached the end of their dietary manipulation (at day
56) were injected with a 4mg/kg dose of LPS in order to induce microglial activation. Microglial
activation is associated with a morphological shift from a ramified to an amoeboid phenotype and
systemic LPS application induces microglia activation via TLR4. Two-photon imaging stacks
were collected 24 hours after LPS administration and quantified. This was done to refine my ana-
lysis approach so that it could detect morphological changes associated with microglial activation,
allowing me to have confidence in its sensitivity when applied to analysing the effects of HFD
feeding.
Microglial morphology can be quantified in a number of ways. In order to avoid my results
being influenced by which of these I elected to measure, I instead opted to measure a wide array of
63 different facets of morphology (Table 4.2; Figure 4.1) before using dimensionality reduction
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techniques to create a compound measure of morphology. These 63 measures were derived from
five different analyses. Basic shape descriptors (Table 4.2; yellow; Fig 4.1 A;), skeleton ana-
lysis (Table 4.2; green), sholl analyses (Table 4.2; purple; Fig 4.1 B, C, D), hull and circularity
morphometrics (Table 4.2; red; Fig 4.1 A), and fractal analysis (Table 4.2; blue). These different
domains have previously been used to quantify microglial morphology (Kozlowski and Weimer,
2012; Heindl et al., 2018; Fernández-Arjona et al., 2017).
Given the large number of measures in the morphology dataset, the approach used by Heindl
et al. (2018) to create a compound measure of morphological changes was taken. Briefly, a subset
of measures were selected based on their ability to discriminate between activated and resting mi-
croglia using an ROC analysis, before a PCA was run on these to create a compound morphology
score. Given that the automated segmentation and measurement of microglia was based on user
selected TCA values, this was done across a range of TCA values in order to select the TCA value
that provided the best identification of activation-induced morphological changes.
ROC Analysis and Dimensionality Reduction
In order to identify which of the 63 measures provided the best ability to discriminate between
activated and resting microglia, an ROC analysis was run on each measure. The curves generated
by ROC analyses quantify the discrimination performance of a binary classifier system by plotting
the true positive rate against the false positive rate at various thresholds, i.e. different values of the
variable (Fig 4.5; Rightmost Column). In this way, the ability of each measure to identify the
effects of LPS administration on morphology can be quantified. This was done by measuring the
AUC of the ROC plot, where a higher value signifies better discrimination.
All 63 measures were analysed in this way for a range of TCA values (I chose a range of
200 to 800µm2 given the TCA value used in Kozlowski and Weimer (2012) was 500µm2) with
the best five performing measures for each TCA value retained. The best five were chosen as a
starting point, with the exact number to be retained for final analysis optimised at a later phase.
If any measures were present in the form of multiple variants, the worst performing variant was
dropped given this was the approach taken by Heindl et al. (2018), the paper on which this part of
my analysis was based. In order to create a single measure of activation associated morphological
changes, the dimensionality of the dataset was further reduced by running a PCA on the measures
selected by the ROC analysis to create a single ’inflammation index’ i.e. a composite value based
on the measures most sensitive to the effects of LPS on microglial morphology.
99
0.571 0.524 0.540 0.551 0.665
Pre  Post 
LPS LPS
1
2
3
4
5
0
1000
2000
3000
4
6
8
10
0
2
4
6
0
20
40
60
Va
lu
e
0.00
0.25
0.50
0.75
1.00
Tr
u
e
 P
o
si
tiv
e
 R
at
e
Branches (0.563)
Critical Value (0.572)
Fractal Dimension (0.578)
Quadruple Points (0.579)
Branching Density (0.567)
A
0.116 0.072 0.180
0.05
0.10
0.15
0.20
−4
−3
−2
−1
0
1
0.1
0.2
0.3
0.4
0.5
Va
lu
e
0.00
0.25
0.50
0.75
1.00
Tr
u
e
 P
o
si
tiv
e
 R
at
e
Mean Radius from CC (0.576)
Reg. Coeff. SL (0.61)
Reg. Int. SLP (0.605)
B
0.012 0.027 0.098 0.043
2
3
4
0.1
0.2
0.3
0.4
0.5
−1
0
1
2
50
100
150
Va
lu
e
0.00
0.25
0.50
0.75
1.00
Tr
u
e
 P
o
si
tiv
e
 R
at
e
Reg. Coeff. LL (0.589)
Reg. Coeff. SLP (0.615)
Skewness (fit) (0.593)
Soma Area (0.592)
C
0.025 0.055 0.122 0.026
0.05
0.10
0.15
0.20
2
3
−2
0
2
4
6
10
20
30
40
50
Va
lu
e
0.00
0.25
0.50
0.75
1.00
Tr
u
e
 P
o
si
tiv
e
 R
at
e
CV − All Radii (0.589)
Max. Branch Length (0.585)
Mean Radius from CC (0.61)
Reg. Int. LLP (0.594)
D
0.100 0.048 0.087 0.044
0
1000
2000
0.05
0.10
0.15
0.20
1
2
3
4
5
0
1000
2000
Va
lu
e
0.00
0.25
0.50
0.75
1.00
Tr
u
e
 P
o
si
tiv
e
 R
at
e
CV − All Radii Circle (0.606)
BC Diameter (0.618)
Lacunarity (0.638)
Mean Radius from CC (0.617)
E
0.155 0.130 0.050 0.063
0
1000
2000
0.05
0.10
0.15
0.20
−2
0
2
4
6
1
2
3
4
5
Va
lu
e
0.00
0.25
0.50
0.75
1.00
Tr
u
e
 P
o
si
tiv
e
 R
at
e
Lacunarity (0.622)
Mean Radius from CC (0.63)
Reg. Coeff. LL (0.611)
Reg. Int. LL (0.607)
F
0.457 0.372 0.189 0.300 0.029
0
500
1000
1500
2000
2500
20
40
60
80
5.0
7.5
10.0
12.5
2.5
5.0
7.5
10.0
12.5
0
20
40
60
Condition
Va
lu
e
0.00
0.25
0.50
0.75
1.00
0.00 0.25 0.50 0.75 1.00
False Positive Rate
Tr
u
e
 P
o
si
tiv
e
 R
at
e
Junction Voxels (0.591)
Critical Value (0.611)
Lacunarity (0.611)
Max. Radius from HCM (0.615)
Max. Intersections (0.593)
G
200µm2
300µm2
400µm2
500µm2
600µm2
700µm2
800µm2
Pre  Post 
LPS LPS
Pre  Post 
LPS LPS
Pre  Post 
LPS LPS
Pre  Post 
LPS LPS
Pre        Post 
LPS       LPS
Pre        Post 
LPS       LPS
Pre        Post 
LPS       LPS
Pre    Post 
LPS   LPS
Pre    Post 
LPS   LPS
Pre    Post 
LPS   LPS
Pre    Post 
LPS   LPS
Pre    Post 
LPS   LPS
Pre    Post 
LPS   LPS
Pre    Post 
LPS   LPS
Pre    Post 
LPS   LPS
Pre    Post 
LPS   LPS
Pre    Post 
LPS   LPS
Pre    Post 
LPS   LPS
Pre    Post 
LPS   LPS
Pre    Post 
LPS   LPS
Pre    Post 
LPS   LPS
Pre    Post 
LPS   LPS
Pre    Post 
LPS   LPS
Pre  Post 
LPS LPS
Pre  Post 
LPS LPS
Pre  Post 
LPS LPS
Pre  Post 
LPS LPS
Pre  Post 
LPS LPS
Fig 4.5. Legend on the following page
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TCA Selection
This ’inflammation index’ was calculated for each TCA value in the range I analysed, before
the effect of LPS on its value was analysed with a LMM (Fig 4.6). In this way the TCA value
that provided the inflammation index with the best ability to identify microglial morphological
changes associated with activation could be identified, and used for analysis of dietary effects.
Results showed a significant effect of LPS on the inflammation index built from TCA values of
300-500µm2 inclusive, with the strongest effect at 400µm2 (F(1,174) = 14.21, p = 0.002 followed
by 500µm2 (F(1,161) = 4.87, p = 0.029). Given the strong performance of 500µm2, and the fact
that it was the value used by Kozlowski and Weimer (2012), this was chosen for use in further
analyses.
Inflammation Index Refinement
To further hone the ability of the inflammation index (built using the 5 best performing measures
based on ROC results with a TCA value of 500µm2) to detect LPS induced morphological changes,
the effect of LPS on its value was compared between indices constructed with between 3 and 15 of
the best performing measures from the ROC analysis (Fig 4.7). The most significant effect of LPS
was seen when the 10 or 11 best performing measures were included (F(1,161) = 9.16, p = 0.003).
The 11 measures selected are described in Table 4.4. The reason the effect size was identical
between them is that once variant measures were dropped (as described in the subsection regarding
ROC analysis and dimensionality reduction), both the 10 and 11 best measures were refined down
to the same 7. This is why the effect sizes for 5 and 6, 7 and 8, and 12 and 13 measures are
identical as well. After dropping variants from the best 11 measures, the remaining seven were
used to construct the inflammation index used for all following analyses. The weighting of the
measures in this index was consistent across analyses. Two example cells, their inflammation
Figure 4.5 (preceding page): LPS Discrimination by Morphological Measures per TCA Value Trialled. Right-
most Column; An ROC analysis was run on 63 morphology measures to identify those that performed best at dis-
criminating between cells imaged on day 56 (pre LPS) of dietary manipulation, and those imaged following LPS
administration 24 hours later (post LPS), in control diet mice with cortical windows. This was done for each TCA value
ranging from 200 to 800µm2. (A-G; Left Columns) The top five performing measures, as assessed by the AUC (in-
dicated for each measure in the legend key of the associated ROC curve) are plotted. Where present, worst performing
variants were dropped (points represent raw values, crossbars indicate mean +/- 1 standard deviation, p values indicate
the effect of LPS treatment, colours correspond to colours in the associated ROC curves. Analyses used n = 1184
cells (n = 197/187/179/166/160/152/143 cells for TCA 200/300/400/500/600/700/800, n = 539 cells pre LPS treatment)
measured over n = 4 mice, with all mice imaged both before and after LPS administration)).
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index values, and the values of the constituent individual measures, are illustrated in Figure 4.8.
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Figure 4.6: Inflammation Index Sensitivity by TCA Value. The construction of a compound ’inflammation index’
was done by running a PCA on the five measures selected from the ROC analysis for each TCA value (200 to 800µm2;
labelled at the top of each panel). The effect of LPS treatment on these indices was significant for TCAs of 400,500, and
300µm2 in order of effect size. Values on brackets indicate p values for the effect of LPS. Analysis used n = 1988 cells
(n = 949 pre LPS, n = 804 HFD, n = 329/315/297/280/269/255/243 for TCA values of 200/300/400/500/600/700/800)
measured over n = 7 mice (n = 3 HFD).
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Figure 4.7: Inflammation Index Sensitivity by Number of Measures Included. The significance of the effect of LPS
on the inflammation index constructed with a TCA of 500µm2 was compared between the numbers of best performing
measures included. This ranged from 3 to 15 (labelled at the top of each panel). This was greatest when the 10 or 11
best performing were included. Analysis used n = 280 cells (n = 131 pre LPS, n = 114 HFD) measured over n = 7 mice
(n = 3 HFD).
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Label AUC Type Definition
Soma Area 0.576 Simple Area occupied by the microglial soma mask
Maximum Branch Length 0.585 Skeleton The maximum length of the branches of the skeletonised cell
Regression Coefficient 
(Log-log) [P10-P90] # 0.574 Sholl
The regression coefficient of the linear regression  run on 
the log-log Sholl plot based on the data within the 
10th-90th percentiles
Regression Intercept  
(Log-log) [P10-P90] # 0.594 Sholl
The intercept of the linear regression run on the log-log 
Sholl plot based on the data within the 
10th-90th percentiles
CV For All Radii # 0.589 HC Morph.
The coefficient of variation in the length of the radii from 
the centre of mass of the convex hull to an exterior point
Mean Radius from Circle’s 
Centre # 0.610
HC 
Morph.
Mean length from the centre of the circle to points 
on the convex hull
Lacunarity 0.575 Fractal
A quantification of the inhomogeneity in the cell mask, 
also understood as a measure of ‘gappiness’ , visual 
texture, and translation and rotational invariance
Regression Intercept 
(Log-log) # 0.585 Sholl
The intercept of the linear regression run on 
the log-log Sholl plot
Regression Coefficient 
(Log-log) # 0.573 Sholl
The regression coefficient of the linear regression  
run on the log-log Sholl plot
CV For All Radii 
from Circle’s Centre # 0.582
HC 
Morph.
The coefficient of variation in the length of the radii from 
the centre of the circle to points on the convex hull
Mean Radius # 0.594 HC Morph.
The mean length from the centre of mass of the convex 
hull to to an exterior point
Table 4.4: Morphological Measures Included in Finalised Inflammation Index. AUC values and definitions of
the 11 best performing morphological measures with a TCA of 500µm2. Orange indicates variant measures with
the lowest AUC values that were dropped (e.g. the regression intercept (log-log) for all data had a lower AUC than
that based on data in the 10th-90th percentiles). The # symbol indicates variants. Simple; simple shape descriptors.
Skeleton; measures derived from skeleton analysis. Sholl; values from sholl analyses. HC Morph.; measures based
on covex hull and bounding circle morphometrics. Fractal; values from fractal analysis.
4.3.4 Inflammation Index, Diet, Region, and LPS
In order to investigate diet and LPS induced changes in microglial activation, the inflammation in-
dex (a composite measure of morphological changes) was compared between diets, brain regions,
and timepoints. I injected mice with LPS to investigate if HFD feeding primed microglia, given
that this would lead to their differential response to an inflammatory stimulus. LPS administra-
tion elevated the inflammation index significantly (Table 4.5 A; Fig 4.9 A; F(1,313) = 7.89, p =
0.005), indicating LPS induces microglial activation. However, this activation was not modulated
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Animal 13 19
Region Hippocampus Cortex
LPS Condition Pre LPS Post LPS
Inflammation Index -1.93 1.34
Soma Area 62.57 54.16
Maximum Branch Length 24.103 27.421
Regression Coefficient  (Log-log) [P10-P90] 3.91 2.34
Regression Intercept  (Log-log) [P10-P90] 4.90 1.08
CV For All Radii 1.3909 1.4234
Mean Radius from Circle’s Centre 0.0586 0.0298
Lacunarity 0.750 0.639
Animal: 13
D56
Animal: 19
LPS
Figure 4.8: Inflammation Index Example Cells. Example cells with their inflammation index value indicated. In
addition, the values of all the measures that are used to compose the inflammation index are listed. Cyan; cell perimeter,
Magenta; soma area .
by dietary or regional effects (Table 4.5 A) or any diet, region, and LPS interactions.
In order to evaluate microglial morphological changes occurring at the same timepoint that I
report evidence of hippocampus-specific NOCR deficits in HFD fed mice in my previous chapter,
I restricted analysis of the inflammation index to the two week timepoint (Fig 4.9 B). Here there
were no effects of diet or region (Table 4.5 B). In addition, I restricted this analysis further to mice
implanted with hippocampal windows that had undergone NOCR behavioural testing in order to
correlate cognitive performance with microglial activation. There was no significant correlation
between behavioural performance and the inflammation index (data not shown).
To investigate the possibility of HFD feeding having phasic effects on microglial activation
in the hippocampus and cortex, I looked at changes in the inflammation index in both brain re-
gions at multiple timepoints through the 8 week dietary timecourse. Analysis of the timecourse
(Fig 4.9 C) revealed no significant effects of time, diet, region, or their interactions, on the in-
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LPS Treatment
Changes at Day 14
Dietary Timecourse
Table 4.5: Inflammation Index Analysis Statistics. Analyses were run using LMMs to investigate the change in
the inflammation index in response to LPS treatment, two weeks of HFD feeding, and the 8 week dietary timecourse
(numDF and denDF refer to degrees of freedom. F and p values are rounded to 4 decimal places. Red text indicates
significance. Green text indicates trend level. Background shading indicates size of p value where darker is larger.
Sig shows significance indicator. Factor indicates factors in the model. Measure indicates the model run. Colons
indicate interaction effects).
flammation index (Table 4.5 C), suggesting that microglial morphology was unchanged over the
8 week manipulation period.
Analysis of the Inflammation Index Component Measures
The same analyses were also run on the measures that the inflammation index was composed of
(unshaded rows in Table 4.4). These results are presented in the Appendix A.
4.3.5 Microglial Process Motility
Microglial process motility is involved in immune surveillance of the brain environment (Nim-
merjahn et al., 2005) and is reduced following systemic LPS administration (Paris et al., 2018).
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Figure 4.9: LPS Increased the Inflammation Index, which was Resistant to Dietary Effects at all Timepoints.
(A) LPS significantly elevated the inflammation index, though there were no regional or dietary effects or interactions.
(B) Analysing data collected at day 14 showed no effects of diet, region, behavioural performance, or their interactions.
(C) Over the 8 weeks of dietary manipulation there were no significant effects or interactions between diet, region, or
time, nor did any corrected pairwise dietary comparisons approach significance (brackets and numbers in A, B indicate
p values of corrected pairwise dietary comparisons. In C D-1 refers to measurements taken a day before the beginning
of dietary manipulation, and hours are relative to the the start of dietary manipulation. For LPS/Day 14/Timecourse
analyses subjects used were n = 333/300/3992 cells (n = 198/167/2138 HFD, n = 135/114/1365 hippocampus) measured
over n = 16/22/28 mice (n = 10/12/14 HFD, n = 6/10/11 hippocampus).
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It was quantified using indices that capture the magnitude of process movement (MI), extension
(EI), retraction (RI), extended processes stabilising (SI), and retracted processes remaining retrac-
ted (II). The calculation of these indices is illustrated in Fig 4.2. In addition, a PCA was used to
create the compound motility score (CMS) that was also analysed.
LPS Decreases Microglia Process Motility
To confirm results that suggest LPS alters process motility (Paris et al., 2018) and see if changes
in process motility provided evidence of HFD-induced priming of microglia, I looked at changes
in process motility following LPS administration. The motility index was significantly reduced by
LPS treatment (Fig 4.10; F(1,75) = 13.89, p = < 0.001) as was the retraction index (F(1,75) =
13.52, p = < 0.001) and extension index (F(1,75) = 14.14, p = < 0.001). The stability index was
unaffected whilst the instability index showed a trend level decrease (F(1,75) = 3.65, p = 0.060).
The compound motility score was significantly lowered by LPS administration (Table 4.6; F(1,75)
= 14.43, p = < 0.001), confirming its ability to reflect process motility changes detected in other
indices. No significant of region, diet, or their interaction, on any of the motility indices calculated,
were detected. Values of the statistical analyses for all measures are presented in the Appendix A.
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Figure 4.10: LPS Decreases Process Motility. LPS treatment reduced the motility, retraction, and extension indices,
and the compound motility score. The instability index showed a trend level decrease, whilst the stability index was
unaffected. There were no significant effects of region, diet, or any interactions, on any of the indices (corrected p
values of dietary comparisons are indicated on brackets. Grey background indicates a significant main effect of LPS.
AU indicates arbitrary units. Analysis used n = 97 cells (n = 58 HFD, n = 49 hippocampus) measured over n = 18 mice
(n = 10 HFD, n = 9 hippocampus)).
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The Effects of Two Weeks of HFD Feeding on Microglial Process Motility
As with the inflammation index I restricted analysis of process motility to the two week timepoint
to investigate changes occuring at the same time as the NOCR deficits I reported in the previous
chapter. Analysis of the two week timepoint showed a trend level interaction between diet and
region on the motility index (Fig 4.11; F(1,18) = 3.54, p = 0.076). Here HFD feeding increased
the motility index in the cortex, whilst decreasing it in the hippocampus. This trend level effect,
and the direction of the interaction, were the same for the retraction index, extension index, and
compound motility score (Table 4.6). Neither the stability nor instability index showed any effects
in the two week analysis. To correlate cognitive performance with process motility changes I fur-
ther limited analysis to behaviourally tested animals. This did not show any significant correlation
between behavioural performance and any of the indices (data not shown). Values of the statistical
analyses for all measures are presented in the Appendix A.
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Figure 4.11: Trend Level Region-Specific Dietary Effects on Process Motility. The compound motility score, as
well as the motility, retraction, and extension indices, all showed a trend level diet by region interaction, where their
values were decreased by HFD in the hippocampus, and unaffected - if not marginally increased - in the cortex. Neither
the stability nor the instability index showed any significant effects in the two week analysis (p values of corrected
pairwise dietary comparisons are indicated on brackets. AU indicates arbitrary units. Analysis used n = 84 cells (n =
43 HFD; n = 31 hippocampus) measured over n = 25 mice(n = 13 HFD; n = 19 hippocampus)).
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Dietary Timecourse Analysis of Microglial Process Motility
As with the inflammation index I looked at changes in motility indices over 8 weeks of HFD feed-
ing in both the hippocampus and cortex to investigate the possibility of phasic HFD inflammatory
effects. This revealed a significant effect of region on the motility index (Figure 4.12, F(1,23) =
8.25, p= 0.009), extension index (F(1,23) = 8.47, p = 0.008), retraction index (F(1,23) = 7.99, p =
0.010), and compound motility score (Table 4.6 C; F(1, 23) = 8.26, p = 0.009) where these were
all greater in the hippocampus than the cortex. The stability index showed a significant timepoint
and diet interaction (F(13,991) = 2.28, p = 0.006) that was driven by an elevated stability index
in HFD cells at day 49 (t(23) = 3.29, p = 0.048). The instability index was significantly greater
in control cells overall (F(1,23) = 5.17, p = 0.033) and was also significantly greater in the hip-
pocampus (F(1,23) = 20.36, p = < 0.001). Values of the statistical analyses for all measures are
presents in the Appendix A.
LPS Treatment
Changes at Day 14
Dietary Timecourse
Table 4.6: Compound Motility Score Analysis Statistics. Analyses were run using LMMs to investigate the change
in the compound motility score in response to LPS treatment, two weeks of HFD feeding, and the 8 week dietary
timecourse (numDF and denDF refer to degrees of freedom. F and p values are rounded to 4 decimal places. Red text
indicates significance. Green text indicates trend level. Background shading indicates size of p value where darker is
larger. Sig shows significance indicator. Factor indicates factors in the model. Measure indicates the model run. Colons
indicate interaction effects).
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Figure 4.12. Legend on the following page
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4.4 Discussion
Morphological changes are a key feature of microglial activation (Kettenmann et al., 2011) that
generally involve the retraction of processes and the shift from a ramified to an amoeboid phen-
otype. Morphological changes occur immediately upon acute damage, as demonstrated by two-
photon lesion studies (Nimmerjahn et al., 2005). Similarly, microglial process motility, an im-
portant part of the surveillance by microglia of the parenchyma (Nimmerjahn et al., 2005), is
decreased by LPS (Paris et al., 2018). Given that HFD feeding has been widely reported to in-
duce microglial activation (Thaler et al., 2012; André et al., 2017; Zhou et al., 2018) that has been
documented after as little as 72 hours in the hypothalamus (Thaler et al., 2012; Valdearcos et al.,
2014) and one week in the hippocampus (Calvo-Ochoa et al., 2014), shifts in microglial morpho-
logy and decreases in process motility during the 8 week dietary timecourse were anticipated. In
addition, I hoped my in vivo analysis of microglial changes could shed light on the mechanism be-
hind the results reported in the previous chapter (Chapter 3), where two weeks of HFD increased
microglial density without any associated morphological changes or increases in cytokine levels.
Two explanations for this were proposed, either the priming of microglia by HFD feeding, or the
existence of transient and phasic inflammation in regions outside of the hypothalamus. I sought
to address these two hypotheses by tracking microglial morphology and process motility over the
dietary timecourse, and investigating their response to proinflammatory LPS administration. In
addition, given the absence of studies investigating hippocampal inflammatory changes within
the first week of HFD feeding, I hoped to provide evidence regarding the timecourse of early in-
flammatory changes and therefore evaluate the likely contribution of microglial activation to the
early HFD-induced hippocampus-specific cognitive deficits reported by McLean et al. (2018) and
Kanoski and Davidson (2010).
Figure 4.12 (preceding page): Process Motility is Unaffected by Diet and Lower in the Hippocampus. 8 weeks
of dietary manipulation revealed that compound motility score, and motility, retraction, and extension indices were
lower in the hippocampus on average. The stability index showed a diet by time interaction driven by its elevation
in HFD cells at day 49 in both regions (* indicates p < .05 in corrected pairwise comparisons. Horizontal lines
indicate regional means, where solid lines indicate regional differences were significant. Grey background indicates
a significant interaction between diet and time. Analysis used n = 1121 cells (n = 590 HFD; n = 458 hippocampus)
measured over n = 29 mice (n = 14 HFD; n = 12 hippocampus)).
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4.4.1 Semi-Automated Quantification of Morphological Changes
In order to process the large number of cells needed to detect small changes in morphology across
a wide span of timepoints, I developed a semi-automated approach. The initial phase of the mor-
phology analysis was based on the methodology used by Kozlowski and Weimer (2012), where an
iterative thresholding technique, tuned using results from LPS induced microglial activation stud-
ies, was used to automatically generate masks of microglial cells from two photon image stacks. I
combined this with the work by Heindl et al. (2018), who took a multitude of automatically gener-
ated microglial shape measurements and refined them into a compound index of morphology. The
measures my analysis automatically generated fell into five categories of descriptor; simple shape,
cell skeleton, sholl analysis, fractal analysis, and hull and circle morphometrics. These different
approaches have been used to quantify microglial morphology in the literature (Kozlowski and
Weimer, 2012; Heindl et al., 2018; Fernández-Arjona et al., 2017). Heindl et al. (2018) used an
ROC analysis to select the measures that best distinguished between resting and activated cells,
before running these through a PCA and using the first component as a compound index. For my
approach, I used an ROC analysis to identify measures that best distinguished microglia activated
by systemic LPS administration. I then analysed the effect size of LPS treatment on the value of
the compound index built using these measures. This was done initially on a subset of data to tune
the parameters used in the automated cell mask generation so that these best captured the morpho-
logical changes seen in activated microglia. After tuning, this approach was used to analyse the
rest of the dataset.
4.4.2 LPS Induced Microglial Activation is Consistent Across Diet Groups and
Brain Regions
Microglial priming occurs both in ageing and neurodegenerative diseases (reviewed in Tay et al.
2017; Norden and Godbout 2013; Perry and Holmes 2014). Given that primed microglia show
an exaggerated inflammatory response to proinflammatory stimuli (microglial priming reviewed
in Perry and Holmes 2014) I used LPS administration to test whether microglia were primed by
HFD feeding. An analysis of the compound morphology index, which I have referred to in this
chapter as an ’inflammation index’, revealed that it was significantly elevated by LPS treatment,
confirming its ability to capture inflammation related morphological changes. However, there
was no effect of region or diet, nor any interaction between them, on the index value. Similarly,
microglial process motility showed a decrease following LPS treatment, with no main effects or in-
teractions between diet and brain region. These results demonstrated that LPS induced microglial
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activation as expected, but also provided evidence that microglial cells are not primed following 8
weeks of HFD feeding.
Evidence for Diet and Obesity Induced Microglial Priming
Evidence in the literature for HFD induced inflammatory priming is mixed, where Baufeld et al.
(2016) demonstrated no evidence of it in isolated hypothalamic microglia following 16 weeks of
diet, and Maric et al. (2014) reported no differences in the fever response of rats fed a HFD for
8 weeks following LPS administration. Though these studies support my own results, Pohl et al.
(2009) reported that not only did diet-induced obese rats demonstrate a greater fever response to
LPS, they showed greater LPS induced elevations in levels of circulating IL-6 and TNF-α , and
hypothalamic mRNA levels of IL-1β , IL-6, and SOCS3. In addition, 3 days of HFD led to an ex-
aggerated inflammatory response in the hippocampus (Sobesky et al., 2016) and the hypothalamus
(Souza et al., 2019) following LPS administration.
Evaluation of the differences between the studies initially suggested that the difference in res-
ults might relate the degree of weight gain induced. The HFD fed rats (with butter derived fat)
in Maric et al. (2014) that showed no evidence of priming were only 3.6% heavier than control
counterparts, versus the 15% increase in body weight reported in Pohl et al. (2009) where HFD in-
duced priming seemed apparent. However, the microglia that demonstrated no priming in Baufeld
et al. (2016) were taken from HFD mice that were approximately 35% heavier than controls, and
in Sobesky et al. (2016), HFD fed mice were only ∼5% heavier than control counterparts. An
alternative explanation relates to cell-specific priming. Baufeld et al. (2016) looked specifically at
the response of microglial cells by isolating them, whilst the responses measured by Maric et al.
(2014) and Pohl et al. (2009) were not cell-type specific. It therefore seems possible that whilst
obesity doesn’t induce microglial priming, it may be associated with non-microglial cell priming
to inflammatory stimuli. Indeed, Valdearcos et al. (2014) observed only a small decrease in the
hypothalamic inflammatory response to LPS following microglial depletion, demonstrating either
that non-microglial cells play a significant part in LPS induced inflammation, or that they are
readily able to compensate for the ablation of the microglial response. It is of course also possible
that HFD induced microglial priming requires not only an elevated degree of weight gain, but also
the presence of other cell types, such that looking at them in isolation would mask any priming
effects. Evidence demonstrating the importance of microglia and astrocyte communication in the
enhancement of inflammatory responses (Saijo et al., 2009) suggests this could play a role.
However, neither of these theories can explain the results reported by Sobesky et al. (2016),
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where rats showed a low degree of weight gain and still demonstrated evidence of HFD-induced
priming. Differences in LPS dosage may be responsible, where Sobesky et al. (2016) used a
10 µg/kg dose to avoid the possibility of a large inflammatory response masking signs of priming
(Sobesky et al. (2016) suggest that work by Johnson et al. (2002) using this dosage indicates it
induces a sub-threshold inflammatory response). Whilst initially this appears to explain the null
results reported by Maric et al. (2014), who used a 100 µg/kg dose, this was the same dosage used
by Pohl et al. (2009) where evidence of priming was reported. It may be the case that a high degree
of weight gain is required to observe evidence of priming in the face of large-scale inflammation.
A final consideration is that the differences may simply be the result of regional effects. Sobesky
et al. (2016) investigated hippocampal priming, whilst both Pohl et al. (2009) and Maric et al.
(2014) looked in the hypothalamus. Here it would appear that a high degree of weight gain is
necessary for hypothalamic, but not hippocampal, inflammatory priming.
In the context of these studies, the absence of diet-related priming I detected may be the result
of insufficient weight gain, given my HFD fed animals were only 8.1% heavier than controls at the
time of LPS administration. However, hippocampal HFD priming appears independent of large
changes in weight (Sobesky et al., 2016), so my results may be best explained by the high dose
of LPS used (4mg/kg compared to the 10 µg/kg in Sobesky et al. 2016). This likely produced an
inflammatory response large enough to mask signs of diet-induced microglial priming. I opted
to use this high dose of LPS initially as I wanted to ensure it would induce microglial activation
strong enough for my analysis techniques to detect. Part of my semi-automated cell analysis
technique was based on work by Kozlowski and Weimer (2012), who demonstrated that a dose of
4mg/kg induced morphological changes that were highly significant using an automated analysis
approach. Though these results do not shed more light on the role of HFD-induced priming in
my post-mortem tissue results (described in the previous chapter), the fact that HFD mice in those
experiments were ∼14% heavier than controls (close to the 15% reported by Pohl et al. 2009),
coupled with consideration of the evidence of rapid HFD-induced microglial priming (Sobesky
et al., 2016; Souza et al., 2019), means this still seems an appealing explanation. Future work
should repeat my in vivo experiments with a lower dose of LPS. In addition, correlating results
against the degree of weight gain would help evaluate the theories I have proposed to explain the
differences between studies.
LPS Induced Inflammation is Consistent Between Regions
No regional differences in the effect of LPS on microglial morphology or process motility were
detected, suggesting that microglia in both regions are activated to a similar extent and in a similar
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manner. Studies investigating regional differences in microglial activation are few. Furube et al.
(2018) looked at the effect of LPS on microglial proliferation by analysing bromodeoxyuridine
(BrdU) uptake and reported no effect of a 1mg/kg dose of LPS on the density or percentage of
BrdU labelled microglial cells in the cortex, whilst both the density and percentage of labelled
microglia in the dentate gyrus was increased. However, an important factor to consider is that
their measurements were taken 3 days after LPS administration, compared to the 24 hours in
my experiments. Hoogland et al. (2018) demonstrated that 48 hours post-LPS administration,
microglial densities were seen to be increased in both the hippocampus and cortex, suggesting
that microglia in both regions proliferate in response to LPS, though it seems by the 3 day point
only hippocampal microglia continue to do so. This agrees with my results demonstrating no
regional differences in the microglial response to LPS treatment within the first 24 hours.
With regards to process motility, LPS administration in the hippocampus (Madore et al., 2013)
and cortex (Paris et al., 2018) both significantly reduce process motility, though it appears no
studies but my own have directly compared the response in a single model. As a result, the
evidence I present that no quantitative differences exist in the extent of LPS-mediated effects on
process motility provides a novel insight into regional differences in microglial activation.
In summary, my results demonstrate a lack of region-specific effects of LPS on microglial
activation that seems consistent with published research. My work also represents some of the
first to investigate this. It should be noted that whilst my conclusions are based on morphological
and process motility changes, the work by Furube et al. (2018) and Hoogland et al. (2018) centers
on proliferation. As evidenced by my own work, these facets of microglial activation can be
uncoupled and so do not necessarily reflect similar inflammatory responses. Investigating LPS-
induced changes in microglial density in my data will help relate my findings more closely to those
already published.
4.4.3 Microglial Activation is Resistant to 8 Weeks of HFD Feeding
Neither HFD-feeding, nor time, had any effect on microglial morphology or process motility over
the 8 weeks of dietary manipulation. This suggests an absence of diet-induced inflammation,
and therefore agrees with my post-mortem data that demonstrated no microglial morphological
changes following two weeks of HFD. Though I did not measure cytokine levels, these results
provide evidence that the biphasic pattern of hypothalamic inflammation reported by Thaler et al.
(2012) does not occur in either the cortex or the hippocampus, where it seems instead that mi-
croglia show no signs of activation. This would indicate that phasic inflammatory changes are not
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responsible for the uncoupling of microglial proliferation and morphology detected in my post-
mortem results, nor is early HFD induced activation related to the early hippocampus-specific
cognitive impairment reported (McLean et al., 2018; Kanoski and Davidson, 2010). It is import-
ant to note however that the HFD used in Thaler et al. (2012) was composed of 60% calories
from fat, with their study also focusing on rats, in comparison to my 45% diet in mice. It is
quite possible that species or dietary fat percentage are responsible for mediating the phasic in-
flammatory effects of diet they report. Alternatively, the partial deficiency of Cx3CR1 expression
associated with Cx3CR1-GFP heterozygosity in my in vivo mice could have led to resistance to
the proinflammatory effects of HFD feeding in my experiments, masking the existence of phasic
inflammatory changes. The influence of Cx3CR1 deficiency on my results is discussed in greater
detail in the discussion for Chapter 3, and later in this chapter’s discussion.
A diet by region interaction was detected in microglial motility measures at the two week
timepoint when all other timepoints were excluded. Here HFD feeding in the cortex increased,
and in the hippocampus decreased, the motility, retraction, and extension indices, and the com-
pound motility score. Whilst this might suggest the presence of region-specific dietary inflammat-
ory effects at a timepoint relevant to the detection of hippocampus-specific cognitive deficits (as
detected in the previous chapter), when considered in combination with the variation over multiple
timepoints in the full dietary timecourse, the differences seen at day 14 are well within the normal
time-related variation in readings and therefore are likely unrelated to dietary effects. In addition,
to address the significant pairwise comparison within the hippocampal motility data at day 21,
where motility, retraction, and extension indices, and the compound motility score, are elevated
by HFD, this effect is driven by a single cell with aberrantly high values.
The Timeline of HFD-Induced Microglial Activation Varies Between Studies
Though my results may seem unusual initially, given the rapid inflammatory response detected
by Thaler et al. (2012) and Calvo-Ochoa et al. (2014), early HFD-induced microglial changes are
not always reported. No change in the number of activated hippocampal microglia (cells with
enlarged/irregular cell bodies, and thickened, partial, or complete loss of processes) was reported
following 1 to 2 months of HFD (Knight et al. 2014; with no increase seen until 13-14 months),
whilst after 3 weeks there was no change in hippocampal microglial density or morphology (An-
dré et al., 2017). No change in hippocampal microglial morphology (Spencer et al., 2019), or
hypothalamic (Baufeld et al., 2016) morphology and density, was seen after 3 days of HFD feed-
ing. The latter study also showed no increase in hypothalamic density after 4 weeks, though by
8 weeks this was apparent (Baufeld et al., 2016). Finally, 8 weeks of HFD was associated with
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increased microglial process length in the prefrontal cortex, though there were no effects in CA1
or perirhinal cortex (Bocarsly et al., 2015).
In contrast, Thaler et al. (2012) reported increased microglial density and size in the hypo-
thalamus after 3 days of HFD, whilst Calvo-Ochoa et al. (2014) observed activated microglia in
the hippocampi of rats fed a HFD supplemented with fructose syrup for a week. Valdearcos et al.
(2017) saw an elevation in Iba1 stained microglial cells in the ARC and median eminence of the
hypothalamus after 4 weeks of HFD feeding, whilst André et al. (2017) saw an increase in hypo-
thalamic microglial density after 3 weeks. This was coupled with an increase in the number of
microglia with enlarged somata (in contrast to the lack of microglial activation they observed in
the hippocampus). Zhou et al. (2018) saw an elevated density and size of microglia in the ARC
after 4 weeks of HFD.
Ultimately, the timecourse of reported HFD-induced microglial activation is inconsistent.
What seems clear is that microglial activation tends to occur earlier in the hypothalamus, and that
it is not uncommon to detect an absence, or low levels of, microglial activation in the cortex and
hippocampus within the first 8 weeks of dietary manipulation. Where discrepancies exist, these
may relate to differences in diet composition, species and age of subjects used, and subdivisions
of the regions imaged. A role for the sugar content in mediating the inflammatory effects of HFD
feeding has also been proposed (Sobesky et al., 2016). The lack of morphological changes I de-
tect fits with my post-mortem results, that together suggest there is no role for early HFD-induced
microglial activation in the genesis of hippocampus-specific cognitive deficits. Additionally, this
indicates that HFD-induced priming of microglia in my model, rather than activation, may be what
drives the uncoupling of proliferation and morphological changes. Future analysis of microglial
density in my in vivo data will help to confirm the agreement with post-mortem data.
Baseline Process Motility is Reduced in the Hippocampus
Microglial process motility showed an effect of region, driven by an overall lower value in the
hippocampus of the motility, extension, and retraction indices. There do not appear to be any
published studies that have explicitly looked at baseline differences in microglial process motil-
ity between regions, however plenty of work has been described using alternative approaches to
demonstrate regional heterogeneity in microglial populations (reviewed in Stratoulias et al. 2019;
Hanisch 2013). In one such study, Grabert et al. (2016) looked at the transcriptome of isolated mi-
croglia and demonstrated region-dependent clustering and separation of cortical and hippocampal
microglia, with regional variation also seen using single cell RNA sequencing (Hammond et al.,
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2019; Masuda et al., 2019). There are also morphological differences between microglia from
different brain regions (Lawson et al., 1990). As such, finding differences in baseline process
motility between regions is not surprising. Process motility also correlates with neuronal activity
(in a preprint; Nebeling et al. 2019), so perhaps regional differences in the patterns of neuronal
activity could underlie the differences in microglial process motility demonstrated in my results.
In spite of these process motility differences, no regional differences in overall morphology
were detected, nor did the microglial response to LPS differ by region. Indeed, if regional differ-
ences in microglial transcriptomes exist, one would predict variation in regional morphologies and
inflammatory responses. The lack of evidence for this in my results could be the result of methodo-
logical choices. The inflammation index I used to investigate changes in morphology was designed
to detect LPS-specific indicators of microglial activation, and it is possible that these measures are
unsuited to identifying regional differences. Work by Young et al. (2018) (in a preprint) supports
this. They demonstrated differences between the cortex and hippocampus in microglial process
length, number of process endpoints, fractal dimension, lacunarity, and density, but not span ratio.
Though the measurements I took included all of these (except for process length), only lacunarity
was included in the inflammation index I constructed, supporting the suggestion it is insensitive to
regional differences. However, analysis of lacunarity (see Appendix Fig A.7, Table A.7) revealed
no regional differences. It may then be the case that the reduced image quality in my dataset re-
lative to that in Young et al. (2018) (my data was collected in awake, behaving mice, whilst they
used confocal microscopy on post-mortem tissue) blunts the ability of my analyses to detect re-
gional differences. However, my own post-mortem analyses in Chapter 3 showed no evidence of
regional variation in microglial morphology, though this did not use the same measures as Young
et al. (2018). Future work should look at other measurements that overlap between our studies,
both in vivo and in post-mortem tissue, to better understand these differing results.
4.4.4 Hippocampal Cognitive Deficits Were Not Detected Following Two Weeks of
HFD
Mice were tested on hippocampus-dependent object-context recognition (Balderas et al., 2008;
Mumby et al., 2002) following 14 days of HFD feeding. This involved testing all mice implanted
with hippocampal windows alongside a cohort of naive C57BL/6J wild type mice to assess the
impact of surgery on performance. Results demonstrated that hippocampal window implantation
did not influence cognitive performance, although neither did HFD feeding. This contradicts the
detrimental effect of HFD on NOCR reported at the same timepoint in the previous results chapter,
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though it is worth noting that despite not reaching significance, HFD feeding still decreased per-
formance. Indeed, considering the NOCR experiment reported in this chapter was designed to
evaluate effects of both diet and surgery, the sample size of 20 meant the study was underpowered.
The NOCR results reported both here and in the post-mortem chapter are derived from the same
data, though in the post-mortem analysis hippocampal window mice were excluded, as was a
single wild type mouse, in order to correlate behavioural performance with hippocampal protein
array measurements.
Despite the low statistical power, finding no effect of HFD on NOCR is surprising given the
demonstration of a deficit in NOCR in previous unpublished work by my group, and the fact that
this deficit is present when analysis is limited to a subset of mice (as in the previous chapter).
Additionally, other studies have shown detrimental effects of HFD on hippocampus-dependent
cognition, where it seems to appear very early after the beginning of HFD-feeding (McLean et al.,
2018; Kanoski and Davidson, 2010). One possibility is that the lack of dietary effects on cognitive
performance seen in my data could result from genotype differences, as the hippocampal win-
dow mice included in the analysis in this chapter were Cx3CR1-GFP heterozygous mutants. The
Cx3CR1-GFP mutation is associated with knockdown of the Cx3CR1 gene, and partial Cx3CR1
deficiency appears to impart resistant to diet induced weight gain and cognitive deficits (Cope
et al., 2018), as discussed in the previous chapter. Briefly, Cx3CR1 and its ligand play a role
in neuroinflammation and signalling between neurons and microglia (Lee et al. (2010) introduce
the effects of Cx3CR1 dysfunction), with complete Cx3CR1 deficiency being protective against
obesity and the inflammation of visceral adipose tissue (Polyák et al., 2014). In contrast, work by
Shah et al. (2015) showed no effect of Cx3Cr1 deficiency on diet-induced weight gain, fat content,
feeding, or energy expenditure at any point over 24 weeks in HFD fed mice. It therefore seems
possible that excluding the hippocampal window Cx3CR1-GFP mice from the NOCR analysis,
as was done in the previous chapter, may have revealed dietary effects that their genotype masks
in the overall analysis described here. Indeed, the immunofluorescence cohort of mice (of which
Cx3CR1-GFP mutants were a minority) analysed in the previous chapter appear more susceptible
to HFD induced weight gain than the Cx3CR1-GFP mice described in this chapter (with HFD
immunofluorescence animals showing a 20% increase relative to their starting weight after two
weeks, in comparison to the roughly 7% increase seen after two weeks in the Cx3CR1-GFP in
vivo mice). This fits with the resistance to diet-induced obesity associated with Cx3CR1-GFP
heterozygotes on a 45% HFD reported in Cope et al. (2018).
However, my analysis showed no interaction of surgery status (and given all hippocampal win-
dow mice were Cx3CR1-GFP heterozygotes, genotype) with diet, and when I included genotype
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as a factor in my analyses in the previous chapter, partial Cx3CR1 deficiency appeared to have
no real effect on any of the metrics analysed (its effect on microglial density likely being related
to clearer microglial labelling, and its association with greater pericyte spacing probably due to
the greater mean age in the Cx3CR1-GFP cohort given greater spacing correlated significantly
with increased age). It must be considered though that the underpowered nature of my NOCR
study was insufficient to detect genotype differences. Indeed, though not significant, hippocampal
window mice did appear to show a smaller decrease in NOCR performance in response to HFD
feeding. An effect of Cx3CR1-GFP deficiency on my in vivo results could also explain the lack of
activation related microglial morphological changes I detect over 8 weeks of dietary manipulation,
given that in Cope et al. (2018) this genotype showed no signs of microglial activation after 12
weeks of HFD feeding in the hippocampus.
Genotype and power issues aside, the potential role of hippocampal window surgery (and
the associated cortical aspiration) on NOCR performance must also be addressed. In this regard,
NOCR is a hippocampus-specific task (Mumby et al., 2002; Balderas et al., 2008) so should be
unaffected by cortical changes, and overall performance levels were not different between naive
and hippocampal window mice in my results. Gu et al. (2014) report that the hippocampal window
surgery did not influence performance on an open-field and contextual fear-conditioning paradigm,
and the surgical procedure utilised (as described in Dombeck et al. 2010) is not associated with
any direct contact with the hippocampus as the overlying structures are "peeled away" without
applying direct pressure, with the external capsule (which is left intact) providing a barrier to hip-
pocampal CA1. In addition, neuronal properties measured with electrophysiological and optical
techniques following hippocampal window surgery were reported to be highly similar to elec-
trophysiological recordings from mice that had not undergone surgery, and the aspirated cortical
areas do not provide strong direct projections to the hippocampus (Dombeck et al., 2010). It may
instead be possible that hippocampal window implantation influences the mechanisms responsible
for mediating the detrimental effect of HFD on hippocampal processing, with results from my pre-
vious chapter suggesting this relates to HFD-induced vascular structural changes. Whilst future
work in post-mortem tissue could evaluate whether hippocampal window surgery modulates the
effects of HFD on the vasculature reported in my post-mortem work, and in doing so could help
shed light on these behavioural results, it is important that an adequately powered repeat of the
NOCR task described in this chapter is done.
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4.5 Conclusion
In conclusion, the data presented in this chapter demonstrate that a semi-automated method of
quantifying microglial morphological changes is capable of detecting LPS-induced microglial ac-
tivation, and supports findings demonstrating a reduction in microglial process motility in response
to LPS treatment. Additionally, some of the first results investigating differences in process motil-
ity between brain regions suggests that the magnitude of this is reduced overall in the hippocampus
relative to the cortex. The use of a high dose of LPS in my experiments may have masked the pres-
ence of microglial priming reported to be induced by HFD feeding in other studies. It therefore
remains a likely explanation for the profile of microglial and cytokine changes observed in my
post-mortem data, a suggestion supported by the fact that I observed no changes in microglial
morphology over 8 weeks of HFD feeding in vivo. Future work is needed to validate this. In
addition, my results provided no evidence that the phasic inflammatory response to HFD seen in
the hypothalamus (Thaler et al., 2012) exists in either the hippocampus or the cortex, though this
is not conclusive as I did not measure inflammatory cytokine levels. This would suggest that early
HFD-induced microglial activation is not necessary for the genesis of hippocampus-specific defi-
cits. Finally, the attenuation of the detrimental effect of HFD on NOCR through the inclusion of
hippocampal window mice was suggested to be mediated either by an effect of hippocampal win-
dow surgery, where this may influence the detrimental vascular changes induced by HFD feeding,
or the influence of partial Cx3CR1 deficiency. In order to further investigate this, an appropriately
powered NOCR study should be conducted.
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Chapter 5
In Vivo Neurovascular and Blood
Supply Changes
5.1 Introduction
Recent years have seen a growth in the interest surrounding the vascular changes underlying the
pathology of diseases such as Alzheimer’s disease (reviewed in de la Torre 2002). Dysfunction in
the brain’s vascular network disrupts its ability to support neuronal activity through the delivery of
oxygen and nutrients and the removal of metabolic waste products. This can result from changes
such as a loss of vessel density, or disruption in the mechanisms supporting neurovascular coup-
ling. The cognitive deficits seen in obesity have been proposed to stem from impairments in the
vascular support system (Sorop et al., 2017).
Vascular changes have been widely reported in models of HFD feeding and obesity. Cerebral
microvascular disease is associated with microbleeds, lacunas, and microlacunas (Kalaria, 2012),
and these are seen more commonly in obese individuals with insulin resistance and dyslipidaemia
(Park et al., 2007a). Additionally, cerebral small vessel disease is associated with visceral fat
accumulation (Yamashiro et al., 2014). HFD feeding and obesity in rodents has been associated
with both a loss of cerebral microvascular density, otherwise known as rarefaction, and aberrant
angiogenesis. Both of these processes correlated negatively with cognitive performance (Tucsek
et al., 2014b; Coucha et al., 2019). HFD associated reductions in vascular diameter have also
been reported (He et al., 2016; Constantinescu et al., 2011), as have reductions in blood flow and
perfusion in obesity (Birdsill et al., 2013) and HFD fed rats (Glaser et al., 2012; Obadia et al.,
2017), with cortical blood flow reductions correlating with memory impairment (Birdsill et al.,
2013).
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Besides passive support of neuronal metabolism, the cerebrovasculature also has the ability to
vary regional blood flow levels to support regional differences in neuronal activity. This is referred
to as neurovascular coupling, and generally relies on metabolic signalling to vascular cells. Models
of obesity show deficits in the ability of the vasculature to respond to dilatory signals (Chantler
et al., 2015; Phillips et al., 2005; Schwaninger et al., 2003) whilst HFD fed animals showed a
reduction in endothelial dependent dilation of pial arterioles following 20 weeks of diet (Obadia
et al., 2017). This was associated with elevated levels of NADPH oxidase, a major source of
ROS (Zhang et al., 2016), in the cerebrovasculature. Increases in NADPH oxidase expression and
activity are associated with impairments in neurovascular coupling (Toth et al., 2014; Park et al.,
2007b), and HFD-associated decreases in neuronally stimulated CBF responses in the whisker
barrel cortex were partially attenuated by NADPH oxidase inhibition (Tucsek et al., 2014b). In
addition, a marker of oxidative and nitrosative stress, 3-nitrotyrosine, is elevated by HFD in aged
mice (Tucsek et al., 2014b).
5.1.1 Aims, Hypotheses, and Experimental Approach
Currently, no studies have investigated the effects of short-term (i.e. within the first 8 weeks)
HFD feeding on blood flow. My aim with the work presented in this chapter was to address
this by measuring changes in flow across a variety of parameters (e.g. blood volume, oxygen
saturation) over an 8 week dietary timecourse in both the hippocampus and cortex. This would
allow me to not only evaluate whether flow changes occurred rapidly enough following the start of
HFD feeding to contribute to the development of hippocampus-specific cognitive deficits (reported
after 24 hours in McLean et al. 2018), but also to see if diet-induced changes followed a phasic
pattern over time, and if they occurred in a global or region-specific manner. In this way I hoped
to relate hippocampus-specific deficits either to hippocampus-specific flow changes, or global
changes having a greater effect on the hippocampus than other brain areas.
Beyond this, I also wanted to evaluate hypotheses based on results from the post-mortem tissue
work I described in Chapter 3. These showed that following two weeks of dietary manipulation,
HFD feeding reduced capillary radii, the variation in capillary radii, and the extent of capillary
perfusion. As a result, I hypothesised that the reduction in capillary radii and perfusion levels
would be reflected in vivo by a reduction in blood volume, and if not also a reduction in CBF, then
a compensatory increase in flow speed. In addition I interpreted the decrease in radius variability as
an indicator of an impoverished ability to regulate vascular diameter, which therefore may indicate
an impairment in neurovascular coupling. Whilst I detected vascular structural changes across the
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brain, HFD feeding induces hippocampus-specific cognitive impairment that occurs after only 24
hours (McLean et al., 2018) and remains region-specific for up to 30 days (Kanoski and Davidson,
2010). This suggests the presence of hippocampus-specific vascular deficits that may be picked up
by an analysis of in vivo functional blood flow changes, in contrast to the post-mortem structural
vascular analysis that showed no region-specific differences.
Results from Chapter 3 also suggested that basal differences in hippocampal vascular support
could translate global diet induced deficits into region-specific cognitive effects. Data showed that
the hippocampus not only had the lowest capillary density compared to the hypothalamus and
cortex, but that this was also the case for capillary radii measurements, capillary radii variation,
and pericyte coverage. I therefore hypothesised that in vivo the hippocampus would display a
lower level of oxygen availability, and if not, then a greater flow speed that could compensate
for the reduced vascular density and volume. Literature suggests that the hippocampus might
have at least equal, if not greater, neuronal demand for energy supply (discussed in Chapter 3),
indicating the hippocampus likely suffers from worse vascular support relative to its metabolic
requirement than other brain regions. This was hypothesised to underlie its sensitivity to damage in
a number of pathologies including Alzheimer’s Disease, ageing (reviewed in Fjell et al. 2014), and
hypoxia (Ng et al., 1989; Michaelis, 2012). I aimed to evaluate this by comparing blood flow and
neuronal metabolism between the cortex and hippocampus. In addition, though non-significant
and underpowered, the NOCR behavioural data I presented in the previous two chapters suggested
the presence of hippocampus-specific cognitive deficits following HFD feeding for two weeks. As
such, this suggests that behavioural performance and vascular changes could be correlated.
Finally, it has been suggested that locomotion leads to the uncoupling of blood flow and neur-
onal activity (Pisauro et al., 2013), though this was only assessed using intrinsic optical imaging
(Huo et al., 2014; Pisauro et al., 2013). Locomotion increases neuronal activity in visual (Niell
and Stryker, 2010), somatosensory, and frontal cortices, though this does not always correlate
with increases in haemodynamic activity (Huo et al., 2014). However, to date this has not been
investigated using a comprehensive readout of blood flow changes, something I aimed to address.
Optical imaging is largely restricted to estimates of blood volume, where the absorbance of light
with a wavelength at the isosbestic point of the oxy- and deoxyhaemoglobin absorption spectra
(530nm) represents changes in blood volume (Sirotin et al. (2009) cited by Pisauro et al. 2013).
To investigate the hypotheses and aims proposed I took measurements using a combined laser
doppler flowmetry/haemoglobin spectroscopy probe (Oxy-CBF probe) that measures an assort-
ment of blood flow-related parameters (oxygen saturation, blood volume, flow speed etc., from
which the rate of neuronal oxygen metabolism can also be calculated) in mice implanted with
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cranial windows over hippocampal CA1 and cortical V1 over 8 weeks of dietary manipulation.
This was done in awake, behaving animals, that could run freely during data acquisition. This
allowed me to avoid any confounding effects of anaesthesia, which decreases the amplitude, and
changes the timecourse of, haemodynamic responses in mice (Pisauro et al., 2013). I analysed
data acquired whilst the mice were at rest to evaluate differences in blood flow and neuronal meta-
bolism between the hippocampus and cortex, whilst I used the presentation of visual stimuli to
induce neurovascular coupling events in V1 to investigate the effect of diet and locomotion. The
sparse hippocampal coding of stimuli makes eliciting strong peaks of hippocampal activity chal-
lenging, so investigating hippocampal neurovascular coupling required an alternative approach.
To achieve this I detected peaks in a calculated CMRO2 value, which represents summed neural
activity, and averaged the haemodynamic responses occurring during these peaks. This allowed
me to evaluate changes in haemodynamic parameters associated with peaks in neuronal activity.
Finally, by testing hippocampal window mice on their NOCR performance, I was able to correlate
hippocampus-specific cognition with changes in blood flow in vivo.
The data presented here represents some of the first to investigate the effects of HFD on blood
flow and neurovascular coupling changes in vivo in hippocampus. In addition, it provides a novel
insight into the relationship between hippocampus-specific cognition and blood flow, and evalu-
ated the effect of HFD feeding across more numerous haemodynamic parameters than just CBF
as has typically been done in other studies.
5.2 Methods
5.2.1 Animals, Dietary Manipulation, and Experimental Approach
Details of animal genotypes, diets used, behavioural testing, window implantation surgeries, and
imaging setup, are presented in the main methods (Chapter 2). All in vivo results were collected
from Cx3CR1-GFP heterozygotes that had undergone either cortical, or hippocampal, window
implantation. These mice were housed in a reverse light-dark cycle to minimise the impact of
imaging sessions on circadian rhythms, and fed either a HFD or control diet for 57 days. In
some cases, window implanted mice had to be culled prior to 57 days for welfare purposes. After
imaging on day 56, window implanted mice were injected with LPS to induce microglial activation
and then imaged again 24 hours later. Following this, mice were either culled using cervical
dislocation or given a terminal dose of i.p. sodium pentobarbital (Dolethal; Vétoquinol Ltd) at
120mg/kg (diluted to 10% in saline). Behavioural testing was run on hippocampal window mice
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alongside a cohort of wild type naive mice in order to evaluate the effect of surgery, and dietary
manipulation, on hippocampal functioning. As with the in vivo mice, these wild type animals
were fed either a HFD or control diet. The behavioural protocol began on day 11 of dietary
manipulation, and ran until day 14, the day on which testing took place. After testing wild type
mice were culled using cervical dislocation. Mice were weighed daily, though not always at the
same time of day. As the mice used in this chapter were the same as those used in the microglia
in vivo results (Chapter 4), a table of summary statistics, of count, age, sex split, and diet group
allocation by surgery status, is available there (Table 4.1).
5.2.2 Combined Laser Doppler Flowmetry/Haemoglobin Spectroscopy
A combined laser doppler flowmetry/haemoglobin spectroscopy probe (Oxy-CBF probe, VMS
Oxy, Moor Instruments) allowed for monitoring of the following net haemodynamic measures:
blood flow (CBF), flow speed, oxygen saturation (SO2), oxygenated haemoglobin (HbO), deoxy-
genated haemoglobin (HbR), and total haemoglobin (HbT). The cerebral metabolic rate of oxygen
consumption (CMRO2) was calculated from these variables, where (t) indicates time.
CMRO2(t) =CBF(t)
HbR(t)
HbT (t)
All measures taken using the Oxy-CBF probe except SO2 are measured in arbitrary units, with
SO2 being measured in percent. Recordings were taken by positioning the probe vertically above
the cranial window, as close as was possible without making direct contact. Data were available as
a 2D matrix to visualise continuous haemodynamic activity. The matrix also included recordings
of locomotion and indicators of periods of visual stimulation. Data points were collected at a rate
of 40Hz. Recordings typically lasted ∼10 minutes. These were obtained at the end of imaging
sessions that began with the acquisition of two photon image stacks for the microglial analysis
described in Chapter 4. Acquiring these images typically took around 1.5 hours.
5.2.3 Stimulation of Visual Cortex Neuronal Activity
To investigate stimulus-induced neurovascular coupling in mice with cortical windows implanted
over V1, drifting gratings of black bars on a white background (PsychoPy; spatial frequency of
0.04 cycles per degree, temporal frequency of 2Hz, gratings angled at 315°, bars sized at 220
degrees of visual space at a 17cm distance from the mouse) were presented on screens (Asus
VC239H, 50.92cm x 28.64cm, mean luminance of 15 cd/m2, screen refresh rate of 60 frames per
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second) and paired with simultaneous Oxy-CBF probe recordings (Fig 5.1).
A single visual-stimulus recording session consisted of 10 presentations of the visual stim-
ulus, each lasting five seconds, with each stimulus period preceded by a five-second-long pre-
stimulus period and followed by a 20 second post-stimulus period (Fig 5.1 D). During the pre- and
post-stimulus periods, mice were presented with grey screens that were equi-luminescent with the
visual stimulus. Visual stimulus onset and offset was recorded using a LabJack, and locomotion
was recorded using a rotary encoder (Kubler). Raw locomotion data for each Oxy-CBF probe
recording session was normalised first by setting any values less than 2 standard deviations below
the mean value to 0, and then normalising the values from 0 to 1 (between their minimum and
maximum; Fig 5.1 C).
Trials were assigned to locomotion categories. Analysis was limited to those where loco-
motion occurred both in the pre-stimulus period, and during stimulus presentation (locomotion
trials), and those where there was no locomotion in either of these windows (non-locomotion
trials).
5.2.4 Resting Data Detection
Data were categorised as occurring during periods of rest when there was no locomotion or visual
stimulus presentation. Additionally, any resting data that were within 5 seconds of a previous
visual stimulus presentation, or 1 second of any previous locomotion, was excluded. Resting data
were averaged within epochs i.e. periods of continuous rest within a recording session, and periods
of rest were excluded if their duration was less than 2 seconds (Fig 5.1 C).
5.2.5 CMRO2 Peak Aligned Data Extraction
To detect CMRO2 peaks, the data were first smoothed using a locally weighted smoother (LOESS)
with a span of 0.01. Following this the baseline was made local to 0 (by subtracting the minimum
of the trace, dividing by the maximum of the trace, and then subtracting a further smoothed trace.
This further smoothed trace consisted of data smoothed using a moving average window over 2.5
seconds). Any discrete signal spikes which were >10% of the total maximum value (across the en-
tire trace) were provisionally identified as peaks (Fig 5.2 B). Peaks that occurred within 3 seconds
of one another were compared, and the peak with the greatest value was retained. Events were
excluded if the CMRO2 peak was smaller than 2 standard deviations above the baseline. Events
were classified as occurring during locomotion if there was locomotion in the second preceding
the detected peak. Events were classified as occurring during stimulus presentation if there was a
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Figure 5.1: Experimental Setup and Example Data. (A) Imaging setup schematic. (B) Drifting gratings were
presented on the screens in A to stimulate neuronal activity in V1 during visual stimulus data collection. (C) Example
locomotion trace from a recording session. Raw locomotion values were normalised between their min and max values
for plotting. Red bars indicate resting epochs. Periods of rest were defined as occurring at least 1 second after previous
locomotion, and at least 5 seconds after any previous visual stimulation event. (D) Example haemodynamic recordings
from V1 using the Oxy-CBF probe during visual stimulus presentation (red dotted lines indicate stimulus presentation,
mean of data normalised to baseline (4-5s) plotted. Plotted data averaged over n = 2947 trials, captured over 155
sessions from 17 mice).
stimulus presentation at any time in a 12 second window beginning 8 seconds before the detected
peak and ending 4 seconds after.
5.2.6 Statistical Analysis
As stated in the main methods chapter, all analyses were run using LMMs and all plotted values
represent the estimated marginal mean +/- 1 SEM derived from the appropriate LMM, unless
otherwise indicated. The use of trials (i.e. data averaged around visual stimulus presentations,
resting periods, or peaks in neuronal metabolism) or mice as subjects in an analysis is indicated
in the appropriate figure legends. Where trials were used as subjects this was accounted for by
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Figure 5.2: CMRO2 Peak Aligned Data Extraction. (A) Mean traces from baseline (D-1) for CMRO2, HbR, CBF,
SO2, speed, and HbT data that were cut 3 seconds before, and 6 seconds after, detected peaks in CMRO2 signal. Plotted
values are normalised to the first second and represent percent change (averaged over n = 1385 events, captured over 29
sessions from 29 mice; vertical solid and dotted lines indicate t2o, t2p, and t2r respectively. Horizontal dashed and
dot-dash lines indicate peak and 25% of peak respectively. Shaded areas indicate the AUC). (B) Peaks in CMRO2
signal were detected (red circles) and parameters were cut into segments starting 3 seconds before and ending 6 seconds
after these peaks.
including a random effect structure in the appropriate statistical model that grouped measurements
by animal.
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Visual Stimulus and CMRO2 Peak Aligned Analyses
Visual Stimulus and CPA data were averaged around stimulus presentations and CMRO2 peaks
respectively. The former was averaged over a window starting 5 seconds before stimulus onset,
and ending 20 seconds after stimulus offset, whilst for the latter this window began 3 seconds
before and ended 6 seconds after the detected CMRO2 peak. Averaged data were normalised as a
percent change using the δ F/F method compared to baseline, where the baseline was the second
before stimulus onset in visual stimulus data, and the first second of events in CPA data.
Visual stimulus and CPA data were characterised by finding the peak value (p), timing of the
peak value (t2p), the minimum value (m), timing of the minimum value (t2m), time taken to reach
25% of the peak value (t2o), time taken to fall to 25% of the peak value (t2r), and AUC (Fig 5.2 A).
Given that CPA data were aligned to CMRO2 peaks, the t2p was not analysed for CMRO2. This
was done for each haemodynamic parameter recorded (CBF, speed, SO2, HbO, HbR, HbT, and
CMRO2). In visual stimulus data these values were characterised over the 10 seconds following
stimulus presentation, whilst for CPA data these were characterised from 1 second from the start
of the cut event (the end of the baseline period) through to 8 seconds post event start.
Principle Component Analysis
For visual stimulus timecourse data, a PCA with feature centering and scaling was run on the raw
data for each haemodynamic parameter. The first principle component was taken as a composite
measure of the haemodynamic response and analysed alongside the other metrics (e.g. p, AUC,
t2p). To illustrate how they varied by timepoint, the loadings for each parameters were stand-
ardised to their standard deviation using the formula (L− µL)/σL, where L indicates the loading
value, µL indicates the mean loading, and σL indicates the standard deviation of loading values.
These are plotted by timepoint and haemodynamic parameter in Fig 5.3.
Ratio of SO2 and HbT to CMRO2
For all analyses, the ratio of SO2 and HbT to CMRO2 was calculated. This was done using the
AUC values in the visual stimulus and CPA data.
Statistical Models
The main effects of sex, age, and weight change, were included for all the following described
models. Additionally, neurovascular coupling data were analysed with locomotion group, rather
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Figure 5.3: Visual Stimulus Composite Measure PC1 Loadings by Time. A PCA was run on visual stimulus re-
sponses, and the first principal component was chosen as a composite measure. Colour coding indicates the standard-
ised loadings of the composite measure, which are indicated by time across all measured parameters. Traces represent
the average data normalised to baseline (4-5 seconds) regardless of diet, timepoint, or locomotion status. Dashed white
lines indicates the period of visual stimulus presentation. Horizontal black lines indicate the mean value at baseline
(plotted average of n = 2135 stimulus presentations (n = 1146 locomotion trials) captured over 148 sessions from 17
mice (n = 8 HFD)).
than brain region, as a fixed factor. Data were classified as a locomotion trial if there was loco-
motion during both the stimulus presentation and the pre-stimulus baseline period, and as non-
locomotion if there was no locomotion in either period. Individual visual stimulus and CPA trials,
as well as resting epochs, were used as subjects. For all analyses, except those looking exclusively
at day 14, an autoregressive order 1 model for the correlation between days was included. Data
were analysed using LMMs.
Analyses of timecourse data were done specifying timepoint, diet, brain region, and their
interactions, as fixed effects. A random intercept for each animal and each trial nested within
animal was specified, with a random slope included for the relationship between days.
In both resting and CPA data, hippocampal values showed a consistent trend towards cortical
values over time, where this corresponded to increases in the resting data, and decreases in the
CPA data. This appeared to stabilise at days 42, 49, and 56. As such, a separate analysis of
these three timepoints was conducted. Timepoint, diet, brain region, and their interactions, were
specified as fixed effects. A random intercept for each animal and each trial nested within animal
was specified, with a random slope included for the relationship between days.
Data from hippocampal window mice that underwent behavioural testing at day 14 were ana-
lysed separately to investigate any effect of behavioural performance on haemodynamic data. Here
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diet, behavioural performance, and their interaction, were specified as fixed effects. A random in-
tercept was specified for animal, with a random slope for the relationship between trials.
In order to look at cortical changes at this same timepoint, analyses were run on all mice
limited to day 14. Diet, region, and their interaction, were specified as fixed effects. A random
intercept was specified for animal, with a random slope for the relationship between trials.
5.3 Results
5.3.1 HFD Did Not Significantly Affect In Vivo Weight Gain or NOCR Perform-
ance
In order to evaluate the effect of HFD feeding on weight gain, weights were compared between
groups following normalisation to their value at the beginning of the dietary manipulation in order
to control for differences in starting weight. This value was analysed using an LMM. As the mice
used for both this chapter, and the in vivo microglial work (Chapter 4) were the same, see Fig 4.3
and the associated results section there for a detailed description. In brief, there was no effect of
diet, nor any modulatory effect of diet, on the significant increase in normalised weight seen as
time progressed in either the window implanted mice, or when looking within the first two weeks
of dietary manipulation in mice that underwent behavioural testing.
Short-term HFD feeding is associated with hippocampal deficits. To investigate the effect
of hippocampal window surgery, and diet, on hippocampus-specific cognition, and to correlate
cognitive performance with in vivo blood flow changes, the performance of mice that had not un-
dergone surgery, and hippocampus window implanted mice, on a hippocampus-specific NOCR
task following two weeks of dietary manipulation was assessed. As with the analysis of weight,
the mice used in the previous chapter were the same as those described here. Therefore for a full
presentation of the results and discussion see Chapter 4. Briefly, though HFD impaired NOCR
performance in the subset of mice analysed in the post-mortem chapter (Chapter 3), the HFD-
associated decrease in NI value was attenuated and did not approach significance when hippocam-
pal window mice were included in the analysis.
5.3.2 Neurovascular Coupling in Visual Cortex
HFD induced cognitive impairment has been proposed to be mediated by deficits in neurovascular
coupling (Sorop et al., 2017). In addition, results from Chapter 3 demonstrating a HFD induced
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reduction in capillary radius variation suggested that neurovascular coupling may be impaired in
my model. To investigate the effect of diet on neurovascular coupling, I presented mice with
visual stimuli (drifting gratings) to stimulate neuronal activity in V1 whilst simultaneously taking
Oxy-CBF probe recordings. These recordings were averaged around the 5 seconds of stimulus
presentation, including the 5 seconds before and 15 seconds after. Data were normalised using δ
F/F to the mean value 1 second before stimulus presentation began.
This approach also allowed me to investigate the suggestion that during locomotion, neuronal
activity is uncoupled from blood supply (Pisauro et al., 2013). To do this, I assigned trials (data
averaged around stimulation events) from the visually stimulated V1 recordings a locomotion
category. Trials where the mouse was running both before and during the stimulus presentation
were classified as locomotion trials. Trials with no locomotion either before or during stimulus
presentation were classified as non-locomotion trials. In this way I could investigate whether
locomotion leads to neurovascular uncoupling using a more comprehensive readout of blood flow
changes than had been used previously in Huo et al. (2014) and Pisauro et al. (2013). I was also
able to explore whether this was associated with any dietary effects. As such, locomotion and
non-locomotion trials were compared over time and between diet groups.
Effects of Locomotion on V1 Neurovascular Coupling
Analysing the effect of locomotion on neurovascular coupling in V1 showed that locomotion re-
duced peak and AUC values for HbO and SO2, and increased them for CBF and HbT (Fig 5.4).
HbR showed simultaneously more positive, and therefore weaker, peak responses in locomotion
trials, as well as an elevated AUC value. The timing of peaks, peak onsets, and peak offsets, were
accelerated by locomotion for all parameters except CMRO2. The PCA-based composite measures
also showed locomotion effects for all parameters except CMRO2 (Appendix A.8). The ratio of
oxygen availability (SO2) to oxygen metabolism (CMRO2) was reduced by locomotion, whilst the
ratio of blood volume (HbT) to CMRO2 was elevated. Values from statistical analyses are presen-
ted in Table 5.1. These results reflect that locomotion, whilst not influencing neuronal activity or
overall CBF, leads to a decrease in oxygen saturation despite an elevation in blood volume and
an acceleration of the haemodynamic response to neuronal activity. The decrease in SO2 suggests
that despite the increase in blood volume (HbT), the balance between oxy- and deoxy- haemo-
globin levels is tilted towards deoxyhaemoglobin during locomotion. This is supported in the data
by the presence of locomotion-associated increases in the AUC of HbR responses.
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Figure 5.4: Locomotion Increases Blood Volume, Decreases Oxygen Availability, and Accelerates Haemody-
namic Responses. Locomotion increased both the peak and AUC values for HbT, whilst decreasing them for SO2,
something that is reflected in both a reduced ratio of SO2, and an elevated ratio of HbT, to CMRO2. Locomotion also
accelerated the peak timing for CBF, SO2, and HbT responses to visual stimulation (’Loco’ refers to trials with loco-
motion both during and preceding stimulus presentation. ’No Loco’ refers to trials where no locomotion was present in
either window. The baseline period was the second preceding stimulus presentation. Ratios to CMRO2 are calculated
using AUC values. Time to peak times are relative to the beginning of stimulus trials, where stimulus presentation
occurs from 5 to 10 seconds. Horizontal lines indicate locomotion group means. Solid lines indicate significant (p <
.05) differences. Analysis used n = 2135 trials (n = 1146 locomotion) recorded over 148 sessions taken from n = 17
mice (n = 8 HFD)).
Dietary Effects on V1 Neurovascular Coupling
Investigating the effects of diet revealed time-specific effects on the AUC values of all haemo-
dynamic measures. In addition, CMRO2, CBF, SO2, speed, and HbR showed diet by time by
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Table 5.1: Statistics for the Effect of Locomotion on Visually Stimulated Neurovascular Coupling. The effect
of locomotion on haemodynamic responses to visually stimulated neuronal activity in V1 was analysed using LMMs
(numDF and denDF refer to degrees of freedom. F and p values are rounded to 4 decimal places. Red text indicates
significance. Green text indicates trend level. Background shading indicates size of p value where darker is larger.
Sig indicates significance indicators. Measure indicates the measure analysed. Factors indicate factors in the model.
Parameter indicates the haemodynamic parameters analysed. Analysis indicates the type of data analysed. P values are
corrected for multiple comparisons across parameters using the Bonferroni adjustment).
locomotion interactions, where timepoint-specific dietary differences also varied by locomotion
status (Appendix A.10). These effects were more sparse in peak analyses (Appendix A.9), and of
the timings analysed, only the t2p and t2o for CBF showed a three-way diet, locomotion, timepoint
interaction (data not shown). Corrected pairwise dietary comparisons however, revealed no sig-
nificant differences between diet groups at any timepoint for either locomotion category in any
measure, suggesting these detected effects were driven by time-related noise.
Besides characterising haemodynamic responses by measuring values such as the AUC and
peak levels, I also constructed a composite measure of the neurovascular response in V1 to visual
stimulus using a PCA. This measure was significantly affected by diet by time and diet by time
by locomotion interactions, as well as being associated with a significant dietary effect on speed
and CBF at day 3 in locomotion trials (Fig 5.5). In order to interpret what exactly a significant
effect on the PCA based measure meant, I investigated the raw data traces at day 3 (Fig 5.6) in
locomotion trials. This revealed that whilst peak values and the timing of responses appeared
similar between diet groups, the response in HFD animals seemed to remain elevated for a longer
duration in CBF and flow speed measures. Though potentially a result of noisy data, in the absence
of similar dietary effects on CMRO2, this could suggest that short-term HFD feeding is associated
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with an impaired ability to regulate the dynamics of flow speed (which leads to alterations in CBF)
during neurovascular coupling in V1 during locomotion. Values from statistical analyses of the
composite response measures are presented in Table 5.2.
Figure 5.5: HFD Feeding Induces Early Dysfunction in V1 Neurovascular Coupling During Locomotion. Visual
stimulation of neuronal activity in V1 appeared unaffected by HFD in analysis of peak, AUC, and timing values. How-
ever, a composite PCA-based measure of the haemodynamic response showed dietary effects at day 3 of manipulation
in locomotion trials in both speed and CBF readings. (The composite response measure is the first principal component
(PC1) of a PCA run on the data. ’Loco’ refers to trials with locomotion both during and preceding stimulus presenta-
tion, ’No Loco’ refers to trials where no locomotion was present in either window. The baseline period was the second
preceding stimulus presentation. Thick borders indicate diet by time interactions. Grey backgrounds indicate diet by
time by locomotion interactions. * indicates p < .05. Analysed using n = 2135 trials (n = 1146 locomotion) recorded
over 148 sessions from n = 17 mice (n = 8 HFD)).
The Effects of Two Weeks of HFD on V1 Neurovascular Coupling
Whilst underpowered, the NOCR results presented in Chapter 4 provided some evidence (though
results weren’t significant) that supports the presence of hippocampus-specific cognitive impair-
ment following two weeks of HFD feeding. In order to correlate this with dietary effects on V1
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Figure 5.6: Three Days of HFD Prolongs Visually Stimulated Haemodynamic Responses in V1. Analysis of the
composite response measure indicated dietary effects in locomotion trials after three days of HFD feeding. Normalised
traces indicate that this represents a prolonging of the CBF and flow speed responses to visual stimulation in V1
(Plotted data represents the mean. Vertical dashed lines indicate stimulus presentation. Vertical solid lines indicate
the timing of peak responses. Horizontal dashed lines indicate the peak values. Shading indicates the AUC. Data
were normalised to the second before stimulus presentation and averaged over n = 248 trials captured over 16 sessions
from n = 16 mice (n = 8 HFD)).
neurovascular coupling, I limited analysis of V1 neurovascular coupling trials to the two week
timepoint. Here only the PCA based composite response measure showed dietary effects, where
there was a significant diet by locomotion group interaction for speed, and trend level effects on
HbO and HbT. However, pairwise dietary comparisons revealed no differential dietary effects by
locomotion status (Fig 5.7), suggesting the absence of a correlation between V1 neurovascular
deficits and hippocampus-specific cognitive impairment.
5.3.3 Resting Data
Regional Differences in Resting Haemodynamic Values
The results presented in Chapter 3, where the hippocampus showed the lowest levels of capillary
density and smallest capillary radius, suggested that the hippocampus may show an uncoupling
of oxygen availability, and general vascular support, from neuronal demand. To investigate this,
I analysed haemodynamic parameters during periods of rest, when neither locomotion nor visual
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Table 5.2: Statistics for the Effect of Diet on Visually Stimulated Neurovascular Coupling. The effect of time,
diet, and locomotion, on the haemodynamic responses to visually stimulated neuronal activity in V1 was analysed using
LMMs (numDF and denDF refer to degrees of freedom. F and p values are rounded to 4 decimal places. Red text
indicates significance. Green text indicates trend level. Background shading indicates size of p value where darker
is larger. Sig indicates significance indicators. Measure indicates the measure analysed. Factors indicate factors in the
model. Parameter indicates the haemodynamic parameters analysed. Analysis indicates the type of data analysed. P
values are corrected for multiple comparisons across parameters using the Bonferroni adjustment).
stimulation was taking place (including in the second, or five seconds prior, respectively) and com-
pared them between V1 and hippocampal CA1. A trend over time in CBF, speed, and CMRO2
values in the hippocampus to increase towards the levels seen in the cortex from an initially lower
point was apparent in the timecourse data. These appeared to plateau for the final three imaging
timepoints (D42, D49, D56) so in order to compare values between regions, comparisons were
restricted to days 42, 49, and 56, of dietary manipulation. Here neither CMRO2 nor CBF differed
by region, though SO2 and HbT, and their ratios to CMRO2, were reduced in the hippocampus
(Fig 5.8). These results indicate that despite similar neuronal energy demands (CMRO2), the hip-
pocampus has a poorer level of both absolute and relative oxygen availability and blood volume.
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The results of statistical analyses are presented in Table 5.3.
Figure 5.7: Changes in V1 Neurovascular Coupling Did Not Coincide with Hippocampus-Specific Behavioural
Deficits. To link any potential dietary effects on neurovascular in V1 to the deficits seen in the NOCR task in a subset
of mice after two weeks of dietary manipulation, analyses restricted to the 14 day recording timepoint were conducted.
Only the composite measure showed dietary effects, with the only significant result being a diet by locomotion interac-
tion for flow speed. However, pairwise dietary comparisons revealed no differential dietary effect between locomotion
and non-locomotion trials (The composite response measure is the first principal component (PC1) of a PCA run on the
data. ’Loco’ refers to trials with locomotion both during and preceding stimulus presentation. ’No Loco’ refers to trials
where no locomotion was present in either window. Thick borders indicate diet by locomotion group interactions.
Numbers on brackets indicate corrected pairwise dietary p values. Analysed over n = 249 trials (n = 108 locomotion)
captured over 16 sessions from n = 16 mice (n = 8 HFD)).
Table 5.3: Statistics for the Differences between Regions in Resting Haemodynamic Values The difference in
resting haemodynamic values between regions was analysed using LMMs (numDF and denDF refer to degrees of
freedom. F and p values are rounded to 4 decimal places. Red text indicates significance. Green text indicates trend
level. Background shading indicates size of p value where darker is larger. Sig indicates significance indicators.
Measure indicates the measure analysed. Factors indicate factors in the model. Parameter indicates the haemodynamic
parameters analysed. Analysis indicates the type of data analysed. P values are corrected for multiple comparisons
across parameters using the Bonferroni adjustment).
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Figure 5.8: Neuronal Metabolism is Uncoupled From Oxygen Supply in the Hippocampus. Restricting analysis
to periods of rest and timepoints where hippocampal values plateaued revealed that despite similar levels of neuronal
oxygen metabolism between V1 and CA1 (CMRO2), the hippocampus had reduced levels of oxygen availability (SO2)
and blood volume (HbT; ’V1’ refers to primary visual cortex, ’CA1’ refers to hippocampal CA1. Periods of rest
were epochs where no locomotion or visual stimulation occurred, or had occurred in the preceding one or five seconds
respectively. Horizontal lines indicate regional group means. Solid lines indicate significant (p < .05) differences. n =
18 (HFD: 10, CA1: 11) animals; 50 sessions; 845 resting epochs).
Dietary Effects on Resting Haemodynamic Values
Results described in Chapter 3 demonstrated a reduction in capillary radii and perfusion in both
the hippocampus and cortex after 14 days of HFD feeding. I hypothesised that this could be as-
sociated with in vivo decreases in blood volume, and potentially in CBF as well, if compensatory
increases in flow speed were absent. In the resting timecourse analyses (Fig 5.9) all haemody-
namic parameters showed significant diet by region by time interactions that were associated with
a significant and trend level increase in CBF and speed values respectively in HFD animals at day
3 in the cortex. This elevation persisted to day 7, though non-significantly, and correlates with
elevated CMRO2 values at the same timepoints. Additionally, the ratio of HbT to CMRO2 was
reduced by HFD feeding at the 14 day timepoint in the cortex. Analysis statistics are presented
in Table 5.4. These results indicate that despite reduced capillary radii, no overall decrease in
regional blood volume is observed after two weeks of HFD feeding, and the reduction in the HbT
to CMRO2 ratio at D14 appears driven by an elevation in CMRO2 rather than a reduction in HbT.
In addition, as suggested by the V1 neurovascular coupling analysis, HFD feeding is associated
with transient dysfunction in haemodynamic responses in the cortex at an early timepoint. This
seems most likely related to an elevation in neuronal oxygen metabolism that, though not signific-
ant, appears to drive an increased cortical perfusion by increasing the speed of blood flow within
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the first week of HFD feeding. Presentation of the full dietary timecourse for all parameters is
presented in the Appendix A.12.
Figure 5.9: Early HFD Induced Dysfunction in Resting Cortical Haemodynamic Regulation. Resting epoch
analysis revealed a trend level HFD induced increase in flow speed in V1 at day 3, an elevation that persisted, though
non-significantly, to day 7. This correlated with a non-significant elevation in CMRO2. In addition, the ratio of blood
volume to CMRO2 was decreased in V1 at day 14 (epochs of rest were periods where no locomotion or visual stim-
ulation occurred, or had occurred in the preceding one or five seconds respectively. Thick borders indicate diet by
time interactions. Grey backgrounds indicate diet by time by region interactions. ** and ’ indicates p < .01 and <
.10 respectively. Analysis used n = 4460 resting epochs recorded over 259 sessions from n = 29 mice (n = 14 HFD).
Plotted data excludes the final four imaging timepoints and therefore represents n = 3380 resting epochs captured over
193 sessions from n = 29 mice (n = 14 HFD)).
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Table 5.4: Statistics for the Effect of Diet on Resting Haemodynamic Values The difference in resting haemo-
dynamic values between regions and diet groups was analysed using LMMs (numDF and denDF refer to degrees of
freedom. F and p values are rounded to 4 decimal places. Red text indicates significance. Green text indicates trend
level. Background shading indicates size of p value where darker is larger. Sig indicates significance indicators.
Measure indicates the measure analysed. Factors indicate factors in the model. Parameter indicates the haemodynamic
parameters analysed. Analysis indicates the type of data analysed. P values are corrected for multiple comparisons
across parameters using the Bonferroni adjustment).
Behavioural Correlations
As described in Chapter 4, two weeks of HFD feeding did not significantly impair hippocampus-
specific NOCR performance, though results suggested this may be the case in an adequately
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powered study. In order to correlate hippocampal cognition with changes in resting haemody-
namics, analyses that were restricted to day 14 in hippocampal window mice that had undergone
NOCR testing were run with NOCR performance included as a factor. No effects in the model had
a significant or trend level association with resting haemodynamic parameters (data not shown).
5.3.4 Data Aligned to Peaks of Oxygen Metabolism
Results from Chapter 3 suggested that HFD feeding might be related to deficits in neurovascular
coupling (due to the detection of a HFD induced reduction in capillary radius variation). This result
was not region-specific, suggesting it occurs in the hippocampus as well as the cortex. Whilst
stimulating synchronised neuronal activity in cortical V1 can be done using the presentation of
visual stimuli, doing so in the hippocampus is difficult given its sparse coding of stimuli. To do
so I averaged haemodynamic data over peaks detected in a calculated cerebral metabolic rate of
oxygen consumption (CMRO2) value, which reflects energy used by summed neuronal activity.
By averaging data around peaks in this value, I was able to investigate changes in the relationship
between neuronal oxygen consumption and vascular supply (Fig 5.2). Differences in these events
were compared between timepoints, diet groups, and regions.
Regional Differences
As in the analysis of resting data, a trend for hippocampal values to become more similar to those
in cortex over time was apparent for a number of haemodynamic parameters. In contrast to resting
values however, this was associated with values decreasing over time. This pattern was seen in
both the magnitude of the peaks and AUC values of CPA data. Therefore, to compare regional
differences, analyses restricted to the final three imaging timepoints (D42, D49, D56) where hip-
pocampal values seemed to plateau was conducted. Here hippocampal peak and AUC values were
not different for CMRO2, but reduced for HbT and elevated for SO2. The ratio of SO2 to CMRO2
showed no difference however, whilst the ratio of HbT to CMRO2 was reduced in the hippocam-
pus (Fig 5.10). These results demonstrate that peaks of neuronal metabolism occur with a similar
magnitude in both the cortex and hippocampus, and the similar ratio of SO2 to CMRO2 between
them indicates that during peaks of neuronal activity, the neurovascular coupling of oxygen sup-
ply is consistent. However, the ratio of HbT to CMRO2 is reduced in the hippocampus, indicating
that increasing oxygen availability in the hippocampus in response to CMRO2 peaks likely relies
to a greater extent on changes in flow speed rather than blood volume relative to V1. This is
partially supported by finding a trend level elevation in magnitude of flow speed responses in the
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hippocampus.
The timings of CPA responses varied between regions. The t2p value for CBF was earlier in
the hippocampus, with the same being true for the t2o for SO2, HbR, HbO, and HbT. Similarly,
the t2r for HbR, HbT, and CMRO2, was earlier. However, CMRO2 t2o times were delayed, as
were speed t2r times (Appendix A.14). These results indicate that hippocampal CMRO2 peaks
are sharper, and CBF peaks occur earlier. The HbR and HbT responses seem to onset and offset
sooner, despite no changes in the timing of their peaks, indicating more gradual onsets and sharper
offsets. Altogether, it appears that the dynamics of neurovascular coupling in hippocampal CA1
follow a different timecourse to that in V1. Values for the statistical analysis of regional differences
are presented in Table 5.10.
Figure 5.10: Cortical Neurovascular Coupling, Relative to the Hippocampus, Relies to a Greater Extent on
Blood Volume Increases. To investigate neurovascular coupling in both CA1 and V1, data that were cut around peaks
in CMRO2 was analysed. At timepoints where the effect of time on hippocampal values was attenuated, the magnitude
of CMRO2 peaks did not differ between regions, though HbT did. The ratio of HbT to CMRO2 was reduced in the
hippocampus, despite no difference in the SO2 ratio (’V1’ refers to primary visual cortex, ’CA1’ refers to hippocampal
CA1. Data were cut around detected peaks in CMRO2 signal. Horizontal lines indicate regional group means. Solid
lines indicate significant (p < .05) differences. Analysed using n = 2720 CPA events captured over 57 sessions from n
= 21 mice (n = 11 HFD, n = 11 CA1)).
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Table 5.5: Statistics for the Differences between Regions in Neurovascular Coupling. Neurovascular coupling was
compared between regions using LMMs (numDF and denDF refer to degrees of freedom. F and p values are rounded
to 4 decimal places. Red text indicates significance. Green text indicates trend level. Background shading indicates
size of p value where darker is larger. Sig indicates significance indicators. Measure indicates the measure analysed.
Factors indicate factors in the model. Parameter indicates the haemodynamic parameters analysed. Analysis indicates
the type of data analysed. P values are corrected for multiple comparisons across parameters using the Bonferroni
adjustment).
Dietary Effects
Investigating dietary effects on neurovascular coupling, the AUC values for all haemodynamic
responses showed significant diet by time, as well as three-way diet by time by region, interactions.
This indicates not only the presence of time-specific, but also time and region-specific dietary
effects. This was associated with a spike in hippocampal control AUC and peak values at day 1 for
HbO and SO2, whilst HFD induced an elevation in hippocampal HbR and flow speed AUC values
at days 14 and 35 respectively. Whilst the dietary effect at day 1 is likely due to time-related noise,
due to it being a spike in values in control diet fed animals, the HFD related elevation at day 14
in HbR AUC values was associated with a similar non-significant elevation at day 10, suggesting
that during the second week of HFD feeding the HbR response to neuronal activity is elevated.
This coincides with non-significant elevations in HbT, implying that though a greater volume of
blood is present in the hippocampus, this is disproportionately associated with deoxyhaemoglobin.
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Interestingly, this didn’t correlate with any HFD related increases in CMRO2 or CBF. The increase
in HFD speed AUC values at day 35 is associated with a non-significant increase in CBF, though,
as with the HbR AUC changes, CMRO2 levels show no sign of elevation. No diet related effects
were observed on the timings of responses, nor their ratio to CMRO2. Full graphs for the analysis
of peak and AUC values are presented in the Appendix (Figs A.15, A.16). Statistical analyses are
presented in Table 5.6.
Figure 5.11: HFD Induces Dysfunctional Haemodynamic Regulation during Hippocampal Neurovascular
Coupling. AUC values of neurovascular coupling responses show hippocampus-specific dietary effects, where HFD
significantly elevated the AUC of HbR and speed at days 14 and 35 respectively. (Data were cut around detected peaks
in CMRO2 signal. Thick borders indicate diet by time interactions. Grey backgrounds indicate diet by time by region
interactions. * and ** indicates p < .05 and < .01 respectively. Statistics were calculated using n = 13506 CPA events
captured over 281 sessions from n = 29 mice (n = 14 HFD). Plotted data excludes cortical data and therefore represents
n = 4708 CPA events captured over 133 sessions from n = 12 mice (n = 6 HFD)).
Behavioural Correlations
To investigate the relationship between hippocampus-dependent behaviour and neurovascular coup-
ling, analysis of CPA data at day 14 in behaviourally tested hippocampal window mice was con-
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Table 5.6: Statistics for the Effects of Diet on Neurovascular Coupling. The effects on CPA data of time and diet,
and differences between regions, were analysed using LMMs (numDF and denDF refer to degrees of freedom. F and p
values are rounded to 4 decimal places. Red text indicates significance. Green text indicates trend level. Background
shading indicates size of p value where darker is larger. Sig indicates significance indicators. Measure indicates the
measure analysed. Factors indicate factors in the model. Parameter indicates the haemodynamic parameters analysed.
Analysis indicates the type of data analysed. P values are corrected for multiple comparisons across parameters using
the Bonferroni adjustment).
ducted with their behavioural performance as a factor. This analysis revealed a trend level in-
teraction between diet and performance on the AUC and peak values of CMRO2 and CBF. Here
performance correlated negatively with both peak and AUC values in the control diet group, whilst
there was no correlation in HFD animals (Fig 5.12). Graphs showing changes in peak and AUC
values for all parameters are presented in the Appendix (Figs A.17, A.18).
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Figure 5.12: The Magnitude of Neuronal Activity During Peak Events Correlates Negatively With Hippocampal
Performance Only In Control Animals. Analysis of CPA data at day 14, with NOCR performance included as a factor,
showed that the peak and AUC values of CMRO2 and CBF correlated negatively with NOCR performance but only
in control animals (CPA data were cut around detected peaks in CMRO2 signal. Novelty index reflects the difference
between the proportion of exploration time spent exploring novel versus familiar objects. Dotted line indicates zero
point where no difference exists in proportion of exploration time spent with novel versus familiar objects. Plotted lines
represent the estimated marginal mean +/- 95% confidence intervals. These are predictions of the trend extracted from
the relevant LMM. Text boxes indicate the slope of the trends by diet groups, and the p value of diet by performance
interaction. * next to slope values indicates it is significantly different from zero. n = 11 (HFD: 6); 11 sessions; 374
CPA events).
5.4 Discussion
Results presented in this chapter explored dietary, regional, and time associated changes in resting
and neurovascular coupling related haemodynamic responses. In addition, the effect of locomotion
on visually stimulated responses in V1 was investigated. Analyses were split into four different
models, where data were analysed either over the 8 weeks of the dietary manipulation, exclus-
ively at day 14 (when NOCR behavioural testing was conducted), exclusively at day 14 in the
hippocampal window mice that underwent behavioural testing, and over the final three recording
timepoints (days 42, 49, and 56) given this was when time-related changes in hippocampal resting
and CPA values appeared to plateau.
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5.4.1 Locomotion During Visual Stimulation Accelerated the Vascular Response
and Increased Blood Volume
By stimulating neuronal activity in cortical V1 and measuring associated blood flow responses
and locomotion, I was able to investigate the effects of diet, time, and locomotion on visually-
stimulated neurovascular coupling responses in the cortex (Fig 5.4). This paradigm is well estab-
lished (Niell and Stryker, 2008; Pisauro et al., 2013). It has been suggested that during locomotion
the strength of neurovascular coupling is diminished given that no effect of locomotion was seen
on haemodynamic responses (Pisauro et al., 2013) despite the fact that locomotion increases V1
neuronal activity (Niell and Stryker, 2010). To investigate this I categorised visual stimulus trials
in my data as locomotion trials if locomotion was present both during the pre-stimulus baseline
and stimulus presentation period, and as non-locomotion trials if locomotion was absent in both
periods, and compared them. CMRO2 represents summed neuronal activity, and was unaffected
by locomotion in my data, seemingly contradicting studies by Niell and Stryker (2010) and Ayaz
et al. (2013), where locomotion is associated with increased neuronal activity during visual stimu-
lus presentation. A reason for this is most likely that my readout of neuronal activity is calculated
from haemodynamic parameters, and if locomotion is indeed associated with neurovascular un-
coupling (a change in the relationship between neuronal activity and blood flow responses) as
suggested by Pisauro et al. (2013), and documented in frontal cortex by Huo et al. (2014), it is
reasonable to expect a haemodynamic based measure of neuronal activity to show no effect of
locomotion. To address this future work should utilise the more comprehensive approach to meas-
uring haemodynamic changes that I have used (i.e. measures of blood flow, oxygenation, blood
volume, etc.) coupled with more direct readouts of neural activity. Conversely, if the absence of
any change in my CMRO2 value is unrelated to the fact it is based on haemodynamic responses, its
possible that it simply lacks the sensitivity required to detect the increases reported in local field
potential and single unit recordings by Niell and Stryker (2010) and Ayaz et al. (2013), given I used
similar stimulus properties (with regards to spatial and temporal frequencies) to these studies.
My results showed that locomotion accelerated the haemodynamic responses to visually stim-
ulated neuronal activity, and was associated with a reduced level of oxygen availability despite an
elevation in blood volume. These differences persisted when calculating the ratio of SO2 and HbT
to CMRO2, though as previously stated, the CMRO2 value is based on haemodynamic parameters
that may be uncoupled from neuronal activity during locomotion (Pisauro et al., 2013). These
results indicate that despite locomotion elevating blood volume in the region, this does not occur
to a great enough degree to significantly increase overall perfusion (CBF) levels, and also fails to
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sustain the levels of oxygen availability seen in non-locomotion trials. This may be a result of en-
hanced neuronal activity (Niell and Stryker 2008; Ayaz et al. 2013; though not detected in my data
for reasons outlined previously) leading to a reduction in tissue oxygen levels to a greater degree
than an increase in blood volume is able to buffer. These results demonstrate that though loco-
motion is associated with neurovascular uncoupling to some degree (in that oxygen availability
is decreased, and CBF levels are unchanged despite documented elevations in neuronal activity),
this is not the case with regards to changes in blood volume (HbT). In addition, locomotion ac-
celerates the haemodynamic response to neuronal activity. This is in contrast to work by Pisauro
et al. (2013) that showed no effect of locomotion on neurovascular coupling related blood volume
increases or time dynamics in V1. The difference in our results could be related to the classifica-
tion of locomotion. Whilst Pisauro et al. (2013) distinguished between locomotion and stationary
trials using a threshold for the average running speed, trials were only classified as stationary in
my data if they were accompanied by the complete absence of locomotion during and prior to
stimulus presentation. Consequently the comparison in my results more truly reflect the effect of
locomotion on haemodynamic responses to visually stimulated neuronal activity in V1.
5.4.2 HFD Feeding May Induce Transient, Astrocyte-Mediated, Deficits in Cortical
Neurovascular Coupling
Whilst HFD-induced deficits in neurovascular coupling have been reported previously with long-
term dietary manipulations (20 weeks; Tucsek et al. 2014b), I found that the variation of capillary
radii was reduced after 14 days of HFD feeding in post-mortem tissue, as described in Chapter 3.
This suggested that in vivo neurovascular coupling deficits might be detectable at much earlier
timepoints. However, Oxy-CBF probe data showed no significant pairwise dietary comparisons
when looking across peak and AUC values, or the timing of peaks and their onset and offset.
In contrast, analysis of a PCA-based composite measure of the haemodynamic response in V1
showed significant dietary effects at day 3 on flow speed and CBF in locomotion trials (Fig 5.5).
Given the composite measure is based on differential weighting of data points, the direction of
its dietary effects needs to be interpreted with this in mind. The measure showed strong negative
weightings from 6 to 8 seconds, the period over which values tended to rise to a peak, and strong
positive weightings from 12-18 seconds, a period over which responses tailed off following their
peaks. As a result, more positive composite values suggest smaller peak and pre-peak values,
along with higher values following the offset of responses.
Looking at raw data traces at day 3 in locomotion trials (Fig 5.6), HFD was clearly associated
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with a prolonged CBF and speed response to visual stimulation. Whilst a clear double-bump
neurovascular response is present in control animals, this seems dysregulated by HFD feeding,
with HFD values elevating at the same point that they decline in control animals between the two
phasic elevations. The bimodal response present in control animals appears to be related to two
separate mechanisms of neurovascular coupling. The first rapid response has been suggested to
be mediated by the uptake of synaptic glutamate and potassium by astrocytes, whilst the later
response, which acts on the order of 10’s of seconds, may be regulated by metabotropic astrocytic
signalling triggered by the neurotransmitter N-acetylaspartate (reviewed in Baslow and Guilfoyle
2017). Though not a point made by the authors, work by Rosenegger et al. (2015) appears to
show that antagonism of cyclooxygenase-1 (COX-1) located in astrocytic endfeet disrupts the
secondary peak seen in the dilatory response of cortical arterioles to whisker stimulation. COX-1
mediated production of prostaglandins may link neuronal activity to pericyte regulation of blood
flow (Hall et al., 2014), so this suggests that HFD feeding may alter communication between
astrocytes and pericytes, which would alter their functionality without disrupting their coverage
of the vasculature. Indeed, my post-mortem data demonstrated no effect of two weeks of HFD
feeding on pericyte ISD. It seems possible then that HFD leads to an early and transient selective
disruption of astrocytic mechanisms involved in neurovascular coupling. Why this appears to only
be the case during locomotion is unclear, though it should be considered that this effect may be a
result of the high degree of time-related noise seen in the value of the composite measure.
5.4.3 The Mechanisms Driving Hippocampus-Specific Trends Over Time in Hae-
modynamic Measures Are Unclear
In both the resting data, and CPA analyses, hippocampal values trended towards those in the cortex
as time passed, showing consistent increases and decreases respectively. One possibility is that this
could reflect a summation of detrimental effects over time, or alternatively, this may be a return of
haemodynamic regulation to baseline levels. The former may be the result of repeated restraint-
induced stress associated with chronic in vivo imaging, whilst the latter could reflect long-term
surgical recovery. The effect of time on the hippocampus seemed to be attenuated by day 42,
suggesting that 7 weeks of stress, or ∼10 weeks of surgical recovery (imaging typically began 3
weeks post-surgery), was sufficient either for stress effects to plateau, or surgical recovery to be
complete.
Investigating the literature suggests that a role for chronic restraint-induced stress seems un-
likely. Twelve weeks of stress, where rats were placed in 4°C water for 15 minutes a day, followed
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by a 12 week recovery period, was associated with decreased resting hippocampal CBF in the dark
cycle (Endo et al., 1999), and five weeks of daily social defeat stress in rats was led to a reduc-
tion in the number of hippocampal microvessels (Czéh et al., 2010). In addition, chronic stress
seems largely associated with a blunted dilatory, and accentuated contractile, vascular response
(reviewed in Burrage et al. 2018), which would likely reduce resting blood flow parameters. This
contrasts to my results, where resting hippocampal CBF increases with time in synchrony with
flow speed, whilst total blood volume (a proxy for vascular density) shows no time-related effects.
Surgical recovery therefore seems the more likely. However, no other studies have looked
at changes in resting hippocampal blood flow using the hippocampal window technique over a
timecourse, so it is hard to evaluate this theory. Whilst the effect of time is unlikely to be related
to surgical inflammation, given that 20 days of recovery from hippocampal window implantation
is sufficient for astrocytic and microglial inflammation to subside (Gu et al., 2014), it could be
related to surgery associated BBB breakdown. This could permit the entry of circulating plasma
factors, such as IgG, thrombin, fibrinogen, or albumin, with the latter shown to alter neuronal
activity in the hippocampus (though this was only investigated within a 24 hour period; Frigerio
et al. 2012). However, during acquisition of two-photon image stacks, mice were injected with a
3kDa fluorescently-tagged dextran to image vascular morphology. Though not analysed in detail,
no clear leakage into the brain was observed. Given this dextran is far smaller than albumin, IgG,
fibrinogen, or thrombin (69kDa, ∼155kDa, 340kDa; Saunders et al. 2015, 35.5kDa Davie and
Kulman 2006) this suggests that the hippocampus-specific effects of time are not associated with
long-term surgery-induced BBB disruption.
Ultimately it is unclear what is responsible for the consistent effect of time on hippocampal
values. At rest, this seems to be linked to low rates of neuronal oxygen metabolism that increase,
whilst in neurovascular coupling events, the magnitude of CMRO2 responses is elevated to begin
with before decreasing. This suggests that the underlying mechanism is associated with an initial
down-regulation of hippocampal neuronal activity at rest, though during peaks in neuronal activity,
it promotes greater synchronisation in neuronal responses.
5.4.4 Uncoupling of Oxygen Availability and Neuronal Metabolism in the Hippo-
campus at Rest
As discussed in the post-mortem tissue Chapter 3, the hippocampus has a lower capillary density
and mean capillary radius than the cortex, though appears to posses equal, if not greater, neuronal
energy demands (neuronal density in Keller et al. 2018; glucose uptake and utilisation in Klein-
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ridders et al. 2018 and Zeller et al. 1997). As a result, one would predict the hippocampus to have
a lower blood volume and level of oxygen availability, despite similar, if not greater, levels of
CMRO2. This could be responsible for its enhanced susceptibility to pathology (hypoxia Ng et al.
1989; Alzheimer’s Disease Michaelis 2012) relative to other brain areas.
Resting data analysis limited to timepoints where the hippocampus-specific effects of time
appeared to plateau (Fig 5.8) revealed that, as predicted, the hippocampus possesses significantly
lower levels of oxygen saturation and blood volume, despite a similar, if not greater, rate of neur-
onal oxygen metabolism relative to the cortex. This was reflected by a decreased ratio of SO2 and
HbT to CMRO2. These results indicate that the hippocampus at rest shows a relative degree of
neurovascular uncoupling with regards to oxygen availability. Interestingly, a decrease in blood
volume was not associated with differences in overall levels of perfusion (CBF). Whilst this could
result from compensatory increases in hippocampal flow speed, this did not differ between regions.
However, it should be noted that though non-significant, hippocampal CBF was reduced relative
to the cortex.
5.4.5 Neurovascular Coupling is Consistent Between Brain Regions, but Mechan-
isms Differ
My post-mortem results showed a reduction in the variation of capillary radii in the hippocampus
relative to the cortex, which suggested a relatively poorer ability to regulate vascular diameter
changes. This was proposed to be associated with a degree of hippocampal neurovascular uncoup-
ling during peaks in neuronal activity, unless this was compensated for by increases in flow speed.
To investigate this, data was cut around peaks in the CMRO2 signal (Fig 5.2), which represents
summed neuronal activity. This revealed that during peaks in neuronal activity, the magnitude of
the hippocampal HbT and SO2 responses are reduced and elevated respectively. However, when
compared to the magnitude of the CMRO2 response, only HbT showed a significant reduction,
owing to the non-significant increase in CMRO2 seen in the hippocampus (Fig 5.10). These res-
ults indicate that the coupling of oxygen supply to neuronal activity during peaks in activity is
conserved between regions, though this is mediated to a greater extent in the cortex by increases
in blood volume. This was associated with a a trend towards increased flow speed in the hippocam-
pus. Overall, it appears that as predicted, the hippocampus demonstrates a reduction in its ability
to regulate vascular diameter during peaks in neuronal activity, but is able to maintain consistent
levels of neurovascular coupling of oxygen supply by increasing flow speed. This is contrasted
against the relatively worse ratio of oxygen supply to neuronal metabolism in the hippocampus at
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rest, implying that the functional ability of the hippocampal vasculature to support synchronised
neuronal activity can overcome anatomy-related deficits in neuronal support.
Whilst regional differences in neurovascular coupling have been reported (Devonshire et al.,
2012; Sloan et al., 2010), investigations into whether the underlying mechanisms vary are lacking.
This has been suggested by others (Hosford and Gourine, 2019) and is supported by modelling
work (in a preprint by Jafarian et al. 2019) though work on this area is in its infancy. It is possible
that the reduced ability of the hippocampus to regulate blood volume is related to the relatively
lower coverage of its capillary bed by pericytes seen in my post-mortem tissue results. Pericytes
can regulate capillary blood flow, which may be coupled to neuronal activity via neurotransmit-
ter stimulated astrocytic calcium signalling (reviewed by Fellin and Carmignoto 2004) that drives
astrocytic COX-1 activity and results in the generation of prostaglandins that can mediate the
relaxation of capillary pericytes (Hall et al., 2014). How the hippocampus regulates flow speed in-
creases however, is less obvious. Whilst initially it may seem this could be modulated by changes
in blood pressure, there is evidence that the velocity of red blood cells is maintained despite al-
terations in blood pressure (Hudetz et al. 1995, cited in a review of capillary blood flow by Itoh
and Suzuki 2012). Red blood cells can sense oxygen levels and regulate their own deformability
and therefore flow speed accordingly (Wei et al., 2016), and signalling to endothelial cells from
vascular components, such as red blood cells and leukocytes, has been suggested to also regulate
blood flow (Itoh and Suzuki, 2012). It may therefore be the case that neurovascular coupling in
the hippocampus relies more on red blood cell, and plasma constituent signalling mechanisms to
increase flow speed, whilst in the cortex, greater coverage by pericytes helps to mediate neuronally
stimulated increases in blood volume.
5.4.6 HFD Affects Cortical Neuronal Activity and Haemodynamic Regulation at
Rest
In Chapter 3 I showed that two weeks of HFD feeding, as assessed in post-mortem tissue, reduced
both capillary radii and the extent of capillary perfusion in the cortex and hippocampus. This sug-
gested that in vivo, HFD feeding could induce an overall reduction in blood volume and CBF in
both brain areas. Unexpectedly, dietary effects at rest were specific to the cortex, where within the
first week of HFD feeding speed and CBF values were increased, correlating with non-significant
increases in CMRO2 (Fig 5.9). This was not associated with any degree of neurovascular uncoup-
ling, as neither the ratio of HbT nor SO2 to CMRO2 was affected by diet in the first week. These
results suggest that HFD feeding leads to early increases in cortical neuronal activity, which is
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associated with an elevated flow speed that maintains neurovascular coupling. This could relate to
an imbalance in excitatory vs inhibitory neurotransmission, which HFD feeding seems capable of
inducing. Models of HFD and obesity have been associated with a reduction in GABA levels in
the hippocampus (Sandoval-Salazar et al., 2016) and prefrontal (Hassan et al., 2018) and frontal
(Sandoval-Salazar et al., 2016) cortices. In addition, gephyrin, a protein associated with inhibit-
ory neurotransmission, is reduced in the hippocampus and cortex following HFD feeding (Lizarbe
et al., 2019), and the intensity of perineuronal nets, the degradation of which reduces GABAergic
firing rates (Balmer, 2016), was reduced by HFD in the prefrontal cortex (Dingess et al., 2018).
Finally, rodents fed a HFD show reductions in parvalbumin neurons, a major class of GABAergic
interneurons, in the prefrontal cortex and hippocampus (Lowe et al., 2019). Though no studies
as of yet have investigated the dietary effects on overall inhibitory vs excitatory cortical tone at
as an early a time as one week of HFD feeding, my results suggest that early effects on cortical
neurotransmission exist.
Additionally, the ratio of HbT to CMRO2 was reduced by HFD feeding at the 14 day timepoint
in the cortex. As with changes in the first week, this seems driven by a non-significant increase
in CMRO2, but unlike those changes, this was associated with an impairment in the coupling of
blood volume to neuronal activity. The elevated CMRO2 level could, again, be related to changes
in neuronal transmission, whilst the reduction in the HbT to CMRO2 ratio may derive from the
HFD induced reduction in capillary radii detected after 14 days in my post-mortem results. This
reduction was seem in both cortex and hippocampus, but appears insufficient to change overall in
vivo HbT levels in either region. If the HFD induced reduction in capillary radii is responsible
for the impaired HbT to CMRO2 ratio, it may be the case that this change is transient, given the
ratio was maintained at other timepoints. Otherwise it is possible that a compensatory dilation of
non-capillary vessels, intended to maintain homeostatic levels of blood volume due to reductions
in capillary radii, may be affected at the two week point.
Whilst these results suggest that HFD feeding induces a biphasic elevation in neuronal oxygen
metabolism at days 3 and 14 in the cortex, pairwise comparisons at these timepoints were non-
significant. In addition, the possibility that the dietary effects on speed, CBF, and the HbT to
CMRO2 ratio, are the result of time-related noise must also be considered. Whilst I am confident
in the presence of cortical dietary effects within the first week of HFD feeding, given that speed,
CBF, and CMRO2 values are elevated by HFD feeding at both 3 and 7 days, the fact that these
values, and the HbT to CMRO2 ratio, only appear to be affected at day 14, but not days 10 or
21, makes this effect the more likely of the two to be related to noise. In future, imaging more
timepoints around day 14 (e.g. days 10, 12, 14, 16, and 18) could help to establish whether the
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effect detected here is spurious or legitimate. Otherwise, evidence from both resting, and visually
stimulated neurovascular coupling experiments, appears to indicate the presence of early (within
the first week) HFD induced dysfunctions in the cortex.
The Absence of Hippocampal Dietary Effects
The absence of any dietary effects on resting hippocampal values was unexpected, given that
the my post-mortem tissue experiments showed HFD induced reductions in capillary radii and
perfusion levels in both regions, and that the literature supports HFD induced neuronal effects (i.e.
inhibition of GABAergic tone) in both regions as well (Lizarbe et al., 2019; Lowe et al., 2019).
This may come down to timepoint specific regional effects of dietary manipulation, where longer
dietary manipulation might be necessary to observe similar changes in the hippocampus as those
that appear to be present early on in the cortex.
The existence of timepoint specific dietary effects on the hippocampus seems apparent in the
literature, where neither 6, nor 6.5 months, of HFD feeding changed hippocampal microvascular
blood flow or volume (Fu et al., 2017) or CBF (Zuloaga et al., 2016). In comparison, Gomez-Smith
et al. (2018) demonstrated an increased resting CBF in the hippocampus of rats fed a cafeteria diet
for 3 months, that they suggest could be related to an elevated cerebral metabolic rate, as seems to
be the case in the early cortical dietary effects I detect. These studies show that whilst 3 months of
dietary manipulation may be sufficient to induce CMRO2 and CBF changes in the hippocampus,
these are no longer present at the six month timepoint, highlighting not only that dietary effects
on the hippocampus may be timepoint-specific, but that they also may take longer than 2 months
to appear.
5.4.7 Hippocampus-Specific HFD-Induced Vascular Dysfunction during Neurovas-
cular Coupling
In Chapter 3 I reported that HFD feeding reduced the variation in the radii of capillaries in both
the hippocampus and cortex after two weeks. This was proposed to reflect a reduction in the
ability of both regions to modulate the resistance in their capillary bed, which could be linked to
deficits in neurovascular coupling. To investigate this in both regions, data were cut around peaks
detected in the CMRO2 signal that reflects peaks in neuronal activity. Unexpectedly, this analysis
revealed exclusive dietary effects in the hippocampus (Fig 5.11). Here it appeared that HFD
elevated deoxyhaemoglobin levels during the second week, which correlated with non-significant
HbT increases, indicating that two weeks of HFD feeding leads to an increase in the magnitude of
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the blood volume response during peaks in neuronal activity, but this is predominantly associated
with greater levels of deoxyhaemoglobin. This may indicate the presence of dysfunctional oxygen
exchange, and seems unrelated to issues in linking blood supply to oxygen metabolism as the
ratio of both HbT and SO2 to CMRO2 was unaffected by diet. There was an additional dietary
effect detected at day 35, where hippocampal flow speed was elevated by HFD, which correlated
with a non-significant increase in CBF. This appears to be an exaggerated response to a non-
significant elevation in CMRO2 levels at the same timepoint, and again, may reflect some degree
of dysfunction in the regulation of haemodynamic responses. As stated previously however, to
confirm that this is not a spurious effect relating to noise, future work should look at additional
timepoints closer to 35 days to see if this effect is consistent.
Unlike the resting data analysis, where HFD associated effects on CMRO2 and vascular para-
meters occurred exclusively in the cortex, these results indicate that during peaks in neuronal activ-
ity the hippocampus shows dysfunctional HFD-induced changes in haemodynamic responses. The
hippocampus-specific nature of these effects could link to the hippocampus-specific cognitive de-
ficits induced by 24 hours of HFD feeding (McLean et al., 2018) that persist for 30 days (Kanoski
and Davidson, 2010) given that synchronised peaks in neuronal activity are likely more similar to
the neuronal processing involved in task performance than those occurring at rest. The absence
of any dietary effects on CPA data in the cortex suggests that it is only at rest that HFD induces
elevations in cortical CMRO2 levels. This may indicate that HFD promotes a blanket increase in
cortical activity, but that this has no relation to the size of individual neuronal events. Investigating
dietary differences in the rate of detected CMRO2 peak events in the cortex could shed further light
on this, where the elevation of cortical GABAergic tone proposed to occur may be associated with
a reduction in the rate of synchronised neuronal events.
A final point to make concerns the detection of dietary effects on cortical neurovascular coup-
ling associated with visual stimulation, but not when analysing CPA data. On one hand, this may
strengthen the argument that former are a consequence of time-related noise, but on the other this
difference could relate to the degree of associated neuronal activity in each analysis. Visually
stimulated neurovascular coupling in V1 is associated with a much greater degree of synchron-
ised neuronal activation than that seen in individual detected CMRO2 peaks, something supported
by the fact that V1 CMRO2 peak values were ∼30% above baseline in the visually stimulated
data, compared to ∼9% in the CPA analysis. It may therefore be the case that a greater degree
of synchronised neuronal activity is necessary to reveal HFD induced effects in V1 neurovascular
coupling.
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5.4.8 Hippocampal Vascular Responses Correlate with NOCR Behavioural Per-
formance but not Following HFD Feeding
The detection of HFD induced impairment in hippocampus-specific NOCR performance in a sub-
set of mice described in the post-mortem chapter, in conjunction with the detrimental HFD asso-
ciated reductions in capillary radii, radii variation, and perfusion, suggested that vascular changes
and behavioural performance could be correlated. Though this was not the case at rest, CPA data
analysis of hippocampal window mice that had undergone behavioural testing showed a negat-
ive correlation between the magnitude of the CMRO2 and CBF responses during CMRO2 peak
events with behavioural performance, but only in control diet animals. These results suggest that
improved hippocampal cognitive function is associated with a reduction in the magnitude of neur-
onal activity, and therefore also in the associated CBF response, during periods of synchronised
neuronal firing. This could reflect that better cognition is associated with more efficient hippocam-
pal neuronal activity. This may be explained by the neural efficiency hypothesis, which posits that
intelligence correlates negatively with brain activation and metabolic rates. A review of studies
that have looked into the validity of this suggests that it generally holds true, though it is modulated
by effects of task complexity, existing task expertise, and brain region (reviewed in Neubauer and
Fink 2009). Similar evidence comes from the finding that working memory training is associated
with a reduction in activity in the frontoparietal network (Aguirre et al., 2019). However, work in
this area is largely based in the cortex, and studies investigating the efficiency hypothesis in the
hippocampus appear to be few in number. One study demonstrated that female subjects showed
a negative correlation between measures of intelligence and reasoning and hippocampal volume
(Colom et al., 2013), providing evidence at least for a structural, if not functional, basis for the
efficiency hypothesis in the hippocampus. However, behavioural performance in HFD animals
showed no correlations with haemodynamic parameters in any of the analyses. This indicates
that the mechanisms that relate the magnitude of neuronal activity to cognitive performance are
altered in HFD animals, who as a result may have to engage alternate strategies to cope with
task-related demands. One such strategy could be over-recruitment, something observed in ageing
studies during low-load memory tasks that could be associated with processes that are beneficial
to performance (discussed in Suzuki et al. 2018), though my data shows an absence, rather than
a positive, correlation between neuronal activity and performance in the HFD group, suggesting
this particular strategy may not be at play.
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5.5 Conclusion
Analysis of haemodynamic parameters in both cortex and hippocampus over 8 weeks of dietary
manipulation supported the suggestions made based on post-mortem data analyses that the hippo-
campus has a poorer ratio between vascular support and oxygen supply and neuronal metabolism,
which may underlie its increased susceptibility to pathology and diet induced cognitive deficits.
Interestingly, CPA data analysis indicated a consistent level of neurovascular coupling between
cortex and hippocampus during peaks of neuronal activity, though the coupling of oxygen de-
livery to neuronal metabolism appears to rely more on changes in flow speed rather than blood
volume in the hippocampus. Future work should investigate the mechanisms involved in hippo-
campal flow speed regulation, which likely relate to signalling between plasma constituents and
endothelial cells, and the action of oxygen-sensing red blood cells.
The absence of HFD-induced changes in resting blood volume or compensatory increases in
flow speed, hypothesised to exist based on my post-mortem results, suggests that both the cortex
and hippocampus engage the dilation of non-capillary vessels to maintain blood volume homeo-
stasis. Resting data analysis revealed a cortex-specific HFD induced elevation of CMRO2 within
the first week, which could be linked to dietary effects on cortical GABAergic tone. Additionally,
at day 14, there was evidence of HFD induced uncoupling between CMRO2 and blood volume in
the cortex. These results suggested that dietary effects on cortical neurotransmission occur much
earlier than has been previously investigated, and that perhaps the engagement of compensatory
dilatory mechanisms impairs the ability of the cortical vasculature to respond to HFD-induced in-
creases in the basal levels of neuronal activity. This doesn’t seem to influence the haemodynamic
response to periods of synchronised neuronal activity however, given that no evidence of cortical
neurovascular uncoupling at day 14 was detected in either the visual stimulus or CPA data, im-
plying the effect seen at day 14 in the resting data could be due to noise. The presence of dietary
changes at day 3 in the cortex were however replicated in the visual stimulus analysis, where HFD
was associated with an dysfunctional haemodynamic response in flow speed and CBF regulation,
suggested to relate to dietary effects on astrocyte to vessel signalling.
Whilst resting data analysis showed cortex-specific dietary effects, CPA analysis was associ-
ated with dietary effects exclusively in the hippocampus. The regional differences between the
two analyses may be down to the magnitude of neuronal responses, and region-specific dietary
effects on vascular mechanisms engaged at rest or during neurovascular coupling events. The
hippocampus-specific CPA dietary effects were interpreted as reflecting HFD-induced dysfunc-
tion in haemodynamic regulation taking place during the second week of dietary manipulation.
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These results suggest that during the first two months of dietary manipulation, diet does not influ-
ence neurovascular coupling during peaks of neuronal activity in V1, though following two weeks
of HFD feeding it appears to disrupt this process in the hippocampus. At rest however, the hippo-
campus is resistant to dietary effects, whilst one week of manipulation appears to induce a large
scale elevation of neuronal activity in the cortex.
The magnitude of the peaks in neuronal activity detected in the CPA analysis correlated negat-
ively with hippocampal cognition exclusively in control animals. This may be the result of animals
with more efficient neural processing performing better, a theory that fits with the neural efficiency
hypothesis. In HFD animals this relationship was absent and the animals that performed well on
the NOCR task may have instead used alternative task-related strategies.
Finally, it was suggested that hippocampal window implantation surgery may be associated
with long-term changes in neuronal activity, and results demonstrated that during visually stim-
ulated neuronal activity in V1, locomotion accelerates haemodynamic responses and increases
blood volume.
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Chapter 6
General Discussion
6.1 Main Findings
The primary aim of the work described in this thesis was to investigate the mechanisms underly-
ing the rapid, hippocampus-specific, cognitive deficits induced by HFD feeding (McLean et al.,
2018; Kanoski and Davidson, 2010). I hypothesised that this would be related to either immune
or vascular changes, or both, and that in order for these changes to have hippocampus-specific
cognitive effects, they would either be present in a hippocampus-specific manner, or that by being
present across multiple brain regions, would have an elevated detrimental effect on hippocampal
processing given its enhanced susceptibility to pathology. To investigate this I used immunofluor-
escence imaging approaches in both post-mortem tissue and awake behaving animals that were
fed a HFD.
textbfChapter 3 looked at changes in post-mortem tissue following two weeks of HFD feeding
in the hypothalamus, hippocampus and cortex. This allowed me to evaluate the nature of short-
term dietary vascular and immune changes. I tested mice on a hippocampus-specific cognitive task
to confirm the presence of cognitive deficits in my model. I found that short-term HFD feeding
was associated with a trend towards impaired hippocampal cognition, as well as global microglial
proliferation (without morphological changes) and global impairments in vascular structure, spe-
cifically a decreased capillary luminal radius, an increased resistance to perfusion, and a reduction
in the variation of capillary radii measurements. In addition, compared to other brain regions,
the hippocampus had a lower vessel density, capillary radius, variation in capillary radius, and a
greater spacing between pericytes. These results suggested that short-term HFD feeding is associ-
ated with global priming (but not activation) of microglia, and deficits in the ability of the capillary
bed to support neuronal activity, which likely had a greater effect on hippocampus-specific cogni-
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tion given its impoverished level of vascular support at baseline.
Chapter 4 expanded upon this work by investigating changes in microglial morphology over
an 8 week dietary manipulation in vivo to look into how the results after two weeks described in
Chapter 3 related to the overall timecourse of dietary effects. In addition, analysis of hippocampus-
specific behaviour was expanded to include these in vivo imaging mice. These results revealed
that including the in vivo mice abolished the trend towards decreased hippocampal cognition in
the HFD group, that HFD feeding did not affect hippocampal or cortical microglial morphology
at any point over the 8 week manipulation, and that hippocampus-specific cognitive performance
did not correlate with microglial morphology in the hippocampus. These findings indicated that
the genotype of in vivo mice may have had an influence on the cognitive effects of dietary manip-
ulation, but also that vascular rather than inflammatory changes were likely more responsible for
the rapid appearance of hippocampus-specific cognitive deficits.
Chapter 5 looked at in vivo measures of blood flow over an 8 week dietary timecourse to
further investigate the suggestions from Chapter 3 that vascular changes could underlie cognit-
ive impairment. Results showed that the hippocampus has a worse ratio of oxygen availability
to neuronal metabolism than the cortex at rest, but that during peaks in neuronal activity both
regions show similar ratios between the two. Neurovascular coupling in the cortex appeared to
be more dependent on changes in blood volume, whilst in the hippocampus it seemed to rely
more on changes in blood flow speed. Finally, performance on a hippocampus-specific cognitive
task correlated negatively with the magnitude of the haemodynamic and neural response during
peaks in neuronal activity in the hippocampus in control animals, but in HFD fed animals this
relationship was absent. These results provided in vivo evidence that the elevated susceptibility
of the hippocampus to pathology likely results from its poor ratio of vascular support to neuronal
activity (compared to the cortex), and that the mechanisms driving hippocampal neurovascular
coupling differed from those in cortex. Lastly, it appears that short-term HFD feeding may lead
to hippocampus-specific cognitive impairment by disrupting the relationship between haemody-
namic responses and cognitive performance.
Overall, data presented in this thesis provides a new insight into the causes of HFD induced
hippocampus-specific cognitive impairment, and a greater understanding of the mechanisms un-
derlying the elevated susceptibility of the hippocampus to damage.
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6.2 Diet-Induced Weight Gain
In order to evaluate the effect of my HFD manipulation on weight gain, I analysed changes in
weight (normalised to weight at baseline) over the duration of HFD feeding. The results of this
have raised a number of interesting points regarding the effects of behavioural testing, age, sex,
and genotype, on the impact of HFD feeding on weight. Whilst the mice I used for post-mortem
immunofluorescence experiments showed an elevated rate of weight gain in response to a HFD,
with a non-significant difference in weight apparent after the very first day (reaching trend level by
day 14), those used for behavioural testing (who were not also used for in vivo imaging) showed
a very clear absence of dietary effect on weight gain. In addition, the in vivo imaging mice I used
were resistant to the effects of HFD on weight gain (whilst it did appear to increase their weight
and rate of weight gain, this was to a far lesser extent than the immunofluorescence mice).
Other studies have generally shown that HFD feeding in mice leads to differences in weight
very rapidly. Though the rate of this also depends on dietary fat content (typically either 45% or
60%) given a positive relationship exists in both rats and mice between dietary fat content and
body weight or fat gain (reviewed in Hariri and Thibault 2010), Ouyang et al. (2014) show a 45%
diet leads to a difference in weight after a week, and significant weight increases from four weeks
onwards. Diets composed of 60% fat are associated with significant weight increases after as little
as 3 days (Jais et al., 2016; McLean et al., 2018), with non-significant increases reported in work
by Kim et al. (2008) after a week and in McLean et al. (2018) after 2 days. The timecourse of
these changes fits with the results described for my immunofluorescence mice, who it must also
be remembered varied in age and sex. Male mice are more susceptible to HFD-induced weight
gain (Hwang et al., 2010), with old mice seen to be more susceptible to the metabolic effects of
HFD feeding (Nunes-Souza et al., 2016). A significant difference in weight was only detected in
aged (54-56 week old) mice from 8 weeks onwards during 60% HFD feeding, something that was
not detected over 14 weeks in young (6-8 week old) mice though they did show reduced glucose
tolerance, hyperlipidaemia, and elevated abdominal fat levels. Neither sex nor age significantly
affected weight in any of my statistical analyses however, with this perhaps related to the fact
that significant differences in diet-induced weight gain between sexes only emerges from 4 weeks
onwards (Hwang et al., 2010), and the age of the oldest mouse I used (36 weeks) was still some
way away from the aged category in Nunes-Souza et al. (2016).
With regards to the absence of dietary effects on weight gain in the mice used for behavioural
testing (who were not also used for in vivo imaging), this appeared unrelated to sex or age effects
given neither of these differed significantly from the immunofluorescence mice. Here it is possible
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that the extra handling involved in behavioural testing played a role in disrupting eating behaviours
or elevating stress levels, thereby influencing dietary effects on weight. This could also be at play
in the in vivo mouse results, who showed resistance to HFD effects on weight gain, and were also
handled more often and exposed to more stressors due to the in vivo imaging sessions. Another
factor to consider is the role that genotype could play in modulating susceptibility to diet-induced
weight gain.
None of the immunofluorescence mice were wild type C57BL/6J mice, unlike the cohort of
non in vivo behavioural mice. Immunofluorescence mice had either one, or both, of two reporter
mutations. These were the NG2-DsRed mutation and the Cx3CR1-GFP mutation. Whilst no work
has been published looking at the influence of the former on diet-induced obesity, the latter has
been investigated. The Cx3CR1-GFP mutation involves the knockout of the Cx3CR1 gene, which
is involved in monocyte function (Lee et al. (2010) introduce the effects of Cx3CR1 dysfunction).
As a result, all mice used were only heterozygous for this mutation. Complete Cx3CR1 deficiency
protects against obesity and the inflammation of visceral adipose tissue (Polyák et al., 2014), with
partial deficiency also associated with resistance to diet-induced weight gain and cognitive impair-
ment (Cope et al., 2018). With regards to interpreting my own results, this would suggest that if
anything, the immunofluorescence mice should show greater resistance to diet induced weight
gain than the behavioural cohort, the opposite of what I observed. This suggests the disruption
and stress associated with behavioural testing is the main factor driving the absence of dietary ef-
fects on weight seen in the behavioural cohort. However, the implications of Cx3CR1 deficiency
on diet-induced weight gain are relevant for my in vivo mice, given these were all heterozygous for
the Cx3CR1-GFP mutation. Here it is quite possible that their resistance to diet-induced weight
gain relative to the immunofluorescence mice (of whom Cx3CR1-GFP mutants were a minority)
is the result of their genotype, with HFD immunofluorescence animals showing a 20% increase
relative to their starting weight after two weeks, in comparison to the roughly 7% increase seen
after two weeks in the Cx3CR1-GFP in vivo mice. However, the influence of in vivo associated
stress must also not be discounted.
6.3 Hippocampus-Specific Cognitive Deficits
Besides its influence on HFD-induced weight gain, the Cx3CR1-GFP mutation has also been
reported to impart resistance to dietary effects on cognition (Cope et al., 2018). This could explain
the discrepancy in my NOCR results, given that when analysis was restricted to the wild type,
non in vivo mice, there was a trend towards impaired cognition in HFD mice, with this trend being
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abolished by the inclusion of Cx3CR1-GFP in vivo mice in the analysis. This is in stark contrast to
other HFD studies that have reported rapid hippocampus-specific cognitive impairments following
HFD feeding (McLean et al., 2018; Kanoski and Davidson, 2010). Complete Cx3CR1 knockdown
is associated with impairments in cognition and synaptic plasticity (Rogers et al., 2011), with
its partial deficiency in Cx3CR1-GFP mice protecting against HFD-induced impairments in the
hippocampus-dependent object location task (Cope et al., 2018). It is therefore quite possible
that this is responsible for the difference in dietary effects on NOCR reported in Chapters 3
and 4, although it should be noted that genotype did not significantly affect performance in my
statistical analysis. This could well be related to the lack of power in my NOCR results, as these
are only based on 20 mice and therefore lack sufficient power to evaluate the differential effects
of both diet and genotype, particularly given the fact that behavioural data can be highly variable.
It should be mentioned that whilst testing mice of mixed sex and age also may have influenced
results (given that sex and age influence HFD-induced weight gain, they likely also mediate its
cognitive effects), neither factor had a significant effect on performance in my analysis (though
my study was underpowered) and the NOCR task has previously been shown to be unaffected by
differences in sex in rats (Ramsaran et al., 2016). An additional factor that may have influenced
NOCR performance is the impact of hippocampal window implantation.
Hippocampal window surgery is associated with aspiration of the cortex overlying dorsal CA1,
however, the cognitive task I used (NOCR) is hippocampus-specific (Mumby et al., 2002; Balderas
et al., 2008) so should be unaffected by cortical changes. In addition, Dombeck et al. (2010) report
that the cortical areas aspirated do not provide strong direct projections to the hippocampus. In
another study that used the same surgery, Gu et al. (2014) report that the hippocampal window sur-
gery did not influence performance on an open-field and contextual fear-conditioning paradigm.
It is however possible that hippocampal window implantation influences the mechanisms respons-
ible for mediating the detrimental effect of HFD on hippocampal cognition, and that this could
also be contributing to the abolishment of the diet induced NOCR deficits reported in Chapter 3.
Future work should look at post-mortem tissue from hippocampal window mice fed a HFD for
2 weeks to see how the immune and vascular changes in their tissue compare to that I report in
Chapter 3 to see if this theory hold true.
6.4 Phasic Microglial Activation and Microglial Priming
HFD feeding has previously been associated with the early appearance of neuroinflammation, seen
in the hypothalamus after only 24 hours in terms of elevations in the mRNA levels of proinflam-
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matory cytokines (Thaler et al., 2012), although there are also numerous studies that report a lack
of such early inflammatory responses. No change in hippocampal microglial morphology (Spen-
cer et al., 2019), or hypothalamic (Baufeld et al., 2016) morphology and density, was seen after
3 days of HFD feeding. The latter study also showed no increase in hypothalamic density after
4 weeks, though by 8 weeks this was apparent (Baufeld et al., 2016). My own results after two
weeks of HFD in post mortem tissue showed an increase in the cell density of microglia globally,
although this was not accompanied by any changes in microglial ramification, with increases in
microglial density and changes in morphology and ramification correlating with microglial activ-
ation and inflammation (microglia reviewed in Kettenmann et al. (2011) and Hanisch and Kett-
enmann 2007). The uncoupling of proliferation from morphological changes could indicate the
presence microglial priming rather than overt activation, given that primed microglia show signs
of activation such as proliferation (priming reviewed in Li et al. 2018) though they show less dis-
tinct morphological changes (they remain highly ramified despite showing larger and less-round
somata than resting cells; Torres-Platas et al. 2014) and do not produce inflammatory cytokines
(Perry and Holmes (2014) cited by Hoogland et al. 2018). To evaluate this theory I analysed the
effect of LPS on microglial morphology in vivo given that primed microglia show an elevated
response to secondary inflammatory stimuli (microglial priming reviewed in Perry and Holmes
2014).
My results revealed no effect of HFD feeding on the morphological response of microglia
to LPS, suggesting that HFD does not prime microglia in my model, despite the fact that HFD
induced priming in the hippocampus (Sobesky et al., 2016) and hypothalamus (Souza et al., 2019)
after only 3 days has been reported. However, I used a far stronger dosage of LPS than in other
priming studies. I used 4mg/kg, a much higher dose than the 10 µg/kg used in Sobesky et al.
(2016), whose dosage was chosen in order to avoid the possibility of a large inflammatory response
masking signs of priming. Indeed, my strong dosage likely did just that, and means that my results
cannot be used to rule out the presence of microglial priming in my model. The reason I used such
a high dosage was to induce robust microglial activation that could be used as a positive control
when designing my analysis methods to detect morphological changes associated with microglial
activation.
An alternative explanation for the uncoupling of microglial proliferation from ramification
changes is that a transient phase of microglial activation occurred prior to the two week timepoint,
resulting in an elevated density of microglial cells that were no longer activated by two weeks.
This theory is supported by Thaler et al. (2012), who show that proinflammatory cytokine pro-
duction in the hypothalamus peaks initially before subsiding after one week, and then returns to
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elevated levels by 28 days. In their results this is coupled with significantly elevated microglial
densities at 3, 7, and 14 days (no data was provided for 28 days), suggesting the initial cytokine
peak leads to microglial cell density increases that persist beyond the transient cytokine produc-
tion dip. I evaluated this theory by tracking changes in microglial morphology (as an indicator of
inflammatory activation) at timepoints prior to the two week timepoint in vivo. Here my results
showed no effect of HFD on microglial morphology, suggesting that unlike in the hypothalamus,
neither the hippocampus or cortex show a phasic inflammatory response prior to the two week
timepoint. However, it is quite possible that once again, the effect of Cx3CR1-GFP heterozygos-
ity in the in vivo mice played a role. Cope et al. (2018) provide evidence that in contrast to wild
type C57BL/6J mice, Cx3CR1-GFP hippocampal microglia showed no activation associated mor-
phological changes in response to 12 weeks of HFD feeding. As such, it may indeed be the case
that HFD feeding leads to phasic inflammatory activation in the hippocampus and cortex prior to
the 2 week timepoint, but not in Cx3CR1-GFP heterozygotes. Ultimately, to properly evaluate the
phasic microglial activation and microglial priming theories, more work must be done to look at
transient microglial activation using a genotype that is not potentially resistant to dietary effects,
and with a more appropriate dosage of LPS.
6.5 Dietary Vascular Changes
Whilst HFD induced vascular changes have been reported both in terms of blood flow and struc-
tural changes, with HFD feeding associated with reduced vascular diameters (He et al., 2016;
Constantinescu et al., 2011) and levels of blood flow (Glaser et al., 2012; Obadia et al., 2017),
these have so far not been investigated following short-term HFD feeding. My post mortem tissue
work in Chapter 3 addressed this, and showed that following two weeks of HFD feeding capil-
lary luminal radii are reduced, the resistance to flow in capillaries is increased, and the variation
in capillary luminal radii is reduced. These changes occurred across the hippocampus, hypothal-
amus, and cortex, and suggested that early impairments in blood flow and neurovascular coupling
could underlie HFD-induced cognitive deficits. I investigated this further in vivo, where my results
showed that after 14 days of HFD there was no decrease in blood volume as might be expected
given the reduction in capillary radii and perfusion seen in my post-mortem experiments. In fact,
no effect of HFD on blood volume was detected at any point over the 56 days of dietary manipula-
tion, suggesting that non-capillary vessels dilate in order to compensate for the decreased capillary
radii observed in the post-mortem data (given the in vivo measures didn’t look exclusively at the
capillary bed, as my post mortem tissue analysis did). In addition, neither flow speed nor CBF
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showed any overall affects of diet. These results seem to fit with other longer-term studies, where
dietary effects on blood flow are inconsistent. Twenty weeks of HFD in rats was associated with a
reduced CBF (Obadia et al., 2017), whilst Fu et al. (2017) reported no effect of HFD on microvas-
cular flow or blood volume in the hippocampus of rats after 6 months, and Zuloaga et al. (2016)
saw no effect of 6.5 months of HFD feeding on either cortical or hippocampal blood flow in mice.
Ultimately, whilst in vivo haemodynamic regulation seems resistant to dietary structural changes
in the capillary bed, it may be the case that the engagement of the compensatory mechanisms that
they encourage could be related to the development of HFD-induced cognitive deficits.
With regards to neurovascular coupling, HFD feeding appeared to have no effect, although
there was the suggestion of some form of haemodynamic dysfunction in both the hippocampus and
cortex. The lack of a correlation between a reduction in capillary radii variation in my post-mortem
tissue (which reflects an impoverished ability of the vasculature to locally regulate dilations) with
in vivo measures of neurovascular coupling is surprising. This suggests that HFD-induced deficits
in neurovascular coupling do not play a role in early HFD-induced cognitive deficits. It may be
the case that despite a reduction in dilatory capacity at basal levels (as would be detected in post-
mortem tissue), short-term HFD does not impair the ability of the vasculature to respond to peaks
in neuronal activity to a large enough degree to lead to neurovascular uncoupling. In addition,
my in vivo data suggests that neurovascular coupling in the hippocampus relies more on flow
speed regulation then vascular dilations, another reason why changes in dilatory capacity would
not influence hippocampal neurovascular coupling.
However, whilst neurovascular coupling was largely resistant to HFD, the relationship between
the magnitude of CBF responses during peaks in neuronal activity and cognitive performance was
affected by HFD. Here there was a negative correlation between the magnitude of CBF responses
during peaks of neuronal activity in the hippocampus and performance on the NOCR task in con-
trol animals, but not in HFD animals. The negative correlation in control animals could relate to
the neural efficiency hypothesis that proposes intelligence correlates negatively with brain activ-
ation and metabolic rates (evidence reviewed in Neubauer and Fink 2009). What this means for
HFD feeding however is less clear. Short-term HFD feeding could lead to hippocampus-specific
cognitive deficits by disrupting the mechanisms underlying the relationship between neural effi-
ciency and cognition, leading to HFD fed animals having to use less effective non-hippocampal
strategies to cope with task demands. There is some evidence of this in Kesby et al. (2015), where
HFD fed animals showed a difference in strategies used on the Barnes maze, whilst rats fed a
HFD after weaning used a different strategy on the Morris water maze (Boukouvalas et al., 2008).
My results shed light on what appears to be a relatively new avenue regarding cognition and HFD
168
research, and suggests more work should be done to investigate not only the differential use of
cognitive strategies in HFD studies, but also the mechanisms proposed to underlie the neural effi-
ciency hypothesis.
6.6 Hippocampal Susceptibility
With regards to the region-specific nature of dietary effects, across my results there is an absence
of strong evidence for hippocampus-specific dietary changes taking place, suggesting the global
detrimental effects of HFD feeding are translated into hippocampus-specific cognitive impairment
by the enhanced susceptibility of the hippocampus to pathology. My results provide evidence
that the increased susceptibility of the hippocampus to damage or pathology such as hypoxia (Ng
et al., 1989), Alzheimer’s disease, and ageing (reviewed in Fjell et al. 2014), is likely related to
its paucity of vascular support relative to its neuronal demand. In Chapter 3 I show that the
hippocampus has a lower capillary density, capillary radius, and capillary radius variation, than
the cortex, whilst my results in Chapter 5 extend this, demonstrating that at rest the ratio of
oxygen availability and blood volume to the rate of neuronal oxygen metabolism is reduced in
hippocampal CA1 relative to cortical V1. Whilst my post mortem tissue results reflect the work
of other studies that have looked at regional differences in vascular density (Klein et al., 1986;
Wu et al., 2004b; Bohn et al., 2016), my in vivo work represents what appears to be the first to
compare the hippocampus and cortex with regards to neuronal metabolism, blood volume, and
oxygen availability. The fact that hippocampus-specific cognition is more susceptible to the early
effects of HFD than hippocampus-independent behaviour (Cordner and Tamashiro, 2015), coupled
with the global dietary effects I report, suggests that it is this uncoupling of oxygen supply from
neuronal metabolism that underlies elevated hippocampal-susceptibility in HFD models.
6.7 Limitations
As pointed out in relevant sections, there are a number of limitations to the work presented in
this thesis. The most generously discussed of these is the role of partial Cx3CR1 deficiency, and
the role this may have in mediating dietary effects not only on weight gain, but also cognition
and microglial activation. This may have had an impact on my behavioural results, as well as
my analysis of microglial morphology changes in my in vivo timecourse experiments. Therefore,
future in vivo worked aimed at investigating dietary effects on microglia, and correlating this with
behaviour, should utilise alternative mouse lines that do not involve the knockdown or knockout of
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genes. Such lines include the CD11b-CreERT2; R26-tdTomato mice used by Füger et al. (2017),
or the newly generated Tmem119-EGFP reported in Kaiser and Feng (2019). In addition, the
Cx3CR1-GFP mutation labels not only resident microglia, but also circulating monocytes (Imai
et al., 1997), an additional limitation of my work given the high dosage of LPS I used in Chapter 4
likely led to the entry of peripheral immune cells (as documented in Rummel et al. 2010), mean-
ing my characterisation of the microglial morphological response to LPS was likely not limited
to microglia. This may also have been the case in my post mortem tissue experiments, given that
Iba1 also doesn’t label microglia exclusively (Greter et al., 2015), and the infiltration of circulat-
ing immune cells has been documented in models of short-term HFD feeding before (Valdearcos
et al., 2017). Use of the Tmem119-EGFP mutation in vivo, or an anti Tmem119 antibody in im-
munofluorescence experiments, would address this, as it only labels resident microglia (Kaiser
and Feng, 2019).
Other limitations to consider involve the use of mice of varied age and both sexes. Whilst
not limiting myself to a particular age range or sex allowed me to increase the sample size of my
studies, it also likely introduced extra variability into my results given the elevated susceptibility
of males to HFD induced weight gain (Hwang et al., 2010) and the modulation of dietary effects
on weight with age (Nunes-Souza et al., 2016). The fact that these factors mediate dietary effects
on weight suggests they likely also do so in other aspects of physiology. In future, limiting work
to male mice from 8 to 12 weeks of age (as is predominantly done in the field) would likely help
eliminate variability in results. An additional limitation, specific to my NOCR behavioural testing
and protein array results described in Chapter 3, is to do with sample size, where both were
underpowered. As a result, it is difficult to truly evaluate the effect of diet (and the other factors
analysed, such as surgery status, and cognitive performance) on hippocampus-specific cognition
and hippocampal protein expression. In future these studies need to be conducted with a larger
sample size. Additionally, a limitation specific to my investigation of HFD induced microglial
priming in Chapter 4 is the dose of LPS used, which likely induced a severe enough inflammatory
response that any evidence of a primed response to an inflammatory stimulus would be masked.
To address this, future work should utilise a much smaller dose, as in Sobesky et al. (2016), when
investigating the presence of dietary priming.
Additional limitations relate to the fact that in Chapter 3 the immunofluorescence results
were derived from mice that were not behaviourally tested and so therefore could not be directly
correlated with cognitive deficits, and that in Chapter 4 the cell density of microglia was not
quantified, making it unclear how similar the in vivo microglial results are to those in post-mortem
tissue, and therefore how helpful they are in explaining them. Addressing these limitations would
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require behaviourally testing mice used for immunofluorescence studies, and further analysing the
in vivo data I previously collected.
6.8 Future Directions
With regards to future directions, one of the most interesting avenues of future work centres on the
potential for phasic inflammatory responses to HFD outside of the hypothalamus. Besides tack-
ling this by addressing the limitations of my own work regarding my in vivo microglial studies,
this also requires an investigation of changes in the production of inflammatory cytokines in the
hippocampus and cortex over a similar timecourse to that used in Thaler et al. (2012), i.e. 1, 3, 7,
14, and 28 days, given this would provide a more sensitive measure of inflammation (as the mi-
croglial density and morphology measures in Thaler et al. (2012) showed no such phasic patterns).
In addition, by using a marker of circulating monocytes such as CCR2 (Saederup et al., 2010), the
question of whether circulating immune cells infiltrate brain regions other than the hypothalamus
during HFD feeding could be answered. In line with these suggestions, and given the role that
hypothalamic microglia play in mediating the effect of HFD on weight gain (Valdearcos et al.,
2017), it would be interesting to use a drug such as the CSF1R inhibitor PLX5622, which can
be used to selectively deplete microglia (Elmore et al., 2014), to see if the presence of microglia
mediates the detrimental effects of short-term HFD feeding on hippocampus-specific cognition.
In terms of vascular changes, investigating the possible existence of compensatory non-capillary
dilations following HFD feeding could help to explain my in vivo haemodynamic results, whilst
investigating whether the use of a vasodilator, such as hydralazine, is able to attenuate the det-
rimental effect of HFD on hippocampal cognition would be one of the first steps towards estab-
lishing a causative role for impaired capillary blood flow in HFD induced cognitive deficits. This
could be done in conjunction with a repeat of my in vivo work where I demonstrated the absence
of a negative correlation between the magnitude of the hippocampal CBF response to peaks in
neuronal activity and cognitive performance in HFD animals, in order to see if the use of a vas-
odilator is able to prevent the annulment of this relationship. In addition, measuring the magnitude
of neuronal responses during peaks in neuronal activity more directly (through calcium imaging
perhaps) and correlating this with behavioural performance could help to further investigate the
role of the neural efficiency hypothesis in diet-induced cognitive impairment. Lastly, though noisy,
visually stimulated neurovascular coupling data in Chapter 5 suggested there may be an effect of
short-term HFD on astrocytic regulation of neurovascular coupling. As such, investigating HFD
induced changes in COX-1 activity, and astrocyte to pericyte communication, could be a worth-
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while avenue of exploration.
Exploring the suggestion from my results that the hippocampus uses a different primary mech-
anism for neurovascular coupling than the cortex could also be very interesting. There is a lack
of research into region-specific neurovascular coupling mechanisms, with the suggestion from my
data that the hippocampus relies more on flow speed than blood volume regulation one of the first
region-specific mechanisms to be proposed as far as I am aware. This could be further investigated
by reducing hippocampal blood volume with a vasoconstrictor, and then comparing the ability of
the hippocampus to maintain oxygen availability during peaks in neuronal activity. Should this
be maintained, it would provide further evidence that hippocampal neurovascular coupling is not
critically dependent on blood flow regulation, though more investigation of how exactly the hippo-
campus could regulate flow speed is necessary in order to design future interventions to investigate
this. With regards to the trend over time seen in Chapter 5 for hippocampal haemodynamic values
to approach those in the cortex, I suggest this could be related to a down-regulation of hippocam-
pal neuronal activity at rest that elevates over time, whilst during peaks in neuronal activity, a
greater synchronisation in hippocampal neuronal responses declines over time. Investigating this
could help establish the mechanisms behind the results I report. In addition, taking Oxy-CBF
probe recordings from hippocampal window mice 12 weeks after surgery (or after a similarly long
recovery period), with no recording sessions prior, could help to establish if these changes are
associated with a return to baseline in the hippocampus following surgery, or if they are the result
of persistent detrimental effects of repeated recording sessions.
6.9 Conclusions
The work in this thesis aimed to uncover the mechanisms responsible for the rapid, hippocampus-
specific, cognitive impairment associated with HFD feeding. For the first time I provide evidence
that this is related to diet-induced dysfunction in the mechanisms that relate blood flow during
peaks in neuronal activity to cognitive performance (likely related to neural efficiency). In addi-
tion, my results suggests that a significant part of the elevated susceptibility of the hippocampus
to HFD is due to its poor ratio between vascular support and neuronal metabolism, which though
preserved relative to the cortex during neurovascular coupling events, is significantly reduced at
rest. This has implications for the elevated susceptibility of the hippocampus to a wide range of
pathologies. Though more work is needed to establish a role for phasic inflammatory changes
or microglial priming in the genesis of cognitive deficits, evidence suggests vascular rather than
inflammatory changes are the primary drivers.
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Appendix A
Appendix
A.1 In Vivo Microglial Changes
A.1.1 Components of the Inflammation Index
Figure legends are identical for all figures and tables presented in this subsection of the appendix.
Figure Legends A.1 - A.7
Analysis of LPS and Dietary Effects (A) The effect of LPS treatment split by region. (B) Dietary
and regional differences at the 14 day timepoint. (C) Changes over 8 weeks of dietary manipula-
tion (brackets and numbers in A, B indicate p values of corrected pairwise dietary comparisons.
In C D-1 refers to measurements taken a day before the beginning of dietary treatment, and hours
are relative to the the start of dietary manipulation. ’, *, **, ***, indicates p < .10, .05, .01, and
.001 respectively. LPS N = 333 cells (HFD: 198; Hippocampus: 135). N = 16 mice (HFD:10,
Hippocampus: 6). Day 14 N = 300 cells (HFD: 167; Hippocampus: 114). N = 22 mice (HFD: 12,
Hippocampus: 10). Timecourse N = 3992 cells (HFD: 2138; Hippocampus: 1365). N = 28 mice
(HFD: 14; Hippocampus: 11)).
Table Legends A.1 - A.7
Analysis Statistics. Analyses were run using LMMs to investigate the changes in response to LPS
treatment, two weeks of HFD feeding, and the 8 week dietary timecourse (numDF and denDF refer
to degrees of freedom. F and p values are rounded to 4 decimal places. Red text indicates signi-
ficance. Green text indicates trend level. Background shading indicates size of p value where
darker is larger. Sig shows significance indicator. Factor indicates factors in the model. Measure
indicates the model run. Colons indicate interaction effects).
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Figure A.1: Analysis of LPS and Dietary Effects on Soma Area.
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Table A.1: Soma Area Analysis Statistics.
Table A.2: Maximum Branch Length Analysis Statistics.
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Figure A.2: Analysis of LPS and Dietary Effects on Maximum Branch Length.
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Figure A.3: Analysis of LPS and Dietary Effects on the Log-log Regression Coefficient.
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Table A.3: Log-log Regression Coefficient Analysis Statistics.
Table A.4: Log-log Regression Intercept Analysis Statistics.
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Figure A.4: Analysis of LPS and Dietary Effects on the Log-log Regression Intercept.
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Figure A.5: Analysis of LPS and Dietary Effects on the Coefficient of Variation for All Radii.
214
Table A.5: Coefficient of Variation for All Radii Analysis Statistics.
Table A.6: Mean Radius from Circle’s Centre Analysis Statistics.
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Figure A.6: Analysis of LPS and Dietary Effects on the Mean Radius from Circle’s Centre.
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Figure A.7: Analysis of LPS and Dietary Effects on Lacunarity.
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Table A.7: Lacunarity Analysis Statistics.
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A.1.2 Motility Indices
Table legends are identical for all tables in this subsection so will be defined once here.
Table Legends A.8 - A.10
Analysis Statistics. Analyses were run using LMMs to investigate changes in the motility indices
(numDF and denDF refer to degrees of freedom. F and p values are rounded to 4 decimal places.
Red text indicates significance. Green text indicates trend level. Background shading indicates
size of p value where darker is larger. Sig shows significance indicator. Factor indicates factors in
the model. Measure indicates the motility index analysed. Colons indicate interaction effects).
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Table A.8: Statistics for the Effect of LPS on Motility Indices.
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Table A.9: Statistics for the Effects of Dietary Timecourse Treatment on Motility Indices.
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Table A.10: Statistics for the Effects of Two Weeks of HFD on Motility Indices.
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A.2 In Vivo Neurovascular and Blood Supply Changes
A.2.1 V1 Neurovascular Coupling
The Effect of Locomotion
Legend Figure A.8;
The Effect of Locomotion on V1 Neurovascular Coupling. The effect of locomotion on values
for peak, time to peak, time to onset, time to offset, AUC, and composite measure values, for
visual stimulus data collected from V1. Peak values are displayed as percentages of the baseline.
Timings are in seconds. ’Loco’ refers to trials with locomotion both during and preceding stim-
ulus presentation, ’No Loco’ refers to trials where no locomotion was present in either window.
The baseline period was the second preceding stimulus presentation. Timings are relative to the
beginning of stimulus trials, where stimulus presentation occurs from 5 to 10 seconds. Horizontal
lines indicate locomotion group means. Solid lines indicate significant (p < .05) differences. N =
17 (HFD: 8) animals; 148 sessions; 2135 (’Loco’:1146) stimulus presentations.
Dietary Timecourse
Legend A.9;
V1 Visual Stimulus Peak Values. Peak values as a proportion of baseline. ’Loco’ refers to
trials with locomotion both during and preceding stimulus presentation, ’No Loco’ refers to trials
where no locomotion was present in either window. The baseline period was the second preceding
stimulus presentation. Thick borders indicate diet by time interactions. Grey backgrounds
indicate diet by time by locomotion interactions. N = 17 (HFD: 8) animals; 148 sessions; 2135
(’Loco’:1146) stimulus presentations.
Legend A.10;
V1 Visual Stimulus AUC Values. Area under the curve measurements. ’Loco’ refers to trials with
locomotion both during and preceding stimulus presentation, ’No Loco’ refers to trials where no
locomotion was present in either window. The baseline period was the second preceding stimulus
presentation. Thick borders indicate diet by time interactions. Grey backgrounds indicate diet
by time by locomotion interactions. N = 17 (HFD: 8) animals; 148 sessions; 2135 (’Loco’:1146)
stimulus presentations.
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A.2.2 Resting Data
Regional Differences
Legend A.11;
Regional Differences In Resting Values. Differences in resting values restricted to the final three
imaging timepoints (D42, D49, D56) between regions (’V1’ refers to primary visual cortex, ’CA1’
refers to hippocampal CA1. Periods of rest were epochs where no locomotion or visual stimulation
occurred, or had occurred in the preceding one or five seconds respectively. Horizontal lines
indicate regional group means. Solid lines indicate significant (p < .05) differences. N = 18
(HFD: 10, CA1: 11) animals; 50 sessions; 845 resting epochs).
Dietary Timecourse
Legend A.12;
Resting Values Over The Dietary Timecourse. Epochs of rest were periods where no locomotion
or visual stimulation occurred, or had occurred in the preceding one or five seconds respectively.
Thick borders indicate diet by time interactions. Grey backgrounds indicate diet by time by
region interactions. * and ’ indicates p < .05 and < .10 respectively. N = 29 (HFD: 14) animals;
259 sessions; 4460 resting epochs).
Legend A.13;
Ratio of Resting Values to CMRO2 Over The Dietary Timecourse. Ratio of SO2 and HbT to
CMRO2 at rest. Epochs of rest were periods where no locomotion or visual stimulation occurred,
or had occurred in the preceding one or five seconds respectively. Thick borders indicate diet by
time interactions. Grey backgrounds indicate diet by time by region interactions. ** indicates p
< .01. N = 29 (HFD: 14) animals; 259 sessions; 4460 resting epochs)
A.2.3 CMRO2 Peak Aligned Data
Regional Differences
Legend A.14;
Regional Differences in CPA Data. Differences in CPA data by region for peak, time to peak,
time to onset, time to offset, AUC, and composite measure values. Peak values are displayed as
percentages of the baseline. Timings are in seconds. T2p for CMRO2 was not analysed as all
CMRO2 peaks were set to occur at 3 seconds. ’V1’ refers to primary visual cortex, ’CA1’ refers
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to hippocampal CA1. Data was cut around detected peaks in CMRO2 signal. Times are relative to
trial start (3s before CMRO2 peak). Horizontal lines indicate regional group means. Solid lines
indicate significant (p < .05) differences. N = 21 (HFD: 11, CA1: 11) animals; 57 sessions; 2720
CPA events.
Dietary Timecourse
Legend A.15;
CPA Peak Values. Peak values as a proportion of baseline (Data was cut around detected peaks
in CMRO2 signal. Thick borders indicate diet by time interactions. Grey backgrounds indicate
diet by time by region interactions. * and ** indicates p < .05 and < .01 respectively. N = 29
(HFD: 14) animals; 281 sessions; 13506 CPA events).
Legend A.16;
CPA AUC Values. Data was cut around detected peaks in CMRO2 signal. Thick borders indicate
diet by time interactions. Grey backgrounds indicate diet by time by region interactions. * and
** indicates p < .05 and < .01 respectively. N = 29 (HFD: 14) animals; 281 sessions; 13506 CPA
events.
Behavioural Correlations
Legend A.17;
Peak Value Correlations with NOCR. Analysis of CPA data at day 14, with NOCR performance
included as a factor. Peak values as percent of baseline are plotted on the y-axis. Novelty index
is plotted on the x-axis (CPA data is cut around detected peaks in CMRO2 signal. Novelty index
reflects the difference between the proportion of exploration time spent exploring novel versus
familiar objects. Dotted line indicates zero point where no difference exists in proportion of
exploration time spent with novel versus familiar objects. Plotted lines represent the estimated
marginal mean +/- 95% confidence intervals. These are predictions of the trend extracted from the
relevant LMM. Text boxes indicate the slope of the trends by diet groups, and the p value of diet
by performance interaction. * next to slope values indicates it is significantly different from zero.
N = 11 (HFD: 6); 11 sessions; 374 CPA events).
Legend A.18;
AUC Value Correlations with NOCR. Analysis of CPA data at day 14, with NOCR performance
included as a factor. AUC values are plotted on the y-axis. Novelty index is plotted on the x-axis
(CPA data is cut around detected peaks in CMRO2 signal. Novelty index reflects the difference
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between the proportion of exploration time spent exploring novel versus familiar objects. Dotted
line indicates zero point where no difference exists in proportion of exploration time spent with
novel versus familiar objects. Plotted lines represent the estimated marginal mean +/- 95% con-
fidence intervals. These are predictions of the trend extracted from the relevant LMM. Text boxes
indicate the slope of the trends by diet groups, and the p value of diet by performance interaction. *
next to slope values indicates it is significantly different from zero. N = 11 (HFD: 6); 11 sessions;
374 CPA events).
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Figure A.8: The Effect of Locomotion on V1 Neurovascular Coupling.
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Figure A.9: V1 Visual Stimulus Peak Values.
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Figure A.10: V1 Visual Stimulus AUC Values.
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Figure A.11: Regional Differences in Resting Values.
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Figure A.12: Resting Values Over the Dietary Timecourse.
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Figure A.13: Ratio of Resting Values to CMRO2 Over the Dietary Timecourse.
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Figure A.14: Regional Differences in CPA Data.
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Figure A.15: CPA Peak Values.
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Figure A.16: CPA AUC Values.
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Figure A.17: Peak Value Correlations with NOCR..
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Figure A.18: AUC Value Correlations with NOCR.
